Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (45956)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 28, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol 2016; 22(44): 9694-9705 [PMID: 27956793 DOI: 10.3748/wjg.v22.i44.9694] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i44/9694.htm |
| Number | Citing Articles |
| 1 |
Amitabha Ray. Tumor-linked HER2 expression: association with obesity and lipid-related microenvironment. Hormone Molecular Biology and Clinical Investigation 2017; 32(3) doi: 10.1515/hmbci-2017-0020
|
| 2 |
Mingming Chen, Shilei Yang, Yu Wu, Zirui Zhao, Xiaohan Zhai, Deshi Dong. High temperature requirement A1 in cancer: biomarker and therapeutic target. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02203-4
|
| 3 |
Peng Li, Yaoyue Hu, Ghislaine Scelo, Mikko Myrskylä, Pekka Martikainen. Pre-existing psychological disorders, diabetes, and pancreatic cancer: A population-based study of 38,952 Finns. Cancer Epidemiology 2023; 82: 102307 doi: 10.1016/j.canep.2022.102307
|
| 4 |
Huiling Li, Lujie Yuan, Yu Long, Hanyi Fang, Mengting Li, Qingyao Liu, Xiaotian Xia, Chunxia Qin, Yongxue Zhang, Xiaoli Lan, Yongkang Gai. Synthesis and Preclinical Evaluation of a 68Ga-Radiolabeled Peptide Targeting Very Late Antigen-3 for PET Imaging of Pancreatic Cancer. Molecular Pharmaceutics 2020; 17(8): 3000 doi: 10.1021/acs.molpharmaceut.0c00416
|
| 5 |
Yi Liu, Long Cheng, Xiangyang Song, Chao Li, Jiantao Zhang, Lei Wang. A TP53-associated immune prognostic signature for the prediction of the overall survival and therapeutic responses in pancreatic cancer. Mathematical Biosciences and Engineering 2022; 19(1): 191 doi: 10.3934/mbe.2022010
|
| 6 |
Yi‑Hang Yuan, Jian Zhou, Yan Zhang, Meng‑Dan Xu, Jing Wu, Wei Li, Meng‑Yao Wu, Dao‑Ming Li. Identification of key genes and pathways downstream of the β‑catenin‑TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10444
|
| 7 |
Microbiota Alterations in Gastrointestinal Cancers. Applied Sciences 2020; 10(2): 585 doi: 10.3390/app10020585
|
| 8 |
Gouling Zhan, Jianbing Hu, Shijian Da, Jie Weng, Chuanyi Zhou, Fang Wen, Songlian Liu, Fang Fang, Erdong Shen, Qiang Zhou, Pan Luo, Min Xu, Dahe Zhan, Yuqi Su. A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1110624
|
| 9 |
Yogesh Vohra, Carolyn M. Brown, Leticia R. Moczygemba, Lalan Wilfong. Evaluating the relationship between patient activation and health-related quality of life (HRQOL) in patients with pancreatic cancer (PwPC). Supportive Care in Cancer 2023; 31(3) doi: 10.1007/s00520-023-07632-7
|
| 10 |
Pranathi Tata, Piyush Gondaliya, Aditya Sunkaria, Akshay Srivastava, Kiran Kalia. Modulation of CD44, EGFR and RAC Pathway Genes (WAVE Complex) in Epithelial Cancers. Current Pharmaceutical Design 2019; 25(8): 833 doi: 10.2174/1381612825666190222143044
|
| 11 |
Feiyu Mao, Duguang Li, Zechang Xin, Yan Du, Xiaodong Wang, Peng Xu, Zhennan Li, Jianjun Qian, Jie Yao, Sumanta Chatterjee. High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/8868245
|
| 12 |
Shunsuke Watanabe, Jun Miyoshi, Masao Toki, Komei Kambayashi, Shuichi Kitada, Takeshi Nosaka, Tomoyuki Goto, Hirotaka Ota, Kazushige Ochiai, Koichi Gondo, Nobuhito Ikeuchi, Shujiro Tsuji, Kenji Nakamura, Junji Shibahara, Tadakazu Hisamatsu. Effectiveness of introducing a 20-gauge core biopsy needle with a core trap in EUS-FNA/B for diagnosing pancreatic cancer. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-020-01583-7
|
| 13 |
Xiaoman He, Yongzhou Li, Qing Chen, Lei Zheng, Jianyao Lou, Chuanshuai Lin, Jiali Gong, Yi Zhu, Yulian Wu. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. Cell Death & Differentiation 2022; 29(10): 1970 doi: 10.1038/s41418-022-00984-3
|
| 14 |
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer. 2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
|
| 15 |
Changqing Xie, Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry-Hrones, Melissa Walker, Cecilia Monge Bonilla, Bradford J. Wood, Deborah E. Citrin, Elizabeth M. Gil Ramirez, Freddy E. Escorcia, Bernadette Redd, Jonathan M. Hernandez, Jeremy L. Davis, Billel Gasmi, David Kleiner, Seth M. Steinberg, Jennifer C. Jones, Tim F. Greten. Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2020; 26(10): 2318 doi: 10.1158/1078-0432.CCR-19-3624
|
| 16 |
Abi Judit Vázquez-Ríos, Marta Alonso-Nocelo, Belén López Bouzo, Juan Ruiz-Bañobre, María de la Fuente. Handbook of Nanomaterials for Cancer Theranostics. 2018; : 199 doi: 10.1016/B978-0-12-813339-2.00008-6
|
| 17 |
Matthew A. Firpo, Kenneth M. Boucher, Josh Bleicher, Gayatri D. Khanderao, Alessandra Rosati, Katherine E. Poruk, Sama Kamal, Liberato Marzullo, Margot De Marco, Antonia Falco, Armando Genovese, Jessica M. Adler, Vincenzo De Laurenzi, Douglas G. Adler, Kajsa E. Affolter, Ignacio Garrido-Laguna, Courtney L. Scaife, M. Caterina Turco, Sean J. Mulvihill. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma. JCO Clinical Cancer Informatics 2023; (7) doi: 10.1200/CCI.22.00160
|
| 18 |
Rebekah Rittberg, Hanbo Zhang, Pascal Lambert, Robert Kudlovich, Christina A. Kim, David E. Dawe. Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy. Journal of Geriatric Oncology 2021; 12(1): 112 doi: 10.1016/j.jgo.2020.07.004
|
| 19 |
Navni Sharma, Vimal Arora. Strategies for drug targeting in pancreatic cancer. Pancreatology 2022; 22(7): 937 doi: 10.1016/j.pan.2022.08.001
|
| 20 |
Ut Kei Lou, Chi Hin Wong, Yangchao Chen. A simple and rapid colorimetric detection of serum lncRNA biomarkers for diagnosis of pancreatic cancer. RSC Advances 2020; 10(14): 8087 doi: 10.1039/C9RA07858D
|
| 21 |
Michelle A. Garlin Politis, Hyungsoon Im, Bob S. Carter, Johan Skog, Leonora Balaj, Cesar M. Castro, Hakho Lee. Circulating Tumor Cells. Current Cancer Research 2023; : 61 doi: 10.1007/978-3-031-22903-9_4
|
| 22 |
Asif Ahmad Bhat, Gaurav Gupta, Rajiv Dahiya, Riya Thapa, Archana Gahtori, Moyad Shahwan, Vikas Jakhmola, Abhishek Tiwari, Mahish Kumar, Harish Dureja, Sachin Kumar Singh, Kamal Dua, Vinoth Kumarasamy, Vetriselvan Subramaniyan. CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis. Non-coding RNA Research 2024; 9(2): 277 doi: 10.1016/j.ncrna.2024.01.013
|
| 23 |
Qianna Jin, Qianqian Ren, Xiaona Chang, Xiaoming Lu, Guobin Wang, Nan He. Pylorus‐preserving versus Pylorus‐resecting: Impact on dynamic changes of nutrition and body composition in pancreatic cancer patients before and after pancreatoduodenectomy. Cancer Medicine 2023; 12(3): 2713 doi: 10.1002/cam4.5155
|
| 24 |
P Laoveeravat, S Thavaraputta, W Vutthikraivit, S Suchartlikitwong, T Mingbunjerdsuk, A Motes, K Nugent, A Rakvit, E Islam, S Islam. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis. QJM: An International Journal of Medicine 2019; doi: 10.1093/qjmed/hcz234
|
| 25 |
Yan-Bo Zheng, Meng-Ran Zhang, Yi Li, Xiu-Jun Liu, Yong-Su Zhen. DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic mice. Cancer Biology & Therapy 2020; 21(8): 749 doi: 10.1080/15384047.2020.1776580
|
| 26 |
Denis Revskij, Jakob Runst, Camilla Umstätter, Luise Ehlers, Sarah Rohde, Dietmar Zechner, Manuela Bastian, Brigitte Müller-Hilke, Georg Fuellen, Larissa Henze, Hugo Murua Escobar, Christian Junghanss, Axel Kowald, Uwe Walter, Rüdiger Köhling, Olaf Wolkenhauer, Robert Jaster. Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. Hepatobiliary & Pancreatic Diseases International 2023; 22(2): 190 doi: 10.1016/j.hbpd.2022.12.003
|
| 27 |
Youjin Kim, Boyoung Hwang. Effects of Meaning in Life and Social Support on Posttraumatic Growth in Pancreatic Cancer Survivors. Journal of Korean Academy of psychiatric and Mental Health Nursing 2021; 30(4): 330 doi: 10.12934/jkpmhn.2021.30.4.330
|
| 28 |
Pan Pantziarka, Gauthier Bouche. Perioperative Therapies—Using Repurposed Drugs to Improve Cancer Surgery Outcomes. The Cancer Journal 2019; 25(2): 100 doi: 10.1097/PPO.0000000000000361
|
| 29 |
Thomas J. Vogl, Bita Panahi, Moritz H. Albrecht, Nagy Naguib Naeem Naguib, Nour-Eldin A. Nour-Eldin, Tatjana Gruber-Rouh, Zachary M. Thompson, Lajos M. Basten. Microwave ablation of pancreatic tumors. Minimally Invasive Therapy & Allied Technologies 2018; 27(1): 33 doi: 10.1080/13645706.2017.1420664
|
| 30 |
Etienne J. Slapak, Mouad el Mandili, Maarten F. Bijlsma, C. Arnold Spek. Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview. Pharmaceutics 2022; 14(2): 390 doi: 10.3390/pharmaceutics14020390
|
| 31 |
Wanrui Lv, Qingfeng Wang, Qiancheng Hu, Xin Wang, Dan Cao. Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol. BMJ Open 2022; 12(7): e050558 doi: 10.1136/bmjopen-2021-050558
|
| 32 |
James A. McCubrey, Stephen L. Abrams, Matilde Y. Follo, Lucia Manzoli, Stefano Ratti, Alberto M. Martelli, Melchiorre Cervello. Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies. Advances in Biological Regulation 2023; 87: 100917 doi: 10.1016/j.jbior.2022.100917
|
| 33 |
Wei Wang, Jie Wang, Chuanxin Yang, Jian Wang. MicroRNA‐216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer—A transcriptome analysis. IUBMB Life 2021; 73(6): 866 doi: 10.1002/iub.2468
|
| 34 |
Atukuri Dorababu. Report on Recently (2017–20) Designed Quinoline‐Based Human Cancer Cell Growth Inhibitors. ChemistrySelect 2020; 5(44): 13902 doi: 10.1002/slct.202003888
|
| 35 |
Clare Toms, Charbel Sandroussi, David Yeo, James Morkaya, Carlo Pulitano, Daniel Steffens. Patient-Reported Outcomes and Survival Following Pancreatic Cancer Resection—Results from a Cross-Section Study. Gastrointestinal Disorders 2023; 5(4): 508 doi: 10.3390/gidisord5040042
|
| 36 |
OffeiK Asare, Fred Osei, AndreaA Y Appau, BenjaminD Sarkodie, Kenneth Tachi, AdwoaA Nkansah, Timothy Acheampong, Christopher Nwaokweanwe, David Olayiwola. Aetiology of Obstructive Jaundice in Ghana: A Retrospective Analysis in a Tertiary Hospital. Journal of West African College of Surgeons 2020; 10(3): 36 doi: 10.4103/jwas.jwas_46_21
|
| 37 |
Chao-Ming Tseng, Hsi-Hao Wang, Wen-Lun Wang, Ching-Tai Lee, Chi-Ming Tai, Cheng-Hao Tseng, Chih-Cheng Chen, Ying-Nan Tsai, Meng-Shun Sun, Yao-Chun Hsu. Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer. Endocrine Practice 2020; 26(7): 707 doi: 10.4158/EP-2019-0565
|
| 38 |
|
| 39 |
Tasnimul Alam Taz, Md Kawsar, Sinthia Siddique, Kawsar Ahmed, Mohammad Ali Moni, Bikash Kumar Paul. Drug compound prediction-based analysis of cigarette smoking to Pancreatic Cancer patients: A Bioinformatics study. 2020 IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE) 2020; : 320 doi: 10.1109/WIECON-ECE52138.2020.9397979
|
| 40 |
Deanna L Huffman, Urwat T Vusqa, Karthik Shankar, Lynna Alnimer, Yazan Samhouri, Srividya Srinivasamaharaj, Srikrishna V Malayala, Dulabh Monga. An Internal Review of Rates of Palliative Medicine Referral for Patients With Advanced Pancreatic Cancer. Cureus 2021; doi: 10.7759/cureus.19670
|
| 41 |
Naohisa Kuriyama, Koki Maeda, Toru Shinkai, Takahiro Ito, Kazuyuki Gyoten, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Akihiro Tanemura, Masashi Kishiwada, Motonori Nagata, Shuhei Ichikawa, Shugo Mizuno. Anterior versus posterior radical antegrade modular pancreatosplenectomy for pancreatic body and tail cancer: an inverse probability of treatment weighting with survival analysis. Surgery Today 2023; 53(8): 917 doi: 10.1007/s00595-023-02651-7
|
| 42 |
Lisa M. Hoffman. Precision Medicine, Future Risk and the Present Self. Anthropology Today 2024; 40(1): 16 doi: 10.1111/1467-8322.12864
|
| 43 |
Elvira Pelosi, Germana Castelli, Ugo Testa. Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Biomedicines 2017; 5(4): 65 doi: 10.3390/biomedicines5040065
|
| 44 |
Hsuan-Yu Peng, Ming-Chu Chang, Chun-Mei Hu, Hwai-I Yang, Wen-Hwa Lee, Yu-Ting Chang. Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer. Annals of Surgical Oncology 2019; 26(3): 807 doi: 10.1245/s10434-018-07109-6
|
| 45 |
Mansour Bahardoust, Mohammad Ali Abyazi, Sayed Ali Emami, Parmida Ghadimi, Mehrdad Khodabandeh, Farhad Mahmoudi, Ramin Hosseinzadeh, Mohammad Heiat, Shahram Agah. Predictors of survival rate in patients with pancreatic cancer: A multi‐center analytical study in Iran. Cancer Reports 2022; 5(8) doi: 10.1002/cnr2.1547
|
| 46 |
Mohamed Sharshar, Toshimi Kaido, Hisaya Shirai, Shinya Okumura, Siyuan Yao, Yosuke Miyachi, Sena Iwamura, Naoko Kamo, Shintaro Yagi, Mahmoud Macshut, Shinji Uemoto. Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Surgery Today 2020; 50(7): 757 doi: 10.1007/s00595-019-01954-y
|
| 47 |
Jinnian Ge, Chunlin Ge. Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer. Virchows Archiv 2019; 474(1): 59 doi: 10.1007/s00428-018-2455-5
|
| 48 |
Liang Li, Nan Wang, Jun Wang, Jiangang Li. Hsa_circRNA_001859 regulates pancreatic cancer progression and epithelial-mesenchymal transition through the miR-21-5p/SLC38A2 pathway. Cancer Biomarkers 2023; 37(1): 39 doi: 10.3233/CBM-220229
|
| 49 |
Aitao SUN, Jiancheng LIU, Fei YANG, Guangzhu SU. Regulation of plastin 1 expression modulates pancreatic carcinoma progression by affecting the glycolytic signaling pathway. Minerva Biotechnology and Biomolecular Research 2024; 35(4) doi: 10.23736/S2724-542X.23.03010-9
|
| 50 |
Satoshi Sai, Masanori Toyoda, Kazutoshi Tobimatsu, Hironaga Satake, Hisateru Yasui, Shiro Kimbara, Taiji Koyama, Yoshimi Fujishima, Yoshinori Imamura, Yohei Funakoshi, Naomi Kiyota, Hirochika Toyama, Yuzo Kodama, Hironobu Minami. Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial). Cancer Chemotherapy and Pharmacology 2021; 87(1): 65 doi: 10.1007/s00280-020-04174-1
|
| 51 |
Antonio Doronzo, Letizia Porcelli, Donatello Marziliano, Gianfranco Inglese, Antonella Argentiero, Amalia Azzariti, Antonio Giovanni Solimando. Gene Expression Comparison between Alcohol-Exposed versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis. Medicina 2023; 59(5): 872 doi: 10.3390/medicina59050872
|
| 52 |
Ghazaleh Pourali, Ghazaleh Donyadideh, Shima Mehrabadi, Fiuji Hamid, Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Khazaei, Amir Avan. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 345 doi: 10.1016/B978-0-443-19142-8.00008-5
|
| 53 |
Hewei Zhang, Lijun Kong, Yan Zhang, Cheng Wang, Linxiao Sun. Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells. Aging 2021; 13(19): 23308 doi: 10.18632/aging.203623
|
| 54 |
Anouk E.J. Latenstein, Lydia G.M. van der Geest, Bert A. Bonsing, Bas Groot Koerkamp, Nadia Haj Mohammad, Ignace H.J.T. de Hingh, Vincent E. de Meijer, Izaak Q. Molenaar, Hjalmar C. van Santvoort, Geertjan van Tienhoven, Joanne Verheij, Pauline A.J. Vissers, Judith de Vos-Geelen, Olivier R. Busch, Casper H.J. van Eijck, Hanneke W.M. van Laarhoven, Marc G. Besselink, Johanna W. Wilmink. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. European Journal of Cancer 2020; 125: 83 doi: 10.1016/j.ejca.2019.11.002
|
| 55 |
Min Li, Xiaohan Nie, Yilidan Reheman, Pan Huang, Shuailei Zhang, Yushuai Yuan, Chen Chen, Ziwei Yan, Cheng Chen, Xiaoyi Lv, Wei Han. Computer-Aided Diagnosis and Staging of Pancreatic Cancer Based on CT Images. IEEE Access 2020; 8: 141705 doi: 10.1109/ACCESS.2020.3012967
|
| 56 |
Ilkay Gulturk, Mesut Yilmaz, Seher Y. Tacar, Oguz K. Bakkaloglu, Gulru B. Sonmezoz, Gulcin S. Erdal, Aykut Ozmen, Deniz Tural. Naples prognostic score may predict overall survival in metastatic pancreatic cancer. Journal of Cancer Research and Therapeutics 2024; 20(1): 249 doi: 10.4103/jcrt.jcrt_1392_22
|
| 57 |
Francesco Natale, Maria Vivo, Geppino Falco, Tiziana Angrisano. Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0728-8
|
| 58 |
Yutong Gao, Xiangdi Yu, Fangxiang Zhang, Jing Dai. Propofol inhibits pancreatic cancer progress under hypoxia via ADAM8. Journal of Hepato-Biliary-Pancreatic Sciences 2019; 26(6): 219 doi: 10.1002/jhbp.624
|
| 59 |
Xiaoyang Lan, Gabrielle Robin, Jessica Kasnik, Grace Wong, Omar Abdel-Rahman. Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(4): 1331 doi: 10.3390/cancers15041331
|
| 60 |
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
|
| 61 |
Lorena Ostios-Garcia, Julia Villamayor, Esther Garcia-Lorenzo, David Vinal, Jaime Feliu. Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer. World Journal of Gastroenterology 2021; 27(40): 6775-6793 doi: 10.3748/wjg.v27.i40.6775
|
| 62 |
Rui Fang, Bin Zhang, Xiaoming Lu, Xin Jin, Tao Liu. FASTKD2 promotes cancer cell progression through upregulating Myc expression in pancreatic ductal adenocarcinoma. Journal of Cellular Biochemistry 2020; 121(3): 2458 doi: 10.1002/jcb.29468
|
| 63 |
L. B. Bolotina, L. I. Moskvicheva, A. L. Kornietskaya, D. V. Sidorov, N. A. Grishin, M. V. Lozhkin, A. D. Kaprin. PRELIMINARY EVALUATION OF THE EFFECTIVENESS OF HIFU-THERAPY IN PATIENTS WITH PANCREATIC CANCER. Siberian journal of oncology 2021; 20(3): 18 doi: 10.21294/1814-4861-2021-20-3-18-27
|
| 64 |
Chengfei Zhao, Feng Gao, Quwen Li, Qicai Liu, Xinhua Lin. The Distributional Characteristic and Growing Trend of Pancreatic Cancer in China. Pancreas 2019; 48(3): 309 doi: 10.1097/MPA.0000000000001222
|
| 65 |
Thuan Van Tran, Tu Van Dao, Khac-Dung Nguyen, To van TA, Khanh Truong Vu, Son Hong Trinh, Hoang Cong Nguyen, Oanh Thi Bui, Quang Tien Nguyen, Hoan Duc Vu, Hiep Le Nguyen, Huong Thanh Tran. Risk factors of Pancreatic Cancer in Vietnam: A Matched Case–Control Hospital-Based Study. Cancer Control 2021; 28: 107327482198932 doi: 10.1177/1073274821989320
|
| 66 |
Alexandre Brind’Amour, Mitchell Webb, Marina Parapini, Lucas Sidéris, Maja Segedi, Stephen W. Chung, Stéphanie Chartier-Plante, Pierre Dubé, Charles H. Scudamore, Peter T. W. Kim. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review. Clinical & Experimental Metastasis 2021; 38(2): 187 doi: 10.1007/s10585-021-10074-2
|
| 67 |
Jeffery Ho, Xianchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny C.W. Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse, William K.K. Wu. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset. Seminars in Cancer Biology 2019; 55: 70 doi: 10.1016/j.semcancer.2018.04.004
|
| 68 |
Fangfang Hu, Liangtao Zhao, Yang Wang, Hao Ye, Haodong Tang, Jiahua Zhou. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer. Open Medicine 2022; 17(1): 1935 doi: 10.1515/med-2022-0606
|
| 69 |
Liqing Ye, Weijian Feng, Hanqin Weng, Chongde Yuan, Jia Liu, Zaiguo Wang. MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01669-y
|
| 70 |
Yukihiko Hiroshima, Rika Kasajima, Yayoi Kimura, Daisuke Komura, Shumpei Ishikawa, Yasushi Ichikawa, Michael Bouvet, Naoto Yamamoto, Takashi Oshima, Soichiro Morinaga, Shree Ram Singh, Robert M. Hoffman, Itaru Endo, Yohei Miyagi. Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters 2020; 469: 217 doi: 10.1016/j.canlet.2019.10.031
|
| 71 |
Shufang Yang, Jie Liu, Haiying Jin, Xiang He, Peng Nie, Changfu Wang. Value of magnetic resonance images in preoperative staging and resectability assessment of pancreatic cancer. Journal of Cancer Research and Therapeutics 2018; 14(1): 155 doi: 10.4103/jcrt.JCRT_590_17
|
| 72 |
Xixi Jiang, Qingqing Luo, Zhiwei Wang, Tao Mei, Yu Wen, Xin Li, Kwang-Ting Cheng, Xin Yang. Medical Image Computing and Computer Assisted Intervention – MICCAI 2020. Lecture Notes in Computer Science 2020; 12264: 460 doi: 10.1007/978-3-030-59719-1_45
|
| 73 |
Ahmad Hamad, Matthew DePuccio, Bradley N. Reames, Apeksha Dave, Natasha Kurien, Jordan M Cloyd, Chengli Shen, Timothy M. Pawlik, Allan Tsung, Ann Scheck McAlearney, Aslam Ejaz. Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma. Journal of Gastrointestinal Surgery 2021; 25(11): 2889 doi: 10.1007/s11605-021-04984-5
|
| 74 |
Vittorio Gebbia, Marzia Mare, Stefano Cordio, Maria Rosaria Valerio, Dario Piazza, Roberto Bordonaro, Alberto Firenze, Dario Giuffrida. Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?. Journal of Geriatric Oncology 2021; 12(1): 163 doi: 10.1016/j.jgo.2020.06.022
|
| 75 |
Honam Hwang, Hongbeom Kim, Hee Ju Sohn, Mirang Lee, Hyeong Seok Kim, Youngmin Han, Wooil Kwon, Jin-Young Jang. Stool Elastase as an Independent Prognostic Factor in Patients with Pancreatic Head Cancer. Journal of Clinical Medicine 2022; 11(13): 3718 doi: 10.3390/jcm11133718
|
| 76 |
Na Li, Jionghuang Chen, Weihua Yu, Xiaoling Huang. Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02916-y
|
| 77 |
Qing Hua, Tianjiao Li, Yixuan Liu, Xuefang Shen, Xiaoyan Zhu, Pingbo Xu. Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.624837
|
| 78 |
Daniele Fanale, Giorgio Madonia, Antonio Galvano, Marc Peeters, Albert J. ten Tije, Juan Lucio Iovanna, Antonio Russo. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; : 645 doi: 10.1007/978-3-030-56051-5_40
|
| 79 |
Mihoko Yamada, Teiichi Sugiura, Yukiyasu Okamura, Takaaki Ito, Yusuke Yamamoto, Ryo Ashida, Keiko Sasaki, Masato Nagino, Katsuhiko Uesaka. Microscopic Venous Invasion in Pancreatic Cancer. Annals of Surgical Oncology 2018; 25(4): 1043 doi: 10.1245/s10434-017-6324-2
|
| 80 |
Mariko Tsukagoshi, Satoshi Wada, Seiko Hirono, Shintaro Yoshida, Erica Yada, Tetsuro Sasada, Ken Shirabe, Hiroyuki Kuwano, Hiroki Yamaue. Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer. Oncotarget 2018; 9(59): 31448 doi: 10.18632/oncotarget.25837
|
| 81 |
Ge Gao, Can Liu, Sona Jain, Dai Li, Hai Wang, Yongxin Zhao, Juewen Liu. Potential use of aptamers for diagnosis and treatment of pancreatic cancer. Journal of Drug Targeting 2019; 27(8): 853 doi: 10.1080/1061186X.2018.1564924
|
| 82 |
Sebastian Lundgren, Jacob Elebro, Margareta Heby, Björn Nodin, Karin Leandersson, Patrick Micke, Karin Jirström, Artur Mezheyeuski. Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma. International Journal of Cancer 2020; 146(12): 3461 doi: 10.1002/ijc.32945
|
| 83 |
Shengmin Zhang, Jianrong Yang, Hongsheng Wu, Tiansheng Cao, Tengfei Ji. Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1091378
|
| 84 |
Dominic King, Umair Kamran, Amandeep Dosanjh, Ben Coupland, Jemma Mytton, John S. Leeds, Manu Nayar, Prashant Patel, Kofi W. Oppong, Nigel J. Trudgill. Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors. Endoscopy 2022; 54(11): 1053 doi: 10.1055/a-1784-1661
|
| 85 |
Muhammad Subhan, Nisha Saji Parel, Parimi Vamsi Krishna, Anuradha Gupta, Kamsika Uthayaseelan, Kivonika Uthayaseelan, Monika Kadari. Smoking and Pancreatic Cancer: Smoking Patterns, Tobacco Type, and Dose-Response Relationship. Cureus 2022; doi: 10.7759/cureus.26009
|
| 86 |
Yong Tang, Guojun Cao, Gang Zhao, Chunyou Wang, Qi Qin. LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer. Investigational New Drugs 2020; 38(3): 714 doi: 10.1007/s10637-019-00798-0
|
| 87 |
Masataka Kikuyama. A Novel Diagnostic Imaging Method for the Early Detection of Pancreatic Cancer. Diagnostics 2023; 13(12): 2080 doi: 10.3390/diagnostics13122080
|
| 88 |
Prashanth Rawla, Krishna Chaitanya Thandra, Tagore Sunkara. Pancreatic cancer and obesity: epidemiology, mechanism, and preventive strategies. Clinical Journal of Gastroenterology 2019; 12(4): 285 doi: 10.1007/s12328-019-00953-3
|
| 89 |
Zahra Tolou-Ghamari. Pancreatic cancer: Demographics and prevalence. Clinical Cancer Investigation Journal 2020; 9(4): 155 doi: 10.4103/ccij.ccij_13_20
|
| 90 |
Yasuhiro Oyama, Hideya Onishi, Satoko Koga, Mutsunori Murahashi, Shu Ichimiya, Kazunori Nakayama, Akiko Fujimura, Makoto Kawamoto, Akira Imaizumi, Masayo Umebayashi, Kenoki Ohuchida, Takashi Morisaki, Masafumi Nakamura. Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. Journal of Immunotherapy 2020; 43(4): 121 doi: 10.1097/CJI.0000000000000305
|
| 91 |
Rita Peila, Rhonda S. Arthur, Thomas E. Rohan. Association of Sex Hormones with Risk of Cancers of the Pancreas, Kidney, and Brain in the UK Biobank Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(9): 1832 doi: 10.1158/1055-9965.EPI-20-0246
|
| 92 |
Mónika Lipp, Dorottya Tarján, Jimin Lee, Ádám Zolcsák, Eszter Szalai, Brigitta Teutsch, Nándor Faluhelyi, Bálint Erőss, Péter Hegyi, Alexandra Mikó. Fatty Pancreas Is a Risk Factor for Pancreatic Cancer: A Systematic Review and Meta-Analysis of 2956 Patients. Cancers 2023; 15(19): 4876 doi: 10.3390/cancers15194876
|
| 93 |
Eunseo Jang, Minhee Son, Junhee Jang, In-Hyun Lee, Sol Kim, Taejun Kwon, Yong-hyun Jeon, Woo-Suk Koh, Kil-Soo Kim, Sang Kyoon Kim, Sumitra Deb. DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy. PLOS ONE 2019; 14(11): e0225095 doi: 10.1371/journal.pone.0225095
|
| 94 |
Sarah K. Madden, Aline Dantas de Araujo, Mara Gerhardt, David P. Fairlie, Jody M. Mason. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-020-01291-6
|
| 95 |
Oluseyi Abidoye, Young Min Cho, Sheena Bhushan, Comfort Adewunmi, Hasan Choudhury. Trends in pancreatic cancer incidence and mortality in the United States from 2000 to 2019; a SEER based study. F1000Research 2023; 12: 15 doi: 10.12688/f1000research.122872.1
|
| 96 |
Elisa Giommoni, Evaristo Maiello, Vanja Vaccaro, Ermanno Rondini, Caterina Vivaldi, Giampaolo Tortora, Laura Toppo, Guido Giordano, Tiziana Pia Latiano, Cinzia Lamperini, Serena Pillozzi, Luca Boni, Lorenzo Antonuzzo, Francesco Di Costanzo. Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study). Current Oncology 2021; 28(3): 1761 doi: 10.3390/curroncol28030164
|
| 97 |
Sosmitha Girisa, Sahu Henamayee, Dey Parama, Varsha Rana, Uma Dutta, Ajaikumar B. Kunnumakkara. Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer. Molecular Biomedicine 2021; 2(1) doi: 10.1186/s43556-021-00035-2
|
| 98 |
Paola Di Carlo, Nicola Serra, Teresa Maria Assunta Fasciana, Anna Giammanco, Francesco D’Arpa, Teresa Rea, Maria Santa Napolitano, Alessandro Lucchesi, Antonio Cascio, Consolato Maria Sergi, Massimiliano Galdiero. Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer. PLOS ONE 2024; 19(2): e0294049 doi: 10.1371/journal.pone.0294049
|
| 99 |
Jaideep Chakladar, Selena Z. Kuo, Grant Castaneda, Wei Tse Li, Aditi Gnanasekar, Michael Andrew Yu, Eric Y. Chang, Xiao Qi Wang, Weg M. Ongkeko. The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers. Cancers 2020; 12(9): 2672 doi: 10.3390/cancers12092672
|
| 100 |
Gabriel Carvajal, Denis Dupoiron, Valerie Seegers, Nathalie Lebrec, François Boré, Pierre-Yves Dubois, Damien Leblanc, Thierry Delorme, Sabrina Jubier-Hamon. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center. Anesthesia & Analgesia 2018; 126(6): 2038 doi: 10.1213/ANE.0000000000002903
|
| 101 |
Jakub Wnuk, Joanna Katarzyna Strzelczyk, Iwona Gisterek. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences 2023; 24(6): 5113 doi: 10.3390/ijms24065113
|
| 102 |
Katarzyna Nadolska, Agnieszka Białecka, Elżbieta Zawada, Wojciech Kazimierczak, Zbigniew Serafin. Analysis of IVIM Perfusion Fraction Improves Detection of Pancreatic Ductal Adenocarcinoma. Diagnostics 2024; 14(6): 571 doi: 10.3390/diagnostics14060571
|
| 103 |
Xi Wang, Chunbin Wang, Haijun Zhang. Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase. Cancer Management and Research 2021; : 4879 doi: 10.2147/CMAR.S312312
|
| 104 |
Wang Gu, Zhong Tong. Clinical Application of Metabolomics in Pancreatic Diseases: A Mini-Review. Laboratory Medicine 2019; doi: 10.1093/labmed/lmz046
|
| 105 |
Zhuo Fu, Yan Jiao, Yanqing Li, Bai Ji, Baoxing Jia, Bin Liu. TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer. Medicine 2019; 98(51): e18487 doi: 10.1097/MD.0000000000018487
|
| 106 |
Ling Zuo, Hongyu Tao, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo, Shousong Cao, Minghua Liu, Xiukun Lin. <p>Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo</p>. Drug Design, Development and Therapy 2020; : 3495 doi: 10.2147/DDDT.S265423
|
| 107 |
Meiqi Liu, Moran Wang, Sheng Li. Prognostic Factors of Survival in Pancreatic Cancer Metastasis to Liver at Different Ages of Diagnosis: A SEER Population-Based Cohort Study. Frontiers in Big Data 2021; 4 doi: 10.3389/fdata.2021.654972
|
| 108 |
Prashant Kesharwani, Jyoti Chandra, Shahid Karim, Garima Gupta, Ritu Karwasra, Ajay Sharma. αvβ3 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment. Journal of Drug Delivery Science and Technology 2024; 96: 105663 doi: 10.1016/j.jddst.2024.105663
|
| 109 |
Jianing Zhang, T. Zhu, M. Anpo, A. Sharifi. Analysis on the Treatments on Early Diagnosis of Pancreatic Cancer (PC). E3S Web of Conferences 2021; 271: 03052 doi: 10.1051/e3sconf/202127103052
|
| 110 |
Liang Chen, Wenyang Niu, Dongmei Zhu, Weibin Shao, Yi Qian. Long noncoding RNA HOXD-AS1 promotes the progression of pancreatic cancer through miR-664b-3p/PLAC8 axis. Pathology - Research and Practice 2022; 232: 153836 doi: 10.1016/j.prp.2022.153836
|
| 111 |
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16): 12633 doi: 10.3390/ijms241612633
|
| 112 |
Tao Ma, Jin-Ling Jiang, Wei-Xiang Qi, Jia-Yi Chen, Hao-Ping Xu. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy. Drug Design, Development and Therapy 2022; : 2395 doi: 10.2147/DDDT.S366558
|
| 113 |
Takafumi Mie, Takashi Sasaki, Tsuyoshi Takeda, Koshiro Fukuda, Takaaki Furukawa, Yuto Yamada, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira. Comparison of Treatment Outcomes Between Gemcitabine With Nab-Paclitaxel and Modified FOLFIRINOX for First-Line Chemotherapy in Metastatic and Recurrent Pancreatic Cancer. Pancreas 2021; 50(4): 595 doi: 10.1097/MPA.0000000000001801
|
| 114 |
Akriti Gupta Jain, Mohammed Wazir, Hammad Zafar, Julie Zhou, Kishor Khanal, Abdul Kareem Khan, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; : 295 doi: 10.1016/B978-0-12-819457-7.00015-3
|
| 115 |
Jeffrey H. Lee, Osman Ahmed. Endoscopic Management of Pancreatic Cancer. Surgical Oncology Clinics of North America 2019; 28(1): 147 doi: 10.1016/j.soc.2018.07.002
|
| 116 |
Ehsan Aali, Saeed Aamadi, Arezoo Bajelan, Mehdi Ghaebi. Cytotoxic Effects of Methanolic Extract of Ferula assa-foetida on SKOV-3 and MIA PaCa-2 Cells. Annals of Cancer Research and Therapy 2021; 29(1): 110 doi: 10.4993/acrt.29.110
|
| 117 |
Jianming Hu, Leyi Zhang, Wuzhen Chen, Lesang Shen, Jingxin Jiang, Shanshan Sun, Zhigang Chen. Role of Intra- and Extracellular Lipid Signals in Cancer Stemness and Potential Therapeutic Strategy. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.730751
|
| 118 |
Qing-Guo Liu, Yan-Ju Li, Lan Yao. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis. Pancreatology 2018; 18(6): 678 doi: 10.1016/j.pan.2018.07.003
|
| 119 |
Umme Hani, Riyaz Ali M. Osmani, Ayesha Siddiqua, Shadma Wahab, Sadia Batool, Hissana Ather, Norhan Sheraba, Ali Alqahtani. A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer. Journal of Drug Delivery Science and Technology 2021; 63: 102539 doi: 10.1016/j.jddst.2021.102539
|
| 120 |
Syed Rahmanuddin, Ronald Korn, Derek Cridebring, Erkut Borazanci, Jordyn Brase, William Boswell, Asma Jamil, Wenli Cai, Aqsa Sabir, Pejman Motarjem, Eugene Koay, Anirban Mitra, Ajay Goel, Joyce Ho, Vincent Chung, Daniel D. Von Hoff. Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.678617
|
| 121 |
Julia Arribas Anta, Iván Martínez-Ballestero, Daniel Eiroa, Javier García, Júlia Rodríguez-Comas. Artificial intelligence for the detection of pancreatic lesions. International Journal of Computer Assisted Radiology and Surgery 2022; 17(10): 1855 doi: 10.1007/s11548-022-02706-z
|
| 122 |
Boma E Jacks, Chinwendum U Ekpemiro, Adeyemi A Adeosun, Uchechukwu O Ogbonna, Faithful T Ogundiran, Funmilola Babalola, Nkemputaife P Onyechi, Olamide O Ajayi, Maureen G Boms, Adaugo N Nwanguma, Uduak A Udo, Okelue E Okobi, Evidence E Ohikhuai, Endurance O Evbayekha. Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances. Cureus 2022; doi: 10.7759/cureus.29485
|
| 123 |
Hanzhang Zhu, Weijiang Zhou, Yafeng Wan, Jun Lu, Ke Ge, Changku Jia. CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression. International Journal of Molecular Sciences 2022; 23(20): 12061 doi: 10.3390/ijms232012061
|
| 124 |
Séverin Muyisa Kavatsurwa, Blaise Kimbadi Lombe, Doris Feineis, Dya Fita Dibwe, Vinesh Maharaj, Suresh Awale, Gerhard Bringmann. Ancistroyafungines A-D, 5,8′- and 5,1′-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells. Fitoterapia 2018; 130: 6 doi: 10.1016/j.fitote.2018.07.017
|
| 125 |
Stefano Cascinu, Rossana Berardi, Roberto Bianco, Domenico Bilancia, Alberto Zaniboni, Daris Ferrari, Stefania Mosconi, Andrea Spallanzani, Luigi Cavanna, Silvana Leo, Francesca Negri, Giordano D. Beretta, Alberto Sobrero, Maria Banzi, Alberto Morabito, Alessandro Bittoni, Roberta Marciano, Domenica Ferrara, Silvia Noventa, Maria C. Piccirillo, Roberto Labianca, Cristina Mosconi, Andrea Casadei Gardini, Ciro Gallo, Francesco Perrone. Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial. European Journal of Cancer 2021; 148: 422 doi: 10.1016/j.ejca.2021.02.023
|
| 126 |
Jinlan Yang, Tianyin Qu, Yajun Li, Jingjing Ma, Huangfei Yu. Biological role of long non-coding RNA FTX in cancer progression. Biomedicine & Pharmacotherapy 2022; 153: 113446 doi: 10.1016/j.biopha.2022.113446
|
| 127 |
Jill Gwiasda, Zhi Qu, Harald Schrem, Felix Oldhafer, Markus Winny, Jürgen Klempnauer, Gerrit Grannas, Alexander Kaltenborn. Prediction of survival after left-sided pancreatic resection for adenocarcinoma: Introduction of a new prognostic score. Hepatobiliary & Pancreatic Diseases International 2019; 18(6): 569 doi: 10.1016/j.hbpd.2019.06.007
|
| 128 |
Giri B. Laya, Amaranathan Anandhi, Balakrishnan Gurushankari, Jharna Mandal, Vikram Kate. Association Between Helicobacter pylori and Periampullary and Pancreatic Cancer: a Case–Control Study. Journal of Gastrointestinal Cancer 2022; 53(4): 902 doi: 10.1007/s12029-021-00766-z
|
| 129 |
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
|
| 130 |
De Luo, Fei Kuang, Juan Du, Mengjia Zhou, Fangyi Peng, Yu Gan, Cheng Fang, Xiaoli Yang, Bo Li, Song Su. Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677609
|
| 131 |
Iveta Mikolaskova, Tatjana Crnogorac-Jurcevic, Bozena Smolkova, Luba Hunakova. Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review. Biology 2023; 12(2): 158 doi: 10.3390/biology12020158
|
| 132 |
Xin Zhang, Luming Li, Yan Wu. Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells. Acta Pharmaceutica 2023; 73(3): 503 doi: 10.2478/acph-2023-0024
|
| 133 |
Wojciech Blogowski, Katarzyna Dolegowska, Anna Deskur, Barbara Dolegowska, Teresa Starzynska. Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.757073
|
| 134 |
Manh Tien Tran. Effects of Tumor Microenvironment Acidification on Progression of Pancreatic Ductal Adenocarcinoma: A Review. Asia-Pacific Journal of Oncology 2021; : 17 doi: 10.32948/ajo.2021.08.14
|
| 135 |
Abdulrahman K. Ibnawadh, Hamad I. Alashgar, Musthafa Peedikayil, Tarek Amin. Pancreatic cancer presenting with acute pancreatitis complicated by Wernicke’s encephalopathy and a colonic fistula: a case report. Annals of Medicine & Surgery 2023; 85(3): 574 doi: 10.1097/MS9.0000000000000257
|
| 136 |
O. Abdel-Rahman. Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies. Clinical and Translational Oncology 2019; 21(6): 810 doi: 10.1007/s12094-018-1992-3
|
| 137 |
Chun Lei, Yafeng Hou, Jiong Chen. Specificity protein 1‑activated bone marrow stromal cell antigen 2 accelerates pancreatic cancer cell proliferation and migration. Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10894
|
| 138 |
Smriti Mishra, Gaurang Telang, Darpan Bennur, Shruti Chougule, P. B. Dandge, Shantanu Joshi, Nishant Vyas. T Cell Exhaustion and Activation Markers in Pancreatic Cancer: A Systematic Review. Journal of Gastrointestinal Cancer 2023; doi: 10.1007/s12029-023-00965-w
|
| 139 |
Luís Ramalhete, Emanuel Vigia, Rúben Araújo, Hugo Pinto Marques. Proteomics-Driven Biomarkers in Pancreatic Cancer. Proteomes 2023; 11(3): 24 doi: 10.3390/proteomes11030024
|
| 140 |
Zhe Liu, Neha Parveen, Urushi Rehman, Aisha Aziz, Afsana Sheikh, Mohammed A. S. Abourehab, Wei Guo, Junhao Huang, Zhenning Wang, Prashant Kesharwani. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-022-01696-5
|
| 141 |
Mohsen Nakhaie, Javad Charostad, Gholam Abbas Kaydani, Ebrahim Faghihloo. The role of viruses in adenocarcinoma development. Infection, Genetics and Evolution 2020; 86: 104603 doi: 10.1016/j.meegid.2020.104603
|
| 142 |
Xiaotao Zhang, Carrie R. Daniel. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; : 329 doi: 10.1007/978-3-030-67951-4_11
|
| 143 |
F. Edward Boas, Fuad Nurili, Achiude Bendet, Christopher Cheleuitte-Nieves, Olca Basturk, Gokce Askan, Adam O. Michel, Sebastien Monette, Etay Ziv, Constantinos T. Sofocleous, Aaron W. P. Maxwell, Lawrence B. Schook, Stephen B. Solomon, David P. Kelsen, Avigdor Scherz, Hooman Yarmohammadi, Francisco X. Real. Induction and characterization of pancreatic cancer in a transgenic pig model. PLOS ONE 2020; 15(9): e0239391 doi: 10.1371/journal.pone.0239391
|
| 144 |
Hehe Li, Zhengle Zhang, Chenggang Gao, Shihong Wu, Qingke Duan, Heshui Wu, Chunyou Wang, Qiang Shen, Tao Yin. Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0312-0
|
| 145 |
Xin Qiu, Qin-Han Hou, Qiu-Yue Shi, Hai-Xing Jiang, Shan-Yu Qin. Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.595361
|
| 146 |
Yu-qing Du, Xiu-mei Bai, Wei Yang, Zhong-yi Zhang, Song Wang, Wei Wu, Kun Yan, Min-hua Chen. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma. International Journal of Hyperthermia 2022; 39(1): 517 doi: 10.1080/02656736.2022.2048907
|
| 147 |
Asmaa A. Salem, Gerardo G. Mackenzie. Pancreatic cancer: A critical review of dietary risk. Nutrition Research 2018; 52: 1 doi: 10.1016/j.nutres.2017.12.001
|
| 148 |
Monish Ram Makena, Himavanth Gatla, Dattesh Verlekar, Sahithi Sukhavasi, Manoj K. Pandey, Kartick C. Pramanik. Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance. International Journal of Molecular Sciences 2019; 20(17): 4242 doi: 10.3390/ijms20174242
|
| 149 |
Timothy J. O’Brien, Michael Passeri, Melvin F. Lorenzo, Jesse K. Sulzer, William B. Lyman, Jacob H. Swet, Dionisios Vrochides, Erin H. Baker, David A. Iannitti, Rafael V. Davalos, Iain H. McKillop. Experimental High-Frequency Irreversible Electroporation Using a Single-Needle Delivery Approach for Nonthermal Pancreatic Ablation In Vivo. Journal of Vascular and Interventional Radiology 2019; 30(6): 854 doi: 10.1016/j.jvir.2019.01.032
|
| 150 |
Qiang Ren, Jian Wang, Chao Liu, Ling-xin Meng, Rui-kun Qian, Hui-jie Gao, Wei Qin, Cai-ju Zhou, Sen Qiao, Hui-yun Wang, Li-tao Zhang, Yun-tao Zhang. Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. Journal of Pharmaceutical and Biomedical Analysis 2021; 205: 114339 doi: 10.1016/j.jpba.2021.114339
|
| 151 |
Narges Lotfalizadeh, Soheil Sadr, Solmaz Morovati, Mohammadhassan Lotfalizadeh, Ashkan Hajjafari, Hassan Borji. A potential cure for tumor‐associated immunosuppression by Toxoplasma gondii. Cancer Reports 2024; 7(2) doi: 10.1002/cnr2.1963
|
| 152 |
Stanisław Głuszek, Artur Kowalik, Dorota Kozieł, Iwona Wawrzycka, Martyna Głuszek-Osuch, Jarosław Matykiewicz. CTRC gene polymorphism may increase pancreatic cancer risk – preliminary study. Polish Journal of Surgery 2017; 89(5): 48 doi: 10.5604/01.3001.0010.5411
|
| 153 |
E. Christodoulou, M. Visser, T. P. Potjer, N. van der Stoep, M. Rodríguez-Girondo, R. van Doorn, N. Gruis. Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers. Familial Cancer 2019; 18(4): 439 doi: 10.1007/s10689-019-00137-5
|
| 154 |
Elinor Tan, Jialu Song, Susanna Lam, Mario D'Souza, Michael Crawford, Charbel Sandroussi. Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis. International Journal of Surgery 2019; 72: 59 doi: 10.1016/j.ijsu.2019.09.030
|
| 155 |
Mohamed M. Gad, Anas M. Saad, Muneer J. Al-Husseini, Youssef M. Abdel-Gawad, Obai M. Alsalhani, Razan Alhaddad, Bashar Mohamad, Mohannad Abou Saleh, Carlos Roberto Simons-Linares. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 204 doi: 10.1016/j.clinre.2019.07.001
|
| 156 |
Calogero Casà, Antonio Piras, Andrea D’Aviero, Francesco Preziosi, Silvia Mariani, Davide Cusumano, Angela Romano, Ivo Boskoski, Jacopo Lenkowicz, Nicola Dinapoli, Francesco Cellini, Maria Antonietta Gambacorta, Vincenzo Valentini, Gian Carlo Mattiucci, Luca Boldrini. The impact of radiomics in diagnosis and staging of pancreatic cancer. Therapeutic Advances in Gastrointestinal Endoscopy 2022; 15: 263177452210815 doi: 10.1177/26317745221081596
|
| 157 |
Yi Yu, Yunxing Wang, Yufeng Zou, Yuan Yu, Xuan Huang. CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and In Vitro Experiments. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/5286820
|
| 158 |
Xun Liu, Bobo Chen, Jiahui Chen, Zuoyuan Su, Shaolong Sun. Deubiquitinase ubiquitin‐specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma. Cancer Science 2022; 113(5): 1868 doi: 10.1111/cas.15326
|
| 159 |
Brandon M. Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose Kochupurakkal, David B. Martignetti, Golbahar Sadatrezaei, Thomas A. Abrams, Leah H. Biller, Marios Giannakis, Kimmie Ng, Anuj K. Patel, Kimberly J. Perez, Harshabad Singh, Douglas A. Rubinson, Benjamin L. Schlechter, Elizabeth Andrews, Alison M. Hannigan, Stanley Dunwell, Zoe Getchell, Srivatsan Raghavan, Brian M. Wolpin, Caroline Fortier, Alan D. D'Andrea, Andrew J. Aguirre, Geoffrey I. Shapiro, James M. Cleary. A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma. Clinical Cancer Research 2023; 29(24): 5047 doi: 10.1158/1078-0432.CCR-23-2005
|
| 160 |
Xun Ye, Jinhu Li, Zibo Liu, Xue Sun, Daneng Wei, Linjiang Song, Chunjie Wu. Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects. Biomedicine & Pharmacotherapy 2023; 157: 113978 doi: 10.1016/j.biopha.2022.113978
|
| 161 |
James K. Sanayei, Neeral R. Patel, Martin E. Simons. Severe hypoglycemia after celiac plexus neurolysis: An underreported adverse event?. American Journal of Interventional Radiology 2021; 5: 8 doi: 10.25259/AJIR_8_2021
|
| 162 |
Adem Polat, Dilek Göktürk. An alternative approach to tracing the volumic proliferation development of an entire tumor spheroid in 3D through a mini-Opto tomography platform. Micron 2022; 152: 103173 doi: 10.1016/j.micron.2021.103173
|
| 163 |
Yu Min, Xiaoyuan Wei, Xi Xia, Zhigong Wei, Ruidan Li, Jing Jin, Zheran Liu, Xiaolin Hu, Xingchen Peng. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1141956
|
| 164 |
Eid Alshammari, Ying-Xue Zhang, Zhe Yang. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer. World Journal of Gastroenterology 2022; 28(29): 3753-3766 doi: 10.3748/wjg.v28.i29.3753
|
| 165 |
Irena Ilic, Milena Ilic. Opium consumption and pancreatic cancer: A meta-analysis. Cancer Epidemiology 2022; 81: 102287 doi: 10.1016/j.canep.2022.102287
|
| 166 |
Rongxi Shen, Xinbo Wang, Sizhen Wang, Daojun Zhu, Min Li. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1. Pancreas 2021; 50(4): 617 doi: 10.1097/MPA.0000000000001806
|
| 167 |
Xingpeng Shi, Yanni Quan, Yixuan Wang, Ying Wang, Yanping Li. Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells. Bioorganic & Medicinal Chemistry Letters 2021; 33: 127725 doi: 10.1016/j.bmcl.2020.127725
|
| 168 |
Shao-Ming Yu, Chang-Hsien Lu, Keng-Hao Liu, Ping-Tsung Chen, Pei-Hung Chang, Chia-Yen Hung, Shun-Wen Hsueh, Kun-Yun Yeh, Yen-Yang Chen, Yu-Shin Hung, Wen-Chi Chou. External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience in Taiwan. Pancreatology 2020; 20(1): 116 doi: 10.1016/j.pan.2019.11.001
|
| 169 |
Ulrike Heger, Huihui Sun, Ulf Hinz, Ulla Klaiber, Masayuki Tanaka, Bing Liu, Milena Sachsenmaier, Christoph Springfeld, Christoph W. Michalski, Markus W. Büchler, Thilo Hackert. Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival. HPB 2020; 22(2): 224 doi: 10.1016/j.hpb.2019.06.012
|
| 170 |
Justyna Budka, Dawid Debowski, Shaoshan Mai, Magdalena Narajczyk, Stanislaw Hac, Krzysztof Rolka, Eirinaios I. Vrettos, Andreas G. Tzakos, Iwona Inkielewicz-Stepniak. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2024; 16(2): 283 doi: 10.3390/pharmaceutics16020283
|
| 171 |
Alican Tahta, Ahmet Cetinkal, Elif Calis, Cem Dinc. Intramedullary pancreatic adenocarcinoma metastasis: The first case in literature. Neurocirugía (English Edition) 2022; 33(6): 334 doi: 10.1016/j.neucie.2021.03.005
|
| 172 |
Futa Koga, Yasunori Kawaguchi, Mototsugu Shimokawa, Kenichiro Murayama, Shunya Nakashita, Noriko Oza, Norio Ureshino, Hirokazu Takahashi, Yujiro Ueda, Junichi Nakazawa, Azusa Komori, Satoshi Otsu, Shiho Arima, Masaru Fukahori, Akitaka Makiyama, Hiroki Taguchi, Takuya Honda, Taro Shibuki, Kenta Nio, Yasushi Ide, Toshihiko Mizuta, Tsuyoshi Shirakawa, Taiga Otsuka, Kenji Mitsugi. Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study). Journal of Geriatric Oncology 2022; 13(1): 82 doi: 10.1016/j.jgo.2021.06.011
|
| 173 |
Paulo Andrade Lotufo. The burden of pancreatic cancer is rising in Brazil. Sao Paulo Medical Journal 2019; 137(5): 389 doi: 10.1590/1516-3180.2019.13752231019
|
| 174 |
Kaisong Bai, Tong Zhao, Yilong Li, Xinjian Li, Zhantian Zhang, Zuchao Du, Zimin Wang, Yan Xu, Bei Sun, Xuewei Bai. Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.747270
|
| 175 |
Yunjian Wang, Min Zhang, Luyang Zhang, Minghe Zhou, Enze Wang. Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis. Clinical & Experimental Metastasis 2023; 40(1): 53 doi: 10.1007/s10585-022-10197-0
|
| 176 |
Won Jae Yoon, Yul Oh, Changhoon Yoo, Sunguk Jang, Seong-Sik Cho, Jeong-Hun Suh, Seong-Soo Choi, Do Hyun Park. EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial. Journal of Clinical Medicine 2020; 9(6): 1666 doi: 10.3390/jcm9061666
|
| 177 |
Kui Lv, Jianying Yang, Junfeng Sun, Jianguo Guan. Identification of key candidate genes for pancreatic cancer by bioinformatics analysis. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7619
|
| 178 |
Yuan Tian, Wenwen Han, Long Fu, Kaiji Lv, Xinhua Zhou. Silencing of IGHG1 reverses the resistance of pancreatic cancer to multidrug chemotherapy by modulating autophagy. Environmental Toxicology 2023; 38(8): 1835 doi: 10.1002/tox.23810
|
| 179 |
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Caterina Foti, Francesca Ambrogio, Cosmo Damiano Gadaleta, Girolamo Ranieri. Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review. Cancers 2022; 14(2): 450 doi: 10.3390/cancers14020450
|
| 180 |
Peng An, Yong Lin, Junyan Zhang, Yan Hu, Ping Qin, Yingjian Ye, Xiumei Li, Guoyan Feng, Jinsong Wang. Prognostic Predicting Model of Pancreatic Body Tail Carcinoma Using Clinical and CT Radiomic Data. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231186739
|
| 181 |
Josenon Gomes Costa, Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Aldo Lourenço Abbade Dettino. Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experience. Therapeutic Advances in Medical Oncology 2019; 11: 175883591987465 doi: 10.1177/1758835919874650
|
| 182 |
Yanjie Cao, Dedong Yu, Yun Wu, Wei Zhu. Regional intra-arterial vs. systemic chemotherapy for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1197424
|
| 183 |
P SUHAJ, T OLEJAR, R MATEJ. PAR2: The Cornerstone of Pancreatic Diseases. Physiological Research 2022; : 583 doi: 10.33549/physiolres.934931
|
| 184 |
Pengfei Jiang, Youmin Yin, Yan Wu, Zhaoli Sun. Silencing of long non‑coding RNA SNHG15 suppresses proliferation, migration and invasion of pancreatic cancer cells by regulating the microRNA‑345‑5p/RAB27B axis. Experimental and Therapeutic Medicine 2021; 22(5) doi: 10.3892/etm.2021.10708
|
| 185 |
Li Zhang, Cuiping Wang, Shuangni Yu, Congwei Jia, Jie Yan, Zhaohui Lu, Jie Chen. Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. Technology in Cancer Research & Treatment 2018; 17: 153303461875447 doi: 10.1177/1533034618754475
|
| 186 |
Antonin Vary, Loïc Lebellec, Frédéric Di Fiore, Nicolas Penel, Claire Cheymol, Emilia Rad, Farid El Hajbi, Astrid Lièvre, Julien Edeline, André Michel Bimbai, Marie-Cécile Le Deley, Anthony Turpin. FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma. Therapeutic Advances in Medical Oncology 2021; 13: 175883592110298 doi: 10.1177/17588359211029825
|
| 187 |
Emily Truong, Stephen Pandol, Christie Jeon. Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer. eBioMedicine 2022; 79: 103996 doi: 10.1016/j.ebiom.2022.103996
|
| 188 |
Rutger Quispel, Hannah M. Schutz, Augustinus W.P. Keultjes, Nicole S. Erler, Quisette P. Janssen, Jeanin E. van Hooft, Niels G. Venneman, Pieter Honkoop, Lieke Hol, Robert C. Scheffer, Tanya M. Bisseling, Rogier P. Voermans, Frank P. Vleggaar, Matthijs P. Schwartz, Robert C. Verdonk, Chantal V. Hoge, Sjoerd D. Kuiken, Wouter L. Curvers, Frederike G.I. van Vilsteren, Alexander C. Poen, Marcel B. Spanier, Annette H. Bruggink, Frank M. Smedts, Marie-Louise F. van Velthuysen, Casper H. van Eijck, Marc G. Besselink, Bart J. Veldt, Bas G. Koerkamp, Lydi M.J.W. van Driel, Marco J. Bruno. Diagnostic accuracy of endoscopic ultrasonography-guided tissue acquisition prior to resection of pancreatic carcinoma: a nationwide analysis. HPB 2023; 25(11): 1438 doi: 10.1016/j.hpb.2023.07.900
|
| 189 |
Lihan Qian, Junjie Xie, Zhiwei Xu, Xiaxing Deng, Hao Chen, Chenghong Peng, Hongwei Li, Weimin Chai, Jing Xie, Weishen Wang, Baiyong Shen. The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01343
|
| 190 |
LSF Boogerd, FA Vuijk, CES Hoogstins, HJM Handgraaf, MJM van der Valk, PJK Kuppen, CFM Sier, CJH van de Velde, J Burggraaf, A Fariña-Sarasqueta, Alexander L Vahrmeijer. Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue. Biomarkers in Cancer 2017; 9: 1179299X1771001 doi: 10.1177/1179299X17710016
|
| 191 |
Vladislav E. Moiseenko, Alexander V. Pavlovsky, Dmitry A. Granov, Larisa V. Kochorova, Inna V. Dodonova, Valentin V. Khizha, Arkadii Yazenok, Taras V. Yakovenko. Analysis of statistical indicators of the population of Saint Petersburg with malignant neoplasms of pancreas. Bulletin of the Russian Military Medical Academy 2021; 23(2): 155 doi: 10.17816/brmma60343
|
| 192 |
Xunwei Huang, Li Huang, Minhua Shao. Aquaporin 3 facilitates tumor growth in pancreatic cancer by modulating mTOR signaling. Biochemical and Biophysical Research Communications 2017; 486(4): 1097 doi: 10.1016/j.bbrc.2017.03.168
|
| 193 |
Tongyi Zhang, Liyong Zhu, Jianhua Cai, Jiaqi He. Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation. Open Medicine 2022; 17(1): 427 doi: 10.1515/med-2022-0433
|
| 194 |
Cancan Zhou, Weikun Qian, Jie Li, Jiguang Ma, Xin Chen, Zhengdong Jiang, Liang Cheng, Wanxing Duan, Zheng Wang, Zheng Wu, Qingyong Ma, Xuqi Li. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1288-7
|
| 195 |
Yaowu Zhu, Li Tan, Danju Luo, Xiong Wang. Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data. Diagnostics 2024; 14(6): 667 doi: 10.3390/diagnostics14060667
|
| 196 |
Jiahui Tian, Chunyan Fu, Xuan Zeng, Xiaoxiao Fan, Yi Wu, Muhammad Babar Khawar. An Independent Prognostic Model Based on Ten Autophagy-Related Long Noncoding RNAs in Pancreatic Cancer Patients. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/3895396
|
| 197 |
Jie Hou, Zhan Wang, Hong Li, Hongzhi Zhang, Lan Luo. Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00522
|
| 198 |
Alessandro Bittoni, Riccardo Giampieri, Federica Pecci, Giada Pinterpe, Alessandra Mandolesi, Michela Del Prete, Antonio Zizzi, Sonia Crocetti, Carolina Liguori, Giulia Mentrasti, Luca Cantini, Chiara Pellei, Renato Bisonni, Marina Scarpelli, Rossana Berardi. Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Current Oncology 2021; 28(5): 3525 doi: 10.3390/curroncol28050303
|
| 199 |
Marta Fudalej, Daria Kwaśniewska, Paweł Nurzyński, Anna Badowska-Kozakiewicz, Dominika Mękal, Aleksandra Czerw, Katarzyna Sygit, Andrzej Deptała. New Treatment Options in Metastatic Pancreatic Cancer. Cancers 2023; 15(8): 2327 doi: 10.3390/cancers15082327
|
| 200 |
Mengna Zhang, Lirong Zeng, Yanan Peng, Bin Fan, PengFei Chen, Jing Liu. Immune-related genes LAMA2 and IL1R1 correlate with tumor sites and predict poor survival in pancreatic adenocarcinoma. Future Oncology 2021; 17(23): 3061 doi: 10.2217/fon-2020-1012
|
| 201 |
Aleksandra Krstic, Aleksandar Pavic, Edina Avdovic, Zoran Markovic, Milena Stevanovic, Isidora Petrovic. Coumarin-Palladium(II) Complex Acts as a Potent and Non-Toxic Anticancer Agent against Pancreatic Carcinoma Cells. Molecules 2022; 27(7): 2115 doi: 10.3390/molecules27072115
|
| 202 |
Mario Tadic, Tajana Stoos-Veic, Milan Kujundzic, Petra Turcic, Gorana Aralica, Ivo Boskoski. Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma. European Journal of Gastroenterology & Hepatology 2020; 32(4): 496 doi: 10.1097/MEG.0000000000001696
|
| 203 |
Var Ruchi Sharma, Manoj Singh, Vikas Kumar, Mukesh Yadav, Nirmala Sehrawat, Daljit K. Sharma, Anil K. Sharma. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease. Seminars in Cancer Biology 2021; 70: 61 doi: 10.1016/j.semcancer.2020.07.006
|
| 204 |
Jin Zhang, Xuesong Li, Yi Lu, Guowen Wang, Ying Ma. Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study. Cancers 2023; 15(12): 3146 doi: 10.3390/cancers15123146
|
| 205 |
Elif Gündoğdu, Emre Emekli, Mahmut Kebapçı. Relationship among CT-based abdominal adipose tissue areas and pancreatic ductal adenocarcinoma in male. The Aging Male 2020; 23(5): 1455 doi: 10.1080/13685538.2020.1793940
|
| 206 |
Fuad Fares, Soliman Khatib, Jacob Vaya, Lital Sharvit, Einav Eizenberg, Solomon Wasser. Striatal Isolated from Cyathus striatus Extracts Induces Apoptosis in Human Pancreatic Cancer Cells. Molecules 2022; 27(9): 2746 doi: 10.3390/molecules27092746
|
| 207 |
Rosie Meng, John W. Chen, Katina D'Onise, Savio G. Barreto. Pancreatic ductal adenocarcinoma survival in South Australia: time trends and impact of tumour location. ANZ Journal of Surgery 2021; 91(5): 921 doi: 10.1111/ans.16767
|
| 208 |
Vanessa L Gordon-Dseagu, Susan S Devesa, Michael Goggins, Rachael Stolzenberg-Solomon. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. International Journal of Epidemiology 2018; 47(2): 427 doi: 10.1093/ije/dyx232
|
| 209 |
Waclaw Moryson, Barbara Stawinska-Witoszynska. Premature Mortality Due to Tobacco-Related Malignancies in Poland. International Journal of General Medicine 2021; : 2171 doi: 10.2147/IJGM.S310416
|
| 210 |
Catalina Mosquera, Helen M. Johnson, Anastasios T. Mitsakos, Nina E. Neill, Nelly Bellamy, William Irish, Emmanuel E. Zervos, Shachar Laks. Predictive Value of Preoperative Serum CA19-9 on Margin Status. The American Surgeon 2019; 85(9): 965 doi: 10.1177/000313481908500937
|
| 211 |
A. A. Statsenko, V. E. Moiseenko, A. V. Pavlovsky, S. A. Popov, A. A. Polikarpov, E. V. Vlasova. First experience of using combination of conformal radiation therapy with intraarterial administration of gemcitabine and nanostabilized paclitaxel in patients with locally advanced pancreatic cancer complicated by persistent chronic pain. Medical alphabet 2020; (20): 15 doi: 10.33667/2078-5631-2020-20-15-20
|
| 212 |
Xiaojing Gu, Wei Zhou, Juan Han, Fahd Abd Algalil. Factors Affecting the Readmission of Patients with Pancreatic Cancer after Surgery. Applied Bionics and Biomechanics 2022; 2022: 1 doi: 10.1155/2022/6106914
|
| 213 |
Fangfang Nie, Mingli Yu, Kaili Zhang, Luping Yang, Qian Zhang, Shan Liu, Mengwei Liu, Mengke Shang, Fanxin Zeng, Wanyang Liu. Association of MTHFR gene polymorphisms with pancreatic cancer: meta-analysis of 17 case–control studies. International Journal of Clinical Oncology 2020; 25(2): 312 doi: 10.1007/s10147-019-01571-2
|
| 214 |
Anni M.Y. Zhang, Yi Han Xia, Jeffrey S.H. Lin, Ken H. Chu, Wei Chuan K. Wang, Titine J.J. Ruiter, Jenny C.C. Yang, Nan Chen, Justin Chhuor, Shilpa Patil, Haoning Howard Cen, Elizabeth J. Rideout, Vincent R. Richard, David F. Schaeffer, Rene P. Zahedi, Christoph H. Borchers, James D. Johnson, Janel L. Kopp. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metabolism 2023; 35(12): 2119 doi: 10.1016/j.cmet.2023.10.003
|
| 215 |
Dafeng Xu, Yu Wang, Xiangmei Liu, Kailun Zhou, Jincai Wu, Jiacheng Chen, Cheng Chen, Liang Chen, Jinfang Zheng. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. Pharmacological Research 2021; 164: 105370 doi: 10.1016/j.phrs.2020.105370
|
| 216 |
Muhammad Nadeem Yousaf, Fizah S Chaudhary, Amrat Ehsan, Alejandro L Suarez, Thiruvengadam Muniraj, Priya Jamidar, Harry R Aslanian, James J Farrell. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterology 2020; 7(1): e000408 doi: 10.1136/bmjgast-2020-000408
|
| 217 |
Hanqin Weng, Weijian Feng, Fengling Li, Dong Huang, Liangyi Lin, Zaiguo Wang. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial–mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression. Growth Factors 2023; 41(3): 152 doi: 10.1080/08977194.2023.2227272
|
| 218 |
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. Cells 2024; 13(7): 602 doi: 10.3390/cells13070602
|
| 219 |
Jinhong Wu, Dong-Hua Yang. Pancreatic Cancer-Derived Exosomes Promote the Proliferation, Invasion, and Metastasis of Pancreatic Cancer by the miR-3960/TFAP2A Axis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3590326
|
| 220 |
Niloy Ranjan Datta, Bernhard Pestalozzi, Pierre-Alain Clavien, Alexander Siebenhüner, Emsad Puric, Shaka Khan, Christoph Mamot, Oliver Riesterer, Jürg Knuchel, Cäcilia Sophie Reiner, Stephan Bodis. “HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0923-8
|
| 221 |
Pawel Namsolleck, Barbara Kofler, Gert N. Moll. Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(12): 10193 doi: 10.3390/ijms241210193
|
| 222 |
Masahiro Shiihara, Ryota Higuchi, Wataru Izumo, Takehisa Yazawa, Shuichiro Uemura, Toru Furukawa, Masakazu Yamamoto. Impact of the controlling nutritional status score on severe postoperative complications of pancreaticoduodenectomy for pancreatic cancer. Langenbeck's Archives of Surgery 2021; 406(5): 1491 doi: 10.1007/s00423-021-02151-7
|
| 223 |
Alexandria Turner, Danielle R. Bond, Quan V. Vuong, Anita Chalmers, Emma L. Beckett, Judith Weidenhofer, Christopher J. Scarlett. Elaeocarpus reticulatus fruit extracts reduce viability and induce apoptosis in pancreatic cancer cells in vitro. Molecular Biology Reports 2020; 47(3): 2073 doi: 10.1007/s11033-020-05307-8
|
| 224 |
Luis Eduardo Casasola-Sánchez, Fernando Burdio-Pinilla, José Antonio Pereira-Rodríguez, Aleksandar Radosevic, Laura Visa, Patricia Sánchez-Velázquez. Abdominal Wall Metastasis of Pancreatic Cancer. Pancreas 2021; 50(3): e31 doi: 10.1097/MPA.0000000000001761
|
| 225 |
Yingkai Wang, Jijun Zhang, Jiepeng Jia, Bo Qian, Xiaowen Tian. Circ_0008768 Suppresses the Pancreatic Cancer Progression via miR-330-
3p/PTEN Axis. Protein & Peptide Letters 2022; 29(9): 796 doi: 10.2174/0929866529666220726144619
|
| 226 |
Xiaoyuan Sun, Huijun Chu, Ke Lei, Yandong Ci, Haijun Lu, Jia Wang, Meng Zhou, He Ren, Tongsen Zheng. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma. Pancreatology 2022; 22(6): 749 doi: 10.1016/j.pan.2022.06.006
|
| 227 |
Elisabeth Castel-Kremer, Solene De Talhouet, Anne-Laure Charlois, Emmanuelle Graillot, Xavier Chopin-Laly, Mustapha Adham, Brigitte Comte, Catherine Lombard-Bohas, Thomas Walter, Gilles Boschetti. An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma. Journal of Geriatric Oncology 2018; 9(4): 373 doi: 10.1016/j.jgo.2018.03.007
|
| 228 |
Fei Chen, Erica J. Childs, Evelina Mocci, Paige Bracci, Steven Gallinger, Donghui Li, Rachel E. Neale, Sara H. Olson, Ghislaine Scelo, William R. Bamlet, Amanda L. Blackford, Michael Borges, Paul Brennan, Kari G. Chaffee, Priya Duggal, Manal J. Hassan, Elizabeth A. Holly, Rayjean J. Hung, Michael G. Goggins, Robert C. Kurtz, Ann L. Oberg, Irene Orlow, Herbert Yu, Gloria M. Petersen, Harvey A. Risch, Alison P. Klein. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Cancer Epidemiology, Biomarkers & Prevention 2019; 28(7): 1238 doi: 10.1158/1055-9965.EPI-18-1235
|
| 229 |
Ilias P. Nikas, Giannis Mountzios, Guy I. Sydney, Kalliopi J. Ioakim, Jae-Kyung Won, Panagiotis Papageorgis. Evaluating Pancreatic and Biliary Neoplasms with Small Biopsy-Based Next Generation Sequencing (NGS): Doing More with Less. Cancers 2022; 14(2): 397 doi: 10.3390/cancers14020397
|
| 230 |
Shei Li Chung, Wei Meng Lim, Chee Onn Leong, Maxine Swee Li Yee. Optimisation Studies of Mesoporous Silica Nanoparticle as a Drug Carrier for Gemcitabine: Enhancing Therapeutic Effectiveness in Pancreatic Cancer. Key Engineering Materials 2024; 977: 155 doi: 10.4028/p-PdcI7G
|
| 231 |
Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Shinichiro Yamada, Shohei Okikawa, Katsuki Miyazaki, Mitsuo Shimada. Short- and long-term outcomes of pancreatectomy in patients with hemodialysis. The Journal of Medical Investigation 2023; 70(1.2): 105 doi: 10.2152/jmi.70.105
|
| 232 |
Constança Oliveira, João Calmeiro, Mylène A. Carrascal, Amílcar Falcão, Célia Gomes, Bruno Miguel Neves, Maria Teresa Cruz. Exosomes as new therapeutic vectors for pancreatic cancer treatment. European Journal of Pharmaceutics and Biopharmaceutics 2021; 161: 4 doi: 10.1016/j.ejpb.2021.02.002
|
| 233 |
Tomohiko Taniai, Koichiro Haruki, Michinori Matsumoto, Taro Sakamoto, Hiroaki Shiba, Katsuhiko Yanaga. Incidental abdominal lymph node metastases from a known breast cancer in resected specimen of invasive pancreatic ductal adenocarcinoma: report of a case. International Cancer Conference Journal 2019; 8(4): 190 doi: 10.1007/s13691-019-00382-6
|
| 234 |
Beate Haugk, David Horton, Kofi Oppong, John Leeds, Antony Darne, Philip Sloan, Thomas Ness, Claire Jones, Paul Bassett, Manu Nayar. Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00652-5
|
| 235 |
Usama A. Fahmy, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, Nabil A. Alhakamy, Osama A. A. Ahmed, Mohamed F. Radwan, Basma G. Eid, Shaban R. M. Sayed, Gamal A. El Sherbiny, Walaa Abualsunun. Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells. Drug Delivery 2022; 29(1): 1863 doi: 10.1080/10717544.2022.2072544
|
| 236 |
Nilabja Sikdar, Akash Bararia, Ashmita Dutta, Sudeep Banerjee. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1525 doi: 10.1007/978-981-16-5422-0_77
|
| 237 |
Ariel A. Arteta, Martha Milanes‐Yearsley, Nora Cardona‐Castro. Cholangiocyte derived carcinomas and local microbiota. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(10): 1084 doi: 10.1002/jhbp.826
|
| 238 |
G. Carioli, P. Bertuccio, P. Boffetta, F. Levi, C. La Vecchia, E. Negri, M. Malvezzi. European cancer mortality predictions for the year 2020 with a focus on prostate cancer. Annals of Oncology 2020; 31(5): 650 doi: 10.1016/j.annonc.2020.02.009
|
| 239 |
Kexin Zheng, Xiaozhong Guo, Ji Feng, Zhaohui Bai, Xiaodong Shao, Fangfang Yi, Yongguo Zhang, Rui Zhang, Han Liu, Fernando Gomes Romeiro, Xingshun Qi. Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/3825186
|
| 240 |
Pınar KOÇATAKAN, Aziz KÜÇÜK, Zeki KADI, Hilmi ATASEVEN. Whipple Operasyonlarında Endoskopik Ultrasonagrafinin Önemi ve Fayda-Maliyet Analizi. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2021; 8(4): 657 doi: 10.34087/cbusbed.907903
|
| 241 |
Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels, Adam E. Frampton. Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(17): 4265 doi: 10.3390/cancers15174265
|
| 242 |
Hao Zuo, Luojun Chen, Na Li, Qibin Song. Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.612196
|
| 243 |
Lincheng Li, Wenbo Zou, Zhaohui Xiao, Zhaoda Deng, Rong Liu. Hypoxia-induced Long Non-coding RNA LSAMP-AS1 Regulates ceRNA
Network to Predict Prognosis for Pancreatic Cancer. Combinatorial Chemistry & High Throughput Screening 2023; 26(13): 2358 doi: 10.2174/1386207326666230314112238
|
| 244 |
Sumit Sahni, Christoph Krisp, Mark P. Molloy, Christopher Nahm, Sarah Maloney, Josef Gillson, Anthony J. Gill, Jaswinder Samra, Anubhav Mittal. PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression. Biochimica et Biophysica Acta (BBA) - General Subjects 2020; 1864(11): 129682 doi: 10.1016/j.bbagen.2020.129682
|
| 245 |
Sepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Masoud Delfi, Haroon Khan, Milad Ashrafizadeh, Gautam Sethi, Alan Prem Kumar. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells 2021; 10(12): 3348 doi: 10.3390/cells10123348
|
| 246 |
Yuichiro Tozuka, Makoto Ueno, Satoshi Kobayashi, Manabu Morimoto, Taito Fukushima, Yusuke Sano, Kuniyuki Kawano, Akane Hanaoka, Shun Tezuka, Hiroyuki Asama, Satoshi Moriya, Soichiro Morinaga, Shinichi Ohkawa, Shin Maeda. Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab‑paclitaxel: A retrospective study. Oncology Letters 2022; 24(4) doi: 10.3892/ol.2022.13495
|
| 247 |
Adam Polonski, Jakob R. Izbicki, Faik G. Uzunoglu. Centralization of Pancreatic Surgery in Europe. Journal of Gastrointestinal Surgery 2019; 23(10): 2081 doi: 10.1007/s11605-019-04215-y
|
| 248 |
Junxin Li, Jing Shen, Yueshui Zhao, Fukuan Du, Mingxing Li, Xu Xu, Yu Chen, Shurong Wang, Zhangang Xiao, Zhigui Wu. Role of miR‑181a‑5p in cancer (Review). International Journal of Oncology 2023; 63(4) doi: 10.3892/ijo.2023.5556
|
| 249 |
Madiha Niyaz, Mosin S. Khan, Rauf A. Wani, Omar J. Shah, Syed Mudassar. Sonic Hedgehog Protein is Frequently Up-Regulated in Pancreatic Cancer Compared to Colorectal Cancer. Pathology & Oncology Research 2020; 26(1): 551 doi: 10.1007/s12253-018-00564-2
|
| 250 |
C. Jiang, Y. Yuan, B. Gu, E. Ahn, J. Kim, D. Feng, Q. Huang, S. Song. Preoperative prediction of microvascular invasion and perineural invasion in pancreatic ductal adenocarcinoma with 18F-FDG PET/CT radiomics analysis. Clinical Radiology 2023; 78(9): 687 doi: 10.1016/j.crad.2023.05.007
|
| 251 |
Zhou Chen, Xiaodong Wei, Shi Dong, Fangfang Han, Ru He, Wence Zhou. Challenges and Opportunities Associated With Platelets in Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850485
|
| 252 |
Nannan Yang, Lin Liu, Xiaoyu Liu, Yingjie Chen, Jian Lu, Zhongmin Wang, Wen Shi. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6319685
|
| 253 |
Zibo Meng, Dianyun Ren, Kun Zhang, Jingyuan Zhao, Xin Jin, Heshui Wu. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma. Aging 2020; 12(6): 5048 doi: 10.18632/aging.102931
|
| 254 |
Jun Yao, Ce Zhang, Yanfei Chen, Shegan Gao. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sciences 2019; 239: 116871 doi: 10.1016/j.lfs.2019.116871
|
| 255 |
Sheng Yang, Tong Liu, Geyu Liang. The benefits of smoking cessation on survival in cancer patients by integrative analysis of multi‐omics data. Molecular Oncology 2020; 14(9): 2069 doi: 10.1002/1878-0261.12755
|
| 256 |
Huynh Tuan, Bui Minh, Phuong Tran, Jeong Lee, Ha Oanh, Quynh Ngo, Yen Nguyen, Pham Lien, Manh Tran. The Effects of 2′,4′-Dihydroxy-6′-methoxy-3′,5′- dimethylchalcone from Cleistocalyx operculatus Buds on Human Pancreatic Cancer Cell Lines. Molecules 2019; 24(14): 2538 doi: 10.3390/molecules24142538
|
| 257 |
Shuxian Chen, Xu Wang, Xianghui Ye, Jian Jin. Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1. Journal of Biosciences and Medicines 2017; 5(10): 64 doi: 10.4236/jbm.2017.510007
|
| 258 |
Guolin Wu, Zhenfeng Deng, Zongrui Jin, Jilong Wang, Banghao Xu, Jingjing Zeng, Minhao Peng, Zhang Wen, Ya Guo. Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1346045
|
| 259 |
Carlo Caputo, Michela Falco, Anna Grimaldi, Angela Lombardi, Chiara Carmen Miceli, Mariateresa Cocule, Marco Montella, Luca Pompella, Giuseppe Tirino, Severo Campione, Chiara Tammaro, Antonio Cossu, Grazia Fenu Pintori, Margherita Maioli, Donatella Coradduzza, Giovanni Savarese, Antonio Fico, Alessandro Ottaiano, Giovanni Conzo, Madhura S. Tathode, Fortunato Ciardiello, Michele Caraglia, Ferdinando De Vita, Gabriella Misso. Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(4): 824 doi: 10.3390/cancers16040824
|
| 260 |
Daniel Cui Zhou, Reyka G. Jayasinghe, Siqi Chen, John M. Herndon, Michael D. Iglesia, Pooja Navale, Michael C. Wendl, Wagma Caravan, Kazuhito Sato, Erik Storrs, Chia-Kuei Mo, Jingxian Liu, Austin N. Southard-Smith, Yige Wu, Nataly Naser Al Deen, John M. Baer, Robert S. Fulton, Matthew A. Wyczalkowski, Ruiyang Liu, Catrina C. Fronick, Lucinda A. Fulton, Andrew Shinkle, Lisa Thammavong, Houxiang Zhu, Hua Sun, Liang-Bo Wang, Yize Li, Chong Zuo, Joshua F. McMichael, Sherri R. Davies, Elizabeth L. Appelbaum, Keenan J. Robbins, Sara E. Chasnoff, Xiaolu Yang, Ashley N. Reeb, Clara Oh, Mamatha Serasanambati, Preet Lal, Rajees Varghese, Jay R. Mashl, Jennifer Ponce, Nadezhda V. Terekhanova, Lijun Yao, Fang Wang, Lijun Chen, Michael Schnaubelt, Rita Jui-Hsien Lu, Julie K. Schwarz, Sidharth V. Puram, Albert H. Kim, Sheng-Kwei Song, Kooresh I. Shoghi, Ken S. Lau, Tao Ju, Ken Chen, Deyali Chatterjee, William G. Hawkins, Hui Zhang, Samuel Achilefu, Milan G. Chheda, Stephen T. Oh, William E. Gillanders, Feng Chen, David G. DeNardo, Ryan C. Fields, Li Ding. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nature Genetics 2022; 54(9): 1390 doi: 10.1038/s41588-022-01157-1
|
| 261 |
Imtiyaz Yousuf, Mohammad Usman, Musheer Ahmad, Sartaj Tabassum, Farukh Arjmand. Single X-ray crystal structure, DFT studies and topoisomerase I inhibition activity of a tailored ionic Ag(i) nalidixic acid–piperazinium drug entity specific for pancreatic cancer cells. New Journal of Chemistry 2018; 42(1): 506 doi: 10.1039/C7NJ03602G
|
| 262 |
Rui Mu, Yong-Kang Zou, Kui Tu, Dian-Bei Wang, Dan Tang, Zhou Yu, Lijin Zhao. Hypoxia Promotes Pancreatic Cancer Cell Dedifferentiation to Stem-Like Cell Phenotypes With High Tumorigenic Potential by the HIF-1α/Notch Signaling Pathway. Pancreas 2021; 50(5): 756 doi: 10.1097/MPA.0000000000001828
|
| 263 |
Omar Abdel‐Rahman, Yuan Xu, Patricia A. Tang, Richard M. Lee‐Ying, Winson Y. Cheung. A real‐world, population‐based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer. Cancer Medicine 2018; 7(12): 6385 doi: 10.1002/cam4.1841
|
| 264 |
Rituraj Chakraborty, Anupam Dutta, Bhargab Jyoti Baruah, Rajni Kumari, Priyanku Sarma, Ankita Sharma, Krishangi Goswami, Haritha Myakala, Akalesh Kumar Verma. Pancreatic Cancer: A Review on Pathophysiology, Naturopathy, Clinical
Treatment and Outcomes. Current Cancer Therapy Reviews 2024; 20(3): 263 doi: 10.2174/1573394719666230830125213
|
| 265 |
Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas, Ryan M. Thomas, Steven J Hughes, Ibrahim Nassour, Kathryn Hitchcock, Karen Russell, Omar Kayaleh, Anita Turk, Robert Zlotecki, David L DeRemer, Thomas J George. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma. Future Oncology 2023; 19(27): 1841 doi: 10.2217/fon-2023-0256
|
| 266 |
Kelcie D. Willis, Jamie M. Jacobs. Closing the Caregiving Gap: Considerations for Pancreatic and Periampullary Cancer Caregivers. JCO Oncology Practice 2023; 19(8): 523 doi: 10.1200/OP.23.00274
|
| 267 |
Katarzyna Ratajczak, Natalia Glatzel-Plucińska, Katarzyna Ratajczak-Wielgomas, Katarzyna Nowińska, Sylwia Borska. Effect of Resveratrol Treatment on Human Pancreatic Cancer Cells through Alterations of Bcl-2 Family Members. Molecules 2021; 26(21): 6560 doi: 10.3390/molecules26216560
|
| 268 |
Rachel A. High, Edward A. Randtke, Kyle M. Jones, Leila R. Lindeman, Jacqueline C. Ma, Shu Zhang, Lucia G. LeRoux, Mark D. Pagel. Extracellular acidosis differentiates pancreatitis and pancreatic cancer in mouse models using acidoCEST MRI. Neoplasia 2019; 21(11): 1085 doi: 10.1016/j.neo.2019.09.004
|
| 269 |
Qingya Hao, Lihua Gao, Wenyang Niu, Liang Chen, Peng Zhang, Zhong Chen. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK‐3β/β‐catenin signaling. BioFactors 2020; 46(4): 685 doi: 10.1002/biof.1640
|
| 270 |
Saad Atiq, Osman O Atiq, Zainab O Atiq, Syed Samad, Omar Atiq. A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy. Cureus 2021; doi: 10.7759/cureus.13133
|
| 271 |
Norihiro Ishii, Kenichiro Araki, Takehiko Yokobori, Kei Hagiwara, Dorgormaa Gantumur, Takahiro Yamanaka, Tadashi Handa, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Atsushi Masamune, Kazuo Umezawa, Hiroyuki Kuwano, Ken Shirabe. Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts. Cancer Science 2019; 110(1): 334 doi: 10.1111/cas.13847
|
| 272 |
Maria J. Monroy-Iglesias, Saoirse Dolly, Debashis Sarker, Kiruthikah Thillai, Mieke Van Hemelrijck, Aida Santaolalla. Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies. Journal of Clinical Medicine 2021; 10(8): 1665 doi: 10.3390/jcm10081665
|
| 273 |
Ryota Kawamura, Yasutaka Ishii, Masahiro Serikawa, Tomofumi Tsuboi, Ken Tsushima, Shinya Nakamura, Tetsuro Hirano, Juri Ikemoto, Yusuke Kiyoshita, Sho Saeki, Yosuke Tamura, Sayaka Miyamoto, Kazuki Nakamura, Masaru Furukawa, Katsunari Ishida, Koji Arihiro, Kenichiro Uemura, Hiroshi Aikata. Optimal indication of endoscopic retrograde pancreatography-based cytology in the preoperative pathological diagnosis of pancreatic ductal adenocarcinoma. Pancreatology 2022; 22(3): 414 doi: 10.1016/j.pan.2022.02.001
|
| 274 |
G. C. Deng, Y. Lv, H. Yan, D. C. Sun, T. T. Qu, Y. T. Pan, Q. L. Han, G. H. Dai. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08943-w
|
| 275 |
Menggang Zhang, Fang Gao, Xiao Yu, Qiyao Zhang, Zongzong Sun, Yuting He, Wenzhi Guo. LINC00261: a burgeoning long noncoding RNA related to cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01988-8
|
| 276 |
Masataka Kikuyama, Jun Nakahodo, Goro Honda, Mizuka Suzuki, Shin-ichiro Horiguchi, Kazuro Chiba, Hiroki Tabata, Yusuke Ome, Shu-ichiro Uemura, Yusuke Kawamoto, Terumi Kamisawa. Pancreatic duct epithelial malignancy suggested by large focal pancreatic parenchymal atrophy in cystic diseases of the pancreas. Pancreatology 2023; 23(4): 420 doi: 10.1016/j.pan.2023.03.002
|
| 277 |
Urszula Religioni. Cancer incidence and mortality in Poland. Clinical Epidemiology and Global Health 2020; 8(2): 329 doi: 10.1016/j.cegh.2019.12.014
|
| 278 |
Shiu-Jau Chen, Shao-Cheng Wang, Yuan-Chuan Chen. The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(23): 12836 doi: 10.3390/ijms222312836
|
| 279 |
Catarina Melim, Maria R. Lauro, Isabel M. Pires, Paulo J. Oliveira, Célia Cabral. The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics. Pharmaceutics 2022; 14(1): 190 doi: 10.3390/pharmaceutics14010190
|
| 280 |
Shailesh V. Shrikhande, Rajesh S. Shinde, Vikram A. Chaudhari, Sagar R. Kurunkar, Ashwin L. Desouza, Vandana Agarwal, Manish S. Bhandare. Twelve Hundred Consecutive Pancreato‐Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Cancer Surgery Across India. World Journal of Surgery 2020; 44(8): 2784 doi: 10.1007/s00268-019-05235-0
|
| 281 |
A. Carrato, L. Cerezo, J. Feliu, T. Macarulla, E. Martín-Pérez, R. Vera, J. Álvarez, J. I. Botella-Carretero. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clinical and Translational Oncology 2022; 24(1): 112 doi: 10.1007/s12094-021-02674-x
|
| 282 |
Hengqing Zhu, Qing Li, Yulan Zhao, Hong Peng, Liangyun Guo, Jing Zhu, Zi Jiang, Zhaoxia Zeng, Bin Xu, Sisi Chen. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation. Oncogene 2021; 40(28): 4663 doi: 10.1038/s41388-021-01893-4
|
| 283 |
María Cascallar, Sandra Alijas, Alba Pensado-López, Abi Vázquez-Ríos, Laura Sánchez, Roberto Piñeiro, María de la Fuente. What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine. Cancers 2022; 14(9): 2238 doi: 10.3390/cancers14092238
|
| 284 |
Amirhossein Davoodvandi, Sahand Sadeghi, Seyed Mohammad Amin Alavi, Seyedeh Shaghayegh Alavi, Ameneh Jafari, Haroon Khan, Michael Aschner, Hamed Mirzaei, Mehran Sharifi, Zatollah Asemi. The therapeutic effects of berberine for gastrointestinal cancers. Asia-Pacific Journal of Clinical Oncology 2024; 20(2): 152 doi: 10.1111/ajco.13941
|
| 285 |
Jorge Paulino, Hélder Mansinho. Recent Developments in the Treatment of Pancreatic Cancer. Acta Médica Portuguesa 2023; 36(10): 670 doi: 10.20344/amp.19957
|
| 286 |
Peipei Hao, Jiamin Zhang, Shu Fang, Miaomiao Jia, Xian Xian, Sinan Yan, Yunpeng Wang, Qian Ren, Fengming Yue, Huixian Cui. Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway. Human Cell 2022; 35(5): 1475 doi: 10.1007/s13577-022-00735-z
|
| 287 |
Adam C. Mueller, Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia, Andy V. Phan, Benjamin Van Court, Kathryn L. Zolman, Brisa Peña, Ayman J. Oweida, Sara Zakem, Cheryl Meguid, Michael W. Knitz, Laurel Darragh, Thomas E. Bickett, Jacob Gadwa, Luisa Mestroni, Matthew R.G. Taylor, Kimberly R. Jordan, Peter Dempsey, M. Scott Lucia, Martin D. McCarter, Marco Del Chiaro, Wells A. Messersmith, Richard D. Schulick, Karyn A. Goodman, Michael J. Gough, Casey S. Greene, James C. Costello, Antonio Galveo Neto, David Lagares, Kirk C. Hansen, Adrie Van Bokhoven, Sana D. Karam. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Cancer Research 2021; 81(12): 3255 doi: 10.1158/0008-5472.CAN-20-3892
|
| 288 |
Su‐Ran Li, Qi‐Wen Man, Xin Gao, Hao Lin, Jing Wang, Fu‐Chuan Su, Han‐Qi Wang, Lin‐Lin Bu, Bing Liu, Gang Chen. Tissue‐derived extracellular vesicles in cancers and non‐cancer diseases: Present and future. Journal of Extracellular Vesicles 2021; 10(14) doi: 10.1002/jev2.12175
|
| 289 |
Ronit Patnaik, Mustafa Tamim Alam Khan, Ince Spencer, Hassan Aziz. Chronic Kidney Disease Classification Predicts Short-Term Outcomes of Patients Undergoing Pancreaticoduodenectomy. Journal of Gastrointestinal Surgery 2022; 26(12): 2534 doi: 10.1007/s11605-022-05512-9
|
| 290 |
Linda M. Pak, Mithat Gonen, Kenneth Seier, Vinod P. Balachandran, Michael I. D’Angelica, William R. Jarnagin, T. Peter Kingham, Peter J. Allen, Richard K. G. Do, Amber L. Simpson. Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma?. Abdominal Radiology 2018; 43(8): 2113 doi: 10.1007/s00261-017-1407-x
|
| 291 |
Maria Rafaeva, Adina R. D. Jensen, Edward R. Horton, Kamilla W. Zornhagen, Jan E. Strøbech, Lutz Fleischhauer, Alejandro E. Mayorca-Guiliani, Sebastian R. Nielsen, Dina S. Grønseth, Filip Kuś, Erwin M. Schoof, Luis Arnes, Manuel Koch, Hauke Clausen-Schaumann, Valerio Izzi, Raphael Reuten, Janine T. Erler. Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1154528
|
| 292 |
Xabier Osteikoetxea, Márton Benke, Marta Rodriguez, Krisztina Pálóczi, Barbara W. Sódar, Zsuzsanna Szvicsek, Katalin Szabó-Taylor, Krisztina V. Vukman, Ágnes Kittel, Zoltán Wiener, Károly Vékey, László Harsányi, Ákos Szűcs, Lilla Turiák, Edit I. Buzás. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice. Biochemical and Biophysical Research Communications 2018; 499(1): 37 doi: 10.1016/j.bbrc.2018.03.107
|
| 293 |
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
|
| 294 |
Katharina Seidensaal, Semi Ben Harrabi, Jürgen Debus. Molecular Imaging in Oncology. Recent Results in Cancer Research 2020; 216: 865 doi: 10.1007/978-3-030-42618-7_28
|
| 295 |
Yiping He, Yan Liu, Jianping Gong, Changan Liu, Hua Zhang, Hao Wu. Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10041
|
| 296 |
Jindan Li, Chaojiang Fu, Sheng Zhao, Yongzhu Pu, Fake Yang, Shuguang Zeng, Conghui Yang, Hongqiang Gao, Long Chen. The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.920896
|
| 297 |
Shahin Aghamiri, Pourya Raee, Sam Talaei, Samira Mohammadi‐Yeganeh, Shiva Bayat, Delsuz Rezaee, Afshin A. Ghavidel, Alireza Teymouri, Soheil Roshanzamiri, Shohreh Farhadi, Hossein Ghanbarian. Nonviral siRNA delivery systems for pancreatic cancer therapy. Biotechnology and Bioengineering 2021; 118(10): 3669 doi: 10.1002/bit.27869
|
| 298 |
Tomohiro Iguchi, Norifumi Iseda, Kosuke Hirose, Shinji Itoh, Noboru Harada, Mizuki Ninomiya, Keishi Sugimachi, Takuya Honboh, Takashi Maeda, Noriaki Sadanaga, Hiroshi Matsuura. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma. The American Surgeon™ 2023; 89(6): 2213 doi: 10.1177/00031348221086782
|
| 299 |
Dian Dayer, Mohammad R. Tabandeh, Majid Kazemi. The Radio-Sensitizing Effect of Pharmacological Concentration of Ascorbic Acid on Human Pancreatic Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(16): 1927 doi: 10.2174/1871520620666200612144124
|
| 300 |
Nicolette Casarcia, Patrick Rogers, Emma Guld, Samvit Iyer, Yutong Li, Jack T. Burcher, Lindsay K. DeLiberto, Sabyasachi Banerjee, Anupam Bishayee. Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects. British Journal of Pharmacology 2023; doi: 10.1111/bph.16249
|
| 301 |
Jae Jin Lee, Han Taek Jeong, June Hwa Bae. A Case of Complete Remission from Pancreatic Cancer Following Palliative Chemotherapy. The Korean Journal of Pancreas and Biliary Tract 2023; 28(4): 131 doi: 10.15279/kpba.2023.28.4.131
|
| 302 |
Lingdi Yin, Linmei Xiao, Yong Gao, Guangfu Wang, Hao Gao, Yunpeng Peng, Xiaole Zhu, Jishu Wei, Yi Miao, Kuirong Jiang, Zipeng Lu. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer. Medical Oncology 2020; 37(5) doi: 10.1007/s12032-020-01370-0
|
| 303 |
Meng Gao, Yonghua Guo, Jinghua Li, Xi Chen, Yufeng Yuan, Weijie Ma. The Clinicopathological Significance and Prognostic Value of PD-L2 in Patients with HCC, ICC and PAAD: A Meta-Analysis. International Journal of Surgery Oncology 2022; 7(1): 81 doi: 10.29337/ijsonco.142
|
| 304 |
Lu Junliang, Wang Lili, Liang Xiaolong, Liu Xuguang, Wu Huanwen, Liang Zhiyong. High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling. Biochemical and Biophysical Research Communications 2019; 515(3): 493 doi: 10.1016/j.bbrc.2019.05.167
|
| 305 |
Xun Liu, Bobo Chen, Jiahui Chen, Shaolong Sun. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08066-2
|
| 306 |
Haisu Dai, Kaicheng Shen, Yishi Yang, Xingxing Su, Yuandeng Luo, Yan Jiang, Ling Shuai, Ping Zheng, Zhiyu Chen, Ping Bie. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells. Cell Death & Disease 2019; 10(8) doi: 10.1038/s41419-019-1839-z
|
| 307 |
Elham Khanlarzadeh, Saman Nazari, Mehdi Ghobakhlou, Hossein Ranjbar, Sasan Nazari. Epidemiologic and Pathologic Study of Pancreatic Cancer in Hamadan, Iran (2008 to 2018). Journal of Gastrointestinal Cancer 2022; 53(3): 725 doi: 10.1007/s12029-021-00706-x
|
| 308 |
Yeting Lu, Dongjian Ying, Yuan Tian, Yi Ruan, Gong Cheng, Kaiji Lv, Xinhua Zhou, Shuo Han. LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2. Clinics 2022; 77: 100047 doi: 10.1016/j.clinsp.2022.100047
|
| 309 |
Lun Zhang, Wunai Zhang, Xin Zhang, Yihe Min, Yang Zhao, Baofeng Wang, Wei Li, Shuai Mao, Weili Min. High‑glucose microenvironment promotes perineural invasion of pancreatic cancer via activation of hypoxia inducible factor 1α. Oncology Reports 2022; 47(4) doi: 10.3892/or.2022.8275
|
| 310 |
Rongwen Ou, Chengjie Lin, Youting Chen. CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway. Archives of Biochemistry and Biophysics 2023; 747: 109760 doi: 10.1016/j.abb.2023.109760
|
| 311 |
Limei Cui, Naqiang Lv, Bin Li, Jing Tao, Xiaomin Zheng, Yehua Yan, Cuiping Liu. Serum CA 19–9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes 2021; 129(08): 581 doi: 10.1055/a-0994-9970
|
| 312 |
Roshini Kalagara, Abdullah Norain, Yu-Hui Chang, Chee-Chee Stucky, Nabil Wasif. Association of Textbook Outcome and Surgical Case Volume with Long-Term Survival in Patients Undergoing Surgical Resection for Pancreatic Cancer. Journal of the American College of Surgeons 2022; 235(6): 829 doi: 10.1097/XCS.0000000000000407
|
| 313 |
Flavio Roberto Takeda, Ulysses Ribeiro, Fabio Ferrari Makdissi, Marcel Autran Machado, Carlos Frederico Sparapan Marques, Caio Sergio Rizkallah Nahas, Rodrigo Ambar Pinto, Sergio Carlos Nahas. Vascular Surgery in Oncology. 2022; : 97 doi: 10.1007/978-3-030-97687-3_3
|
| 314 |
Dominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, Felix Prinz, Eva Valentina Klocker, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients. Cancer Medicine 2020; 9(15): 5473 doi: 10.1002/cam4.3233
|
| 315 |
Xin Wang, Qingqing Yu, Xue Bai, Xinyu Li, Yanli Sun, Xiaoxiang Peng, Ronglan Zhao. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers. European Journal of Cancer Prevention 2024; 33(3): 271 doi: 10.1097/CEJ.0000000000000851
|
| 316 |
Huilin Zheng, Bisha Ding, Ke Xue, Jinxiao Yu, Weiyang Lou. Construction of a lncRNA/pseudogene-hsa-miR-30d-5p-GJA1 regulatory network related to metastasis of pancreatic cancer. Genomics 2021; 113(4): 1742 doi: 10.1016/j.ygeno.2021.04.013
|
| 317 |
Iván A. González, Liang-I Kang, Gregory A. Williams, Jingxia Liu, David G. DeNardo, William G. Hawkins, Deyali Chatterjee. Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor. American Journal of Surgical Pathology 2020; 44(6): 817 doi: 10.1097/PAS.0000000000001454
|
| 318 |
Tzu-Pin Lu, Chien-Hui Wu, Chia-Chen Chang, Han-Ching Chan, Amrita Chattopadhyay, Wen-Chung Lee, Chun-Ju Chiang, Hsin-Ying Lee, Yu-Wen Tien. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Annals of Surgical Oncology 2022; 29(3): 1608 doi: 10.1245/s10434-021-11030-w
|
| 319 |
Dany Barrak, Anthony M. Villano, Nicole Villafane-Ferriol, Leah G. Stockton, Maureen V. Hill, Mengying Deng, Elizabeth A. Handorf, Sanjay S. Reddy. Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response. European Journal of Surgical Oncology 2022; 48(6): 1356 doi: 10.1016/j.ejso.2021.12.473
|
| 320 |
Nilabja Sikdar, Akash Bararia, Ashmita Dutta, Sudeep Banerjee. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1 doi: 10.1007/978-981-16-1247-3_77-1
|
| 321 |
Morten Hasselstrøm Jensen, Claus Dethlefsen, Ole Hejlesen, Peter Vestergaard. Association of severe hypoglycemia with mortality for people with diabetes mellitus during a 20-year follow-up in Denmark: a cohort study. Acta Diabetologica 2020; 57(5): 549 doi: 10.1007/s00592-019-01447-x
|
| 322 |
Akram Pourshams, Sadaf G Sepanlou, Kevin S Ikuta, Catherine Bisignano, Saeid Safiri, Gholamreza Roshandel, Mehdi Sharif, Morteza Khatibian, Christina Fitzmaurice, Molly R Nixon, Nooshin Abbasi, Mohsen Afarideh, Elham Ahmadian, Tomi Akinyemiju, Fares Alahdab, Tahiya Alam, Vahid Alipour, Christine A Allen, Nahla Hamed Anber, Alireza Ansari-Moghaddam, Jalal Arabloo, Alaa Badawi, Mojtaba Bagherzadeh, Yaschilal Muche Belayneh, Belete Biadgo, Ali Bijani, Antonio Biondi, Tone Bjørge, Antonio M Borzì, Cristina Bosetti, Andrey Nikolaevich Briko, Nikolay Ivanovich Briko, Giulia Carreras, Félix Carvalho, Jee-Young J Choi, Dinh-Toi Chu, Anh Kim Dang, Ahmad Daryani, Dragos Virgil Davitoiu, Gebre Teklemariam Demoz, Rupak Desai, Subhojit Dey, Hoa Thi Do, Huyen Phuc Do, Aziz Eftekhari, Alireza Esteghamati, Farshad Farzadfar, Eduarda Fernandes, Irina Filip, Florian Fischer, Masoud Foroutan, Mohamed M Gad, Silvano Gallus, Birhanu Geta, Giuseppe Gorini, Nima Hafezi-Nejad, James D Harvey, Milad Hasankhani, Amir Hasanzadeh, Soheil Hassanipour, Simon I Hay, Hagos D Hidru, Chi Linh Hoang, Sorin Hostiuc, Mowafa Househ, Olayinka Stephen Ilesanmi, Milena D Ilic, Seyed Sina Naghibi Irvani, Nader Jafari Balalami, Spencer L James, Farahnaz Joukar, Amir Kasaeian, Tesfaye Dessale Kassa, Andre Pascal Kengne, Rovshan Khalilov, Ejaz Ahmad Khan, Amir Khater, Fatemeh Khosravi Shadmani, Jonathan M Kocarnik, Hamidreza Komaki, Ai Koyanagi, Vivek Kumar, Carlo La Vecchia, Platon D Lopukhov, Farzad Manafi, Navid Manafi, Ana-Laura Manda, Fariborz Mansour-Ghanaei, Dhruv Mehta, Varshil Mehta, Toni Meier, Hagazi Gebre Meles, Getnet Mengistu, Tomasz Miazgowski, Mehdi Mohamadnejad, Abdollah Mohammadian-Hafshejani, Milad Mohammadoo-Khorasani, Shafiu Mohammed, Farnam Mohebi, Ali H Mokdad, Lorenzo Monasta, Maryam Moossavi, Rahmatollah Moradzadeh, Gurudatta Naik, Ionut Negoi, Cuong Tat Nguyen, Long Hoang Nguyen, Trang Huyen Nguyen, Andrew T Olagunju, Tinuke O Olagunju, Alyssa Pennini, Mohammad Rabiee, Navid Rabiee, Amir Radfar, Mahdi Rahimi, Goura Kishor Rath, David Laith Rawaf, Salman Rawaf, Robert C Reiner, Nima Rezaei, Aziz Rezapour, Anas M Saad, Seyedmohammad Saadatagah, Amirhossein Sahebkar, Hamideh Salimzadeh, Abdallah M Samy, Juan Sanabria, Arash Sarveazad, Monika Sawhney, Mario Sekerija, Pavel Shabalkin, Masood Ali Shaikh, Rajesh Sharma, Sara Sheikhbahaei, Reza Shirkoohi, Sudeep K Siddappa Malleshappa, Mekonnen Sisay, Kjetil Soreide, Sergey Soshnikov, Rasoul Sotoudehmanesh, Vladimir I Starodubov, Michelle L Subart, Rafael Tabarés-Seisdedos, Degena Bahray Bahrey Tadesse, Eugenio Traini, Bach Xuan Tran, Khanh Bao Tran, Irfan Ullah, Marco Vacante, Amir Vahedian-Azimi, Elena Varavikova, Ronny Westerman, Dawit Dawit Zewdu Wondafrash, Rixing Xu, Naohiro Yonemoto, Vesna Zadnik, Zhi-Jiang Zhang, Reza Malekzadeh, Mohsen Naghavi. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology 2019; 4(12): 934 doi: 10.1016/S2468-1253(19)30347-4
|
| 323 |
Negar Khoshghamat, Niloufar Jafari, Vajiheh Toloue-pouya, Shakiba Azami, Seyyedeh Helya Mirnourbakhsh, Majid Khazaei, Gordon A. Ferns, Majid Rajabian, Amir Avan. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer. Life Sciences 2021; 270: 119118 doi: 10.1016/j.lfs.2021.119118
|
| 324 |
Caterina Arru, Maria Rosaria De Miglio, Antonio Cossu, Maria Rosaria Muroni, Ciriaco Carru, Angelo Zinellu, Panagiotis Paliogiannis. Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review. Advances in Therapy 2021; 38(7): 3674 doi: 10.1007/s12325-021-01796-6
|
| 325 |
Damiano Caputo, Giulio Caracciolo. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma. Cancer Letters 2020; 470: 191 doi: 10.1016/j.canlet.2019.11.030
|
| 326 |
John M. Allen, MegCholack Awunti, Yi Guo, Jiang Bian, Sherise C. Rogers, Lisa Scarton, David L. DeRemer, Diana J. Wilkie. Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(12): 1675 doi: 10.1158/1055-9965.EPI-23-0251
|
| 327 |
Mirang Lee, Wooil Kwon, Hongbeom Kim, Yoonhyeong Byun, Youngmin Han, Jae Seung Kang, Yoo Jin Choi, Jin-Young Jang. The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer. Cancers 2020; 12(8): 2036 doi: 10.3390/cancers12082036
|
| 328 |
Miaobin Mao, Hongjian Ling, Yuping Lin, Yanling Chen, Benhua Xu, Rong Zheng. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.702102
|
| 329 |
Anna Tesei, Michela Cortesi, Sara Pignatta, Chiara Arienti, Giulio Massimo Dondio, Chiara Bigogno, Alessio Malacrida, Mariarosaria Miloso, Cristina Meregalli, Alessia Chiorazzi, Valentina Carozzi, Guido Cavaletti, Marta Rui, Annamaria Marra, Daniela Rossi, Simona Collina. Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00490
|
| 330 |
Karishma M. Parikh, Rajiv S. Magge. Central Nervous System Metastases. 2020; : 245 doi: 10.1007/978-3-030-42958-4_17
|
| 331 |
Mitchell S. von Itzstein, Michael C. Burke, Rolf A. Brekken, Todd A. Aguilera, Herbert J. Zeh, Muhammad Shaalan Beg. Targeting TAM to Tame Pancreatic Cancer. Targeted Oncology 2020; 15(5): 579 doi: 10.1007/s11523-020-00751-9
|
| 332 |
Stavros Parasyris, Ioannis Hatzaras, Vasiliki Ntella, Theodoros Sidiropoulos, Ioannis Margaris, Nikos Pantazis, Panagiotis Kokoropoulos, Panteleimon Vassiliu, Paraskevi Matsota, Vasileios Smyrniotis, Nikolaos Arkadopoulos. Pancreaticoduodenectomy as a feasible choice for periampullary malignancy in octogenarians. Molecular and Clinical Oncology 2022; 17(4) doi: 10.3892/mco.2022.2581
|
| 333 |
Xuanming Liu, Hongbo Zhang, Jianlin Cao, Yuzhen Zhuo, Jiahui Jin, Qiaoying Gao, Xiangfei Yuan, Lei Yang, Dihua Li, Yan Wang. Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.919035
|
| 334 |
Chao-Ming Tseng, Shih-Pei Huang, Wei-Chih Liao, Chun-Ju Chiang, Ya-Wen Yang, Chi-Yang Chang, Yao-Chun Hsu, Hui-Chi Chen, Han-Sun Chiang, Jaw-Town Lin. Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999–2012. Cancer Epidemiology 2017; 49: 75 doi: 10.1016/j.canep.2017.05.011
|
| 335 |
Hsiang‐Lan Lai, Yen‐Yang Chen, Chang‐Hsien Lu, Chia‐Yen Hung, Yung‐Chia Kuo, Jen‐Shi Chen, Hung‐Chih Hsu, Ping‐Tsung Chen, Pei‐Hung Chang, Yu‐Shin Hung, Wen‐Chi Chou. Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan. Cancer Medicine 2019; 8(5): 2085 doi: 10.1002/cam4.2094
|
| 336 |
Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Sara M. Hamouda. Long non‐coding RNA FAM83H‐AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer. Cell Biochemistry and Function 2021; 39(3): 350 doi: 10.1002/cbf.3601
|
| 337 |
Pınar KOÇATAKAN, Hilmi ATASEVEN. PANKREAS KANSERİ. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 2021; 54(1): 59 doi: 10.20492/aeahtd.806164
|
| 338 |
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli, Chun-Wai Mai. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1153-8
|
| 339 |
Jingsheng Ma, Yajun Wu, Shibao Cheng, Wentao Yang, Lin Zhong, Qigen Li, Lu Fang. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2. Digestive Diseases and Sciences 2023; 68(5): 1913 doi: 10.1007/s10620-022-07780-6
|
| 340 |
Anabela Barros, Catarina Pulido, Manuela Machado, Maria Brito, Nuno Couto, Olga Sousa, Sónia Melo, Hélder Mansinho. Treatment optimization of locally advanced and metastatic pancreatic cancer (Review). International Journal of Oncology 2021; 59(6) doi: 10.3892/ijo.2021.5290
|
| 341 |
Tomohiko Sunami, Atsushi Yamada, Tomohiro Kondo, Masashi Kanai, Kazuyuki Nagai, Yoichiro Uchida, Masataka Yokode, Tomoaki Matsumori, Norimitsu Uza, Hiromi Murakami, Takahiro Yamada, Manabu Muto. Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant. Pancreas 2022; 51(9): 1258 doi: 10.1097/MPA.0000000000002150
|
| 342 |
Giuseppe Quero, Nicolò Pecorelli, Salvatore Paiella, Claudio Fiorillo, Maria Chiara Petrone, Fausto Rosa, Giovanni Capretti, Vito Laterza, Emanuele Kauffmann, Sara Nobile, Giovanni Butturini, Giovanni Ferrari, Andrea Coratti, Riccardo Casadei, Vincenzo Mazzaferro, Ugo Boggi, Alessandro Zerbi, Roberto Salvia, Massimo Falconi, Sergio Alfieri. Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers. Updates in Surgery 2022; 74(1): 255 doi: 10.1007/s13304-021-01171-8
|
| 343 |
Mohini Singh, Bani Kumar Jana, Paulami Pal, Ishita Singha, Ananya Rajkumari, Pinky Chowrasia, Venessa Nath, Bhaskar Mazumder. Nanoparticles in pancreatic cancer therapy: a detailed and elaborated review on patent literature. Expert Opinion on Therapeutic Patents 2023; 33(10): 681 doi: 10.1080/13543776.2023.2287520
|
| 344 |
Richard Drexler, Mirco Küchler, Kim C. Wagner, Tim Reese, Bernd Feyerabend, Moritz Kleine, Karl J. Oldhafer. The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2021; 147(2): 373 doi: 10.1007/s00432-020-03427-z
|
| 345 |
Ana Rebelo, Catarina Reis. Emerging therapeutic nanotechnologies in pancreatic cancer: advances, risks and challenges. Therapeutic Delivery 2018; 9(10): 691 doi: 10.4155/tde-2018-0048
|
| 346 |
Takahiro Seimiya, Motoyuki Otsuka, Takuma Iwata, Eri Tanaka, Tatsunori Suzuki, Kazuma Sekiba, Mari Yamagami, Rei Ishibashi, Kazuhiko Koike. Inflammation and de-differentiation in pancreatic carcinogenesis. World Journal of Clinical Cases 2018; 6(15): 882-891 doi: 10.12998/wjcc.v6.i15.882
|
| 347 |
Mueataz A. Mahyoub, Mohamed Elhoumed, Abdulfatah Hassan Maqul, Maged Almezgagi, Mustafa Abbas, Yang Jiao, Jinhai Wang, Mohammed Alnaggar, Ping Zhao, Shuixiang He. Fatty infiltration of the pancreas: a systematic concept analysis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1227188
|
| 348 |
Eva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, Felix Prinz, Joanna Szkandera, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Jörg Lindenmann, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler. Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients. Cancers 2020; 12(5): 1154 doi: 10.3390/cancers12051154
|
| 349 |
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Adenocarcinoma ductal de páncreas. Experiencia de 11 años en un centro de tercer nivel. Revista de Gastroenterología de México 2021; 86(2): 118 doi: 10.1016/j.rgmx.2020.04.004
|
| 350 |
Teresa Starzyńska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber-Lubecka, Filip Ambrożkiewicz, Michał Mikula, Beata Kos-Kudła, Jerzy Ostrowski. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. International Journal of Molecular Sciences 2020; 21(12): 4470 doi: 10.3390/ijms21124470
|
| 351 |
Jorge A. Roacho-Pérez, Elsa N. Garza-Treviño, Paulina Delgado-Gonzalez, Zuca G-Buentello, Juan Luis Delgado-Gallegos, Christian Chapa-Gonzalez, Margarita Sánchez-Domínguez, Celia N. Sánchez-Domínguez, Jose Francisco Islas. Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. Life 2021; 11(11): 1187 doi: 10.3390/life11111187
|
| 352 |
Wei Huang, Jian Lu, Ke-Min Chen, Zhi-Yuan Wu, Qing-Bin Wang, Jing-Jing Liu, Ju Gong, Zhi-Jin Chen, Xiao-Yi Ding, Zhong-Min Wang. Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. World Journal of Gastroenterology 2018; 24(46): 5280-5287 doi: 10.3748/wjg.v24.i46.5280
|
| 353 |
Hao Hua, Huahua Xie, Jian Zheng, Linhan Lei, Zilei Deng, Chao Yu, Mohd Adnan. RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/1728463
|
| 354 |
H.H. Rashwan, A.M. Taher, H.A. Hassan, A.A. Awaji, C.J. Kiriacos, R.A. Assal, R.A. Youness. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice 2024; 256: 155223 doi: 10.1016/j.prp.2024.155223
|
| 355 |
Ankit Dalal, Gaurav Patil, Amol Vadgaonkar, Amit Maydeo. A rare case of intraductal tubulopapillary neoplasm of the pancreas – case report (with video). Postgraduate Medicine 2020; 132(3): 270 doi: 10.1080/00325481.2019.1669058
|
| 356 |
Marion Lassalle, Thien Le Tri, Pauline Afchain, Marine Camus, Julien Kirchgesner, Mahmoud Zureik, Rosemary Dray-Spira. Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case–Control Study Based on the French National Health Data System (SNDS). Cancer Epidemiology, Biomarkers & Prevention 2022; 31(3): 662 doi: 10.1158/1055-9965.EPI-21-0786
|
| 357 |
Yoonseon Jeong, Joo Lim, Hyeyoung Kim. Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells. Nutrients 2019; 11(4): 762 doi: 10.3390/nu11040762
|
| 358 |
Fatemeh Sadoughi, Parisa Maleki Dana, Mina Homayoonfal, Mehran Sharifi, Zatollah Asemi. Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin. Biochimie 2022; 202: 15 doi: 10.1016/j.biochi.2022.05.012
|
| 359 |
Thejus Jayakrishnan, Dhwani Pandya, Dulabh Monga. Colloid Carcinoma of Pancreas in the Setting of Intraductal Papillary Mucinous Neoplasm (IPMN). Journal of Gastrointestinal Cancer 2020; 51(2): 658 doi: 10.1007/s12029-019-00322-w
|
| 360 |
Adam Hermawan, Herwandhani Putri, Rohmad Yudi Utomo. Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy. DARU Journal of Pharmaceutical Sciences 2020; 28(2): 685 doi: 10.1007/s40199-020-00375-4
|
| 361 |
YuBao Song, ZeFeng Gao, CaiHong Zheng. Silencing LINC01234 represses pancreatic cancer progression by inhibiting the malignant phenotypes of pancreatic cancer cells. Immunobiology 2022; 227(6): 152295 doi: 10.1016/j.imbio.2022.152295
|
| 362 |
Zun Fan, Ming Li, Yinjie Xu, Chenxing Ge, Jianfeng Gu. EPS8L3 promotes pancreatic cancer proliferation and metastasis by activating GSK3B. Journal of Medical Biochemistry 2023; 42(1): 105 doi: 10.5937/jomb0-38840
|
| 363 |
Julheli R. Girardelo, Eduarda L. Munari, Julio C.S. Dallorsoleta, Gustavo Cechinel, André L.F. Goetten, Luziane R. Sales, Flávio H. Reginatto, Vitor C. Chaves, Franciele A. Smaniotto, Sabrina Somacal, Tatiana Emanuelli, Juan Claudio Benech, Cristian Soldi, Evelyn Winter, Greicy M.M. Conterato. Bioactive compounds, antioxidant capacity and antitumoral activity of ethanolic extracts from fruits and seeds of Eugenia involucrata DC. Food Research International 2020; 137: 109615 doi: 10.1016/j.foodres.2020.109615
|
| 364 |
旭升 张. Research Progress of GRP78 in Gastrointestinal Cancer. Advances in Clinical Medicine 2022; 12(12): 11430 doi: 10.12677/ACM.2022.12121647
|
| 365 |
Jian Wei Xu, Ye Yan, Lei Wang, Dong Wu, Nai Kuan Ye, Shi Hong Chen, Feng Li. Marine bioactive compound dieckol induces apoptosis and inhibits the growth of human pancreatic cancer cells PANC‐1. Journal of Biochemical and Molecular Toxicology 2021; 35(2) doi: 10.1002/jbt.22648
|
| 366 |
Cuicui Li, Jun Liu, Xu Yang, Qi Yang, Wenpeng Huang, Mingyu Zhang, Dandan Zhou, Rong Wang, Jianhua Gong, Qingfang Miao, Lei Kang, Jigang Yang. Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. European Journal of Nuclear Medicine and Molecular Imaging 2022; 50(1): 168 doi: 10.1007/s00259-022-05954-y
|
| 367 |
Naveen Manisundaram, Jorge I Portuondo, Derek Erstad, Eric Silberfein, Cary Hsu, Omar Barakat, Amy Wood, Martina Navarro-Cagigas, George Van Buren, William E Fisher, E Ramsay Camp. Pretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients. Journal of the American College of Surgeons 2023; 236(4): 861 doi: 10.1097/XCS.0000000000000549
|
| 368 |
Weiwei Shao, Zhenhua Lu, Jingyong Xu, Xiaolei Shi, Tianhua Tan, Cheng Xing, Jinghai Song. Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study. Frontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.804785
|
| 369 |
Yingjun Ma, Yuanyuan Ma, Jinbo Xu. Hypergraph-based logistic matrix factorization for metabolite–disease interaction prediction. Bioinformatics 2022; 38(2): 435 doi: 10.1093/bioinformatics/btab652
|
| 370 |
Shuxian Zhang, Qingqing Li, Huixiao Yuan, Ling Ren, Xuyang Liang, Shouying Li, Shengxiang Lv, Hua Jiang, Alamgeer Yuchi. Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Cancer by Regulating RNA Binding Motif Protein 14. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5091154
|
| 371 |
Paula A. Lopes, Elisabete Fonseca, Inês V. da Silva, Emanuel Vigia, Jorge Paulino, Graça Soveral. Aquaporins Transcripts with Potential Prognostic Value in Pancreatic Cancer. Genes 2023; 14(9): 1694 doi: 10.3390/genes14091694
|
| 372 |
Myrna Hurtado, Sunil Shah, Maya Nair, Riyaz Basha. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; : 13 doi: 10.1016/B978-0-12-817661-0.00002-0
|
| 373 |
Bei Wang, Jinlan Chen, Chen Lin, Ru Liu, Lu Wang, Chengfu Yuan. MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways. Mini-Reviews in Medicinal Chemistry 2022; 22(16): 2138 doi: 10.2174/1389557522666220214100718
|
| 374 |
Ibrahim G Alghamdi, Majid Almadi, Fahad Alsohaibani, Mahmoud Mosli, Edward B De Vol, Faisal Abaalkhail, Faisal A AlSaif, Waleed K Al-hamoudi, Nasser Al-Sanea, Mazen Hassanain, Saleh A Alqahtani. Epidemiology of Pancreatic Cancer in Saudi Arabia: A Retrospective Analysis of Pancreatic Cancer Diagnosed in Saudi Arabia Between 2004 and 2015. Clinical and Experimental Gastroenterology 2021; : 45 doi: 10.2147/CEG.S289269
|
| 375 |
Jian Yang, Yongzheng Li, Zhaowei Sun, Zhiyao Fan, Ming Shi, Shujie Liu, Yufan Meng, Bin Zhou, Yuanyuan Jiang, Hanxiang Zhan. COL17A1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer. Biochemical and Biophysical Research Communications 2022; 632: 1 doi: 10.1016/j.bbrc.2022.09.049
|
| 376 |
Christopher W. Mangieri, Cristian D. Valenzuela, Ian B. Solsky, Richard A. Erali, Timothy Pardee, Caio Max S. Rocha Lima, Russell Howerton, Clancy J. Clark, Perry Shen. Comparison of survival for metastatic pancreatic cancer patients treated with CPI‐613 versus resected borderline‐resectable pancreatic cancer patients. Journal of Surgical Oncology 2023; 128(5): 844 doi: 10.1002/jso.27365
|
| 377 |
Stavros P. Papadakos, Nikolaos Dedes, Alexandros Pergaris, Maria Gazouli, Stamatios Theocharis. Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?. International Journal of Molecular Sciences 2022; 23(7): 3620 doi: 10.3390/ijms23073620
|
| 378 |
Chao Ren, Feng Xue, Yinying Wu, Zheng Wang. The value of the lymph node ratio and total number of lymph nodes examined for resected pancreatic signet ring cell carcinoma: a retrospective cohort study. Journal of Pancreatology 2022; 5(2): 87 doi: 10.1097/JP9.0000000000000094
|
| 379 |
Lana Khalil, Zhonglu Huang, Katerina Zakka, Renjian Jiang, McKenna Penley, Olatunji B. Alese, Walid L. Shaib, Christina Wu, Madhusmita Behera, Michelle D. Reid, Bassel F. El-Rayes, Mehmet Akce. Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma. Pancreas 2023; 52(1): e75 doi: 10.1097/MPA.0000000000002227
|
| 380 |
Ujendra Kumar. Somatostatin and Somatostatin Receptors in Tumour Biology. International Journal of Molecular Sciences 2023; 25(1): 436 doi: 10.3390/ijms25010436
|
| 381 |
Shaoxun Xu, Yufei Chen, Chao Ma, Xiaodong Yue. Deep evidential fusion network for medical image classification. International Journal of Approximate Reasoning 2022; 150: 188 doi: 10.1016/j.ijar.2022.08.013
|
| 382 |
F. Roesch-Dietlen, K.J. Ortuño-García, M. González-Santés, P. Grube-Pagola, J.M. Remes-Troche, F. Díaz-Roesch, A.D. Cano-Contreras, C.S. Silva-Cañetas. Cáncer del aparato digestivo en Veracruz. La magnitud del problema al año 2025. Revista de Gastroenterología de México 2020; 85(2): 145 doi: 10.1016/j.rgmx.2019.03.008
|
| 383 |
Jing Yu, Xue Yang, Hongmei Wu, Jiansheng Li, Muhammad Wasim Khan. Clinical Significance of Color Ultrasound, MRI, miR-21, and CA199 in the Diagnosis of Pancreatic Cancer. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/2380958
|
| 384 |
Seul-Ki Mun, Hyun Bo Sim, Ji Yeon Han, Hyeongyeong Kim, Dae-Han Park, Dong-Jo Chang, Sung-Tae Yee, Young-Tae Chang, Jong-Jin Kim. Visualization of Metastatic Lung Cancer with TiNIR. Tomography 2023; 9(4): 1187 doi: 10.3390/tomography9040096
|
| 385 |
Xiang Chen, Bin Yi, Zhongtao Liu, Heng Zou, Jiangjiao Zhou, Zijian Zhang, Li Xiong, Yu Wen. Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017. Pancreatology 2020; 20(3): 462 doi: 10.1016/j.pan.2020.02.011
|
| 386 |
Atamjit Singh, Preet Mohinder Singh Bedi. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; 25: 379 doi: 10.1007/978-3-031-23621-1_18
|
| 387 |
Leonel Pekarek, Oscar Fraile‑Μartinez, Cielo Garcia‑Montero, Miguel Alvarez‑Mon, Julio Acero, Lidia Ruiz‑Llorente, Natalio García‑Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez‑Mon, Luis Guijarro, Miguel Ortega. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review). Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13070
|
| 388 |
Yu Min, Zheran Liu, Ruidan Li, Jing Jin, Zhigong Wei, Yiyan Pei, Xiaolin Hu, Xingchen Peng. Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1155123
|
| 389 |
Xing Huang, Zihe Wang, Shengzhong Hou, Chao Yue, ZhenLu Li, Weiming Hu, Huimin Lu. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. Bioengineered 2022; 13(2): 4153 doi: 10.1080/21655979.2021.2016326
|
| 390 |
O.I. Kit, E.M. Francianz, V.A. Bandovkina, N.D. Cheryarina, V.I. Aleinov, E.V. Shalashnaya. The content of steroid hormones, their precursors and ACTH in the blood of patients with pathology of pancreas. Onkologiya. Zhurnal imeni P.A.Gertsena 2020; 9(3): 29 doi: 10.17116/onkolog2020903129
|
| 391 |
Peng Li, Yaoyue Hu, Ghislaine Scelo, Mikko Myrskylä, Pekka Martikainen. Pre-Existing Psychological Disorders, Diabetes, and Pancreatic Cancer: A Population-Based Study of 38,952 Finns. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4128736
|
| 392 |
Pancreatic adenocarcinoma of the tail—Unveiling a rare presentation with venous thrombosis: A case report and literature review. SAGE Open Medical Case Reports 2024; 12 doi: 10.1177/2050313X241241197
|
| 393 |
Cai Lu, Lu Fan, Peng-Fei Zhang, Wei-Wei Tao, Cheng-Bin Yang, Er-Xin Shang, Fei-Yan Chen, Chun-Tao Che, Hai-Bo Cheng, Jin-Ao Duan, Ming Zhao. A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. Computational and Structural Biotechnology Journal 2021; 19: 3437 doi: 10.1016/j.csbj.2021.06.011
|
| 394 |
Meena Kishore Sakharkar, Sarinder Kaur Dhillon, Mohit Mazumder, Jian Yang. Key drug-targeting genes in pancreatic ductal adenocarcinoma. Genes & Cancer 2021; 12: 12 doi: 10.18632/genesandcancer.210
|
| 395 |
Marie-Claire Rittmann, Saskia Hussung, Lukas M. Braun, Rhena F. U. Klar, Esther A. Biesel, Stefan Fichtner-Feigl, Ralph Fritsch, Uwe A. Wittel, Dietrich A. Ruess. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86779-x
|
| 396 |
Walid L. Shaib, Katerina Zakka, Farhan N. Hoodbhoy, Astrid Belalcazar, Sungjin Kim, Kenneth Cardona, Maria C. Russell, Shishir K. Maithel, Juan M. Sarmiento, Christina Wu, Mehmet Akce, Olatunji B. Alese, Bassel F. El-Rayes. In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy. Journal of Geriatric Oncology 2020; 11(4): 660 doi: 10.1016/j.jgo.2019.10.012
|
| 397 |
Chao Li, Mengqi Zhu, Jiajia Wang, Hengshuang Wu, Yameng Liu, Di Huang. Role of m6A modification in immune microenvironment of digestive system tumors. Biomedicine & Pharmacotherapy 2023; 164: 114953 doi: 10.1016/j.biopha.2023.114953
|
| 398 |
Han Xie, Xinmei Wang, Min Xue, Yudong Qiu, Weihong Ge. Effectiveness and safety of path‐based analgesic regimens designed by clinical pharmacists based on the type of biliary and pancreatic surgery. Journal of Clinical Pharmacy and Therapeutics 2022; 47(12): 2302 doi: 10.1111/jcpt.13814
|
| 399 |
M. V. Naboka, A. V. Otmakhova, P. V. Bogdanchikova, D. M. Viushkov. Epidemiology of pancreatic cancer. Experimental and Clinical Gastroenterology 2023; (3): 17 doi: 10.31146/1682-8658-ecg-211-3-17-21
|
| 400 |
Concetta Panebianco, Valerio Pazienza. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology. Critical Reviews in Clinical Laboratory Sciences 2019; 56(4): 260 doi: 10.1080/10408363.2019.1615407
|
| 401 |
Huapeng Sun, Na Zhang, Yiqiang Jin, Haisheng Xu. Cardamonin Promotes the Apoptosis and Chemotherapy Sensitivity to Gemcitabine of Pancreatic Cancer Through Modulating the FOXO3a-FOXM1 Axis. Dose-Response 2021; 19(4): 155932582110421 doi: 10.1177/15593258211042163
|
| 402 |
Livia Archibugi, Marianna Signoretti, Gabriele Capurso. The Microbiome and Pancreatic Cancer. Journal of Clinical Gastroenterology 2018; 52(Supplement 1): S82 doi: 10.1097/MCG.0000000000001092
|
| 403 |
Liane J. Ioannou, Ashika D. Maharaj, John R. Zalcberg, Jesse T. Loughnan, Daniel G. Croagh, Charles H. Pilgrim, David Goldstein, James G. Kench, Neil D. Merrett, Arul Earnest, Elizabeth A. Burmeister, Kate White, Rachel E. Neale, Sue M. Evans. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. HPB 2022; 24(8): 1201 doi: 10.1016/j.hpb.2022.01.011
|
| 404 |
Mengwei Wu, Xiaobin Li, Taiping Zhang, Ziwen Liu, Yupei Zhao. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00996
|
| 405 |
Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan. Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment 2021; 20: 153303382110430 doi: 10.1177/15330338211043030
|
| 406 |
Magdalena Misiura, Justyna Zińczuk, Konrad Zaręba, Dorota Kamińska, Katarzyna Guzińska-Ustymowicz, Anna Pryczynicz. Actin-Bundling Proteins (Actinin-4 and Fascin-1) are Involved in the Development of Pancreatic Intraepithelial Neoplasia (PanIN). The American Journal of the Medical Sciences 2020; 359(3): 147 doi: 10.1016/j.amjms.2019.11.013
|
| 407 |
Xin Li, Wenkai Jiang, Yu Gan, Wence Zhou. The Application of Exosomal MicroRNAs in the Treatment of Pancreatic Cancer and Its Research Progress. Pancreas 2021; 50(1): 12 doi: 10.1097/MPA.0000000000001713
|
| 408 |
Andras Bibok, Dae Won Kim, Mokenge Malafa, Bela Kis. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. World Journal of Gastroenterology 2021; 27(27): 4322-4341 doi: 10.3748/wjg.v27.i27.4322
|
| 409 |
Yuefeng Zhang, Shifei Huang, Pengping Li, Qing Chen, Yongzhou Li, Yizhao Zhou, Lantian Wang, Muxing Kang, Bo Zhang, Bin Yang, Xin Dong, Yulian Wu. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Cancer Letters 2018; 431: 190 doi: 10.1016/j.canlet.2018.05.027
|
| 410 |
Dong Song, Xuejing Yang, Xin Guo, Hu Sun. Safety and efficacy analysis of PD-1 inhibitors in combination with chemotherapy for advanced pancreatic cancer. Immunotherapy 2022; 14(16): 1307 doi: 10.2217/imt-2022-0196
|
| 411 |
Robert Hughes, Adam E Snook, Adam C Mueller. The poorly immunogenic tumor microenvironment of pancreatic cancer: the impact of radiation therapy, and strategies targeting resistance. Immunotherapy 2022; 14(17): 1393 doi: 10.2217/imt-2022-0046
|
| 412 |
Jichun Ma, Jing Wang, Long Ge, Bo Long, Junqiang Zhang. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis. Acta Diabetologica 2019; 56(10): 1103 doi: 10.1007/s00592-019-01337-2
|
| 413 |
Sherif B. Elsherif, Mayur Virarkar, Sanaz Javadi, Juan J. Ibarra-Rovira, Eric P. Tamm, Priya R. Bhosale. Pancreatitis and PDAC: association and differentiation. Abdominal Radiology 2020; 45(5): 1324 doi: 10.1007/s00261-019-02292-w
|
| 414 |
Katharina Martini. Raucherassoziierte Malignome. Die Radiologie 2022; 62(9): 758 doi: 10.1007/s00117-022-00992-x
|
| 415 |
Lamia Mouhid, Marta Gómez de Cedrón, Adriana Quijada-Freire, Pablo J. Fernández-Marcos, Guillermo Reglero, Tiziana Fornari, Ana Ramírez de Molina. Yarrow Supercritical Extract Ameliorates the Metabolic Stress in a Model of Obesity Induced by High-Fat Diet. Nutrients 2019; 12(1): 72 doi: 10.3390/nu12010072
|
| 416 |
Sumeed Syed Manzoor, Annemiek Doedens, Michael B. Burns. The promise and challenge of cancer microbiome research. Genome Biology 2020; 21(1) doi: 10.1186/s13059-020-02037-9
|
| 417 |
Shuang-Shuang Li, Cong-Ya Zhou, Rong Liao, Lai Xiong, Ning-Na Weng, Ya-Qin Zhao, Clifford Mason, Hong-Feng Gou, Cheng Yi, Qing Zhu. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma. Medicine 2020; 99(14): e19413 doi: 10.1097/MD.0000000000019413
|
| 418 |
Yilan Zhen, Macarena Pavez, Xinying Li. The role of Pcdh10 in neurological disease and cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(10): 8153 doi: 10.1007/s00432-023-04743-w
|
| 419 |
D. Moschovis, E. Vasilaki, M. Tzouvala, G. Karamanolis, H. Katifelis, E. Legaki, A. Vezakis, G. Aravantinos, M. Gazouli. Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk. Cancer Biomarkers 2019; 24(1): 117 doi: 10.3233/CBM-181959
|
| 420 |
Junyu Huo, Liqun Wu, Yunjin Zang. Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.561254
|
| 421 |
F. Roesch-Dietlen, K.J. Ortuño-García, M. González-Santés, P. Grube-Pagola, J.M. Remes-Troche, F. Díaz-Roesch, A.D. Cano-Contreras, C.S. Silva-Cañetas. Cancer of the digestive system in Veracruz. The magnitude of the problem by 2025. Revista de Gastroenterología de México (English Edition) 2020; 85(2): 145 doi: 10.1016/j.rgmxen.2019.03.008
|
| 422 |
Tamara Alhobayb, Rahul Peravali, Motaz Ashkar. The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review. Diseases 2021; 9(4): 93 doi: 10.3390/diseases9040093
|
| 423 |
Xuan Zeng, Xiaoxiao Fan, Chunyan Fu, Jialu Yang, Jiahui Tian, Qian Peng, WeiGuo Qin, Yi Wu, Abdelwahab Omri. Codelivery of Doxorubicin/PI3K Inhibitor Nanomicelle Linked with Phenylboronic Acid for Enhanced Cytotoxicity to Pancreatic Cancer. Journal of Nanomaterials 2022; 2022: 1 doi: 10.1155/2022/8758356
|
| 424 |
Xiaoyue Jia, Peiling Du, Kusheng Wu, Zhenxi Xu, Jiaying Fang, Xiaoling Xu, Kun Lin. Pancreatic Cancer Mortality in China. Pancreas 2018; 47(2): 233 doi: 10.1097/MPA.0000000000000976
|
| 425 |
Zineb Cherkaoui, Cristians González, Taiga Wakabayashi, Bastien Delattre, Elodie Léost, Sébastien Serra, Jerôme Huppertz, Francine Klein, Marie Stéphan, Jean-Michel Meyer, Alain Schaff, Elisa Martinis, Elena Bangoura, Sophie Kieffer, Sophie Blanès, Elham Haddad, Gabrielle De Guio, Emanuele Felli, Sophie Pernot, Jacques Marescaux, Didier Mutter, Constance Lugiez, Patrick Pessaux, Paulo Amaral, Catherine Anthony, Raphael Araujo, Horacio Asbun, Susan Atkinson, Elena Bangoura, Marie-Pascale Bataille, Kimberly Bertens, Sophie Blanès, Javier Briceno, Hansen Carsten Palnaes, Maria Catalina Mursch, Clara Cesari-Loussouarn, Zineb Cherkaoui, Natalie Coburn, Fabrice Colin, Claudius Conrad, Vincent Cordelier, Francis Crews, Vito De Blasi, Gabrielle Deguio, Bastien Delattre, Nicolas Demartines, Kristine Dengsø, Mark Doherty, Elena Fernandez, David Fuks, Armando Gil, Veronica Goldbarg, Cristians González, Elham Haddad, Julie Hallet, Nathalie Hausser, Ruben Hernandez, Hugo Herrscher, Ryota Higuchi, Jens Hillingsø, Paul Hody, Pauline Horn, Jerôme Huppertz, Naoki Ikari, Wataru Izumo, Emilie Jacky, Shiva Jayaraman, Romane Jenner, Florence Jeune, Hironori Kaneko, Takaaki Kato, Suneil Khanna, Sophie Kieffer, Francine Klein, Jean Emmanuel Kurtz, Calvin Law, Laura Lazarus, Myriam Lekeir, Elodie Léost, Bruno Lemos, Leonardo Lima, Constance Lugiez, Bernadette Lux, Guilherme Machado, Jacques Marescaux, Guillaume Martel, Lysiane Marthey, Pablo Martí-Cruchaga, Elisa Martinis, Riccardo Memeo, Jean-Michel Meyer, Lise Munk Plum, Cesar Munoz, Didier Mutter, Sulaiman Nanji, Amy O’connor, Akiko Omori, Pedro Osorio, Fabrizio Panaro, Fernando Pardo, Lucio Lucas Pereira, Pierre Perez, Sophie Pernot, Patrick Pessaux, Yolanda Quijano, Mariana Ramallo, Nicolas Regenet, Alexandre Resende, Fernando Rotellar, Antonio Sa Cunha, Rodrigo Sanchez Claria, Daniel Santana, Rodolfo Santana, Alain Schaff, Lilian Schwarz, Maja Segedi, Sébastien Serra, Pablo Serrano, Masahiro Shiihara, Olivier Soubrane, Marie Stéphan, Nobuhiro Takeshita, Orlando Torres, Melanie Tsang, Olivier Turrini, Shuichiro Uemura, Eliana Valle, Anna Van Osch, Emilio Vicente, Annie Vincent, Go Wakabayashi, Taiga Wakabayashi, Helmut Weiss, Masakazu Yamamoto, Shingo Yamashita, Takehisa Yazawa, Thomas Zacharias. A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey. Annals of Surgical Oncology 2021; 28(2): 1069 doi: 10.1245/s10434-020-08679-0
|
| 426 |
Maryam Sahlolbei, Mohsen Dehghani, Behghat Kheiri yeghane azar, Somayeh Vafaei, G Roviello, Alberto D’Angelo, Zahra Madjd, Jafar Kiani. Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studies. International Reviews of Immunology 2020; 39(5): 223 doi: 10.1080/08830185.2020.1776274
|
| 427 |
Jia-Rong Li, Ling Liu, Hui Luo, Ze-Guo Chen, Jian-Hua Wang, Nian-Feng Li. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling Axis. Pancreas 2021; 50(3): 317 doi: 10.1097/MPA.0000000000001751
|
| 428 |
Chung-Ze Wu, Yi Cheng Chu, Shiue-Wei Lai, Ming-Shou Hsieh, Vijesh Kumar Yadav, Iat-Hang Fong, Li Deng, Chun-Chih Huang, Yew-Min Tzeng, Chi-Tai Yeh, Jin-Shuen Chen. Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment. Phytomedicine 2022; 100: 154062 doi: 10.1016/j.phymed.2022.154062
|
| 429 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17): 10132 doi: 10.3390/ijms231710132
|
| 430 |
Sayra Dilmac, Bulent Ozpolat. MicroRNA in Human Malignancies. 2022; : 281 doi: 10.1016/B978-0-12-822287-4.00003-7
|
| 431 |
Fengyun Zhao, Yanni Huang, Yingheng Zhang, Xun Li, Kaizhao Chen, Yihao Long, Fugui Li, Xiaodong Ma. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro. Molecular Biology Reports 2022; 49(7): 6613 doi: 10.1007/s11033-022-07504-z
|
| 432 |
K.T. Ramya Devi, Dharshene Karthik, TharunSelvam Mahendran, M.K. Jaganathan, Sanjana Prakash Hemdev. Long noncoding RNAs: role and contribution in pancreatic cancer. Transcription 2021; 12(1): 12 doi: 10.1080/21541264.2021.1922071
|
| 433 |
Asuman Argon, Özden Öz, TuluAyata Kebat. Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas. Indian Journal of Pathology and Microbiology 2023; 66(1): 38 doi: 10.4103/ijpm.ijpm_905_21
|
| 434 |
Felix Wiesmueller, Josephin Kopke, Daniela Aust, Janine Roy, Andreas Dahl, Christian Pilarsky, Robert Grützmann. Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(21): 5437 doi: 10.3390/ijms20215437
|
| 435 |
Yuexian Li, Zhou Su, Biwei Wei, Zhihai Liang. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma. International Journal of General Medicine 2021; : 2677 doi: 10.2147/IJGM.S313584
|
| 436 |
Fatemeh Hadavand Siri, Hamid Salehiniya. Pancreatic Cancer in Iran: an Epidemiological Review. Journal of Gastrointestinal Cancer 2020; 51(2): 418 doi: 10.1007/s12029-019-00279-w
|
| 437 |
Yongli Hu, Bing Wang, Lie Wang, Zhenran Wang, Zhiyuan Jian, Lin Deng. Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy. Molecular Medicine Reports 2020; 22(1): 398 doi: 10.3892/mmr.2020.11098
|
| 438 |
Hadi M.H. Diab, Henry G. Smith, Kristian K. Jensen, Lars N. Jørgensen. The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review. European Journal of Cancer 2021; 154: 73 doi: 10.1016/j.ejca.2021.05.033
|
| 439 |
Sijia Sun, Min Jo Kim, Ashraf M. Omar, Nguyen Duy Phan, Mio Aoike, Suresh Awale. GDP Induces PANC‐1 Human Pancreatic Cancer Cell Death Preferentially under Nutrient Starvation by Inhibiting PI3K/Akt/mTOR/Autophagy Signaling Pathway. Chemistry & Biodiversity 2021; 18(9) doi: 10.1002/cbdv.202100389
|
| 440 |
Weizhen Huang, Jun Li, Siwei Zhou, Yi Li, Xia Yuan. Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.883548
|
| 441 |
Faisal Raza, Lauren Evans, Mahzad Motallebi, Hajra Zafar, Miguel Pereira-Silva, Kalsoom Saleem, Diana Peixoto, Abbas Rahdar, Esmaeel Sharifi, Francisco Veiga, Clare Hoskins, Ana Cláudia Paiva-Santos. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomaterialia 2023; 157: 1 doi: 10.1016/j.actbio.2022.12.013
|
| 442 |
Clare Toms, Daniel Steffens, David Yeo, Carlo Pulitano, Charbel Sandroussi. Quality of Life Instruments and Trajectories After Pancreatic Cancer Resection. Pancreas 2021; 50(8): 1137 doi: 10.1097/MPA.0000000000001896
|
| 443 |
Takamichi Igarashi, Kenichiro Araki, Takehiko Yokobori, Bolag Altan, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norio Kubo, Tadashi Handa, Yasuo Hosouchi, Masahiko Nishiyama, Tetsunari Oyama, Ken Shirabe, Hiroyuki Kuwano. Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression. Oncotarget 2017; 8(7): 12290 doi: 10.18632/oncotarget.14703
|
| 444 |
Carolyn Newberry, Octavia Pickett-Blakely. Geriatric Gastroenterology. 2021; : 781 doi: 10.1007/978-3-030-30192-7_28
|
| 445 |
Abdul Kareem Khan, Akriti Gupta Jain, Summia Afridi, Mohammed Wazir, Jana Srinivas Rao, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; : 111 doi: 10.1016/B978-0-12-819457-7.00006-2
|
| 446 |
Nicolò de Pretis, Antonio Amodio, Luca Frulloni. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. 2021; : 356 doi: 10.1002/9781119570097.ch45
|
| 447 |
Mengyin Wu, Kai Gu, Yangming Gong, Chunxiao Wu, Yi Pang, Wei Zhang, Chunfang Wang, Yan Shi, Yingbin Liu, Chen Fu. Pancreatic cancer incidence and mortality trends in urban Shanghai, China from 1973 to 2017: a joinpoint regression and age-period-cohort analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1113301
|
| 448 |
Qiang Hao, Joel E. Segel, Niraj J. Gusani, Christopher S. Hollenbeak. Do-Not-Resuscitate Orders and Outcomes for Patients with Pancreatic Cancer. Journal of Pancreatic Cancer 2022; 8(1): 15 doi: 10.1089/pancan.2022.0006
|
| 449 |
Alican Tahta, Ahmet Cetinkal, Elif Calis, Cem Dinc. Intramedullary pancreatic adenocarcinoma metastasis: The first case in literature. Neurocirugía 2022; 33(6): 334 doi: 10.1016/j.neucir.2021.03.005
|
| 450 |
鹏 闫. Advances in Diagnosis and Treatment of Pancreatic Cancer. Hans Journal of Surgery 2020; 9(02): 5 doi: 10.12677/HJS.2020.92002
|
| 451 |
Xiao Yu, Qiyao Zhang, Shuijun Zhang, Yuting He, Wenzhi Guo. Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1000447
|
| 452 |
Taskeen Ebrahim, Willem Perold, Anna-Mart Engelbrecht. A Capacitive Biosensor for the Early Detection of Pancreatic Cancer Using Carbohydrate Antigen 19-9. The 9th International Electronic Conference on Sensors and Applications 2022; : 74 doi: 10.3390/ecsa-9-13322
|
| 453 |
Chenlei Wen, XiaXing Deng, Dandan Ren, Xue Song, Hao Chen, Jiancheng Wang, Jiabin Jin, Dongfeng Cheng, Zhiwei Xu, Jun Zhang, Junjie Xie, Wenjing Qi, Jiangning Gu, Chenghong Peng, Dan Chen, Shi Chen, Baiyong Shen, Qian Zhan. Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma. Cancer Medicine 2020; 9(20): 7626 doi: 10.1002/cam4.3425
|
| 454 |
Jian-fei Hu, Zu-wei Wang, Cheng-yu Liao, Zhi-wen Chen, Feng-ping Kang, Cai-feng Lin, Tian-sheng Lin, Long Huang, Yi-feng Tian, Shi Chen. Induced expression of CCL19 promotes the anti-tumor ability of CAR-T cells by increasing their infiltration ability. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.958960
|
| 455 |
Yingliang Miao, Shangxiang Chen. The Effect of Comfort Care on Postoperative Quality of Life, Psychological Status, and Satisfaction of Pancreatic Cancer Patients. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/9483762
|
| 456 |
Ali Khader, Marta Braschi-Amirfarzan, Lacey J. McIntosh, Babina Gosangi, Jeremy R. Wortman, Christoph Wald, Richard Thomas. Importance of tumor subtypes in cancer imaging. European Journal of Radiology Open 2022; 9: 100433 doi: 10.1016/j.ejro.2022.100433
|
| 457 |
Huilin Shao, Hyungsoon Im, Cesar M. Castro, Xandra Breakefield, Ralph Weissleder, Hakho Lee. New Technologies for Analysis of Extracellular Vesicles. Chemical Reviews 2018; 118(4): 1917 doi: 10.1021/acs.chemrev.7b00534
|
| 458 |
Lily M. Channon, Victoria M. Tyma, Zhihong Xu, David W. Greening, Jeremy S. Wilson, Chamini J. Perera, Minoti V. Apte. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188728 doi: 10.1016/j.bbcan.2022.188728
|
| 459 |
Jin Niu, Xue Wang, Jun Qu, Donald E. Mager, Robert M. Straubinger. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07398-9
|
| 460 |
Graziana Digiacomo, Francesco Volta, Ingrid Garajova, Rita Balsano, Andrea Cavazzoni. Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC. Life 2021; 11(8): 843 doi: 10.3390/life11080843
|
| 461 |
Hong Liu, Yue-Tong Chen, Rui Wang, Xin-Zu Chen. Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk. Medicine 2017; 96(33): e7811 doi: 10.1097/MD.0000000000007811
|
| 462 |
K. Y. Kandurova, V. V. Dremin, E. A. Zherebtsov, A. L. Alyanov, A. V. Mamoshin, E. V. Potapova, A. V. Dunaev, V. F. Muradyan, V. V. Sidorov, A. I. Krupatkin. Optical biopsy methods and their prospects of application for intraoperative analysis of tissue metabolism and blood microcirculation in minimally invasive surgery. Regional blood circulation and microcirculation 2018; 17(3): 71 doi: 10.24884/1682-6655-2018-17-3-71-79
|
| 463 |
Tian-Dong Li, Hong-Wei Yang, Peng Wang, Chun-Hua Song, Kai-Juan Wang, Li-Ping Dai, Jian-Xiang Shi, Jian-Ying Zhang, Hua Ye. Coffee consumption and risk of pancreatic cancer: a systematic review and dose–response meta-analysis. International Journal of Food Sciences and Nutrition 2019; 70(5): 519 doi: 10.1080/09637486.2018.1551337
|
| 464 |
Wei Chai, Ruhai Liu, Fengshan Li, Zhiquan Zhang, Bao Lei. Long noncoding RNA TSLNC8 enhances pancreatic cancer aggressiveness by regulating CTNNB1 expression via association with HuR. Human Cell 2021; 34(1): 165 doi: 10.1007/s13577-020-00429-4
|
| 465 |
Liudmila G. Zhukova, Dmitry S. Bordin, Elena A. Dubtsova, Matvey A. Ilin, Mariia A. Kiriukova, Polina S. Feoktistova, Vyacheslav I. Egorov. How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review. Journal of Modern Oncology 2024; 25(4) doi: 10.26442/18151434.2023.4.202541
|
| 466 |
Tianyu Ren, Xiaofei Xue, Xiaogang Wang, Xingtong Zhou, Shengchun Dang. Bioinformatic and experimental analyses of key biomarkers in pancreatic cancer. Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10794
|
| 467 |
Ksenia Kandurova, Victor V. Dremin, Evgeny A. Zherebtsov, Andrey V. Dunaev, Andrian V. Mamoshin, Alexandr L. Alyanov, Vadim F. Muradyan, Elena V. Potapova, Jürgen Popp, Valery V. Tuchin, Francesco S. Pavone. Application of the fluorescence spectroscopy for the analysis of the state of abdominal cavity organs tissues in mini-invasive surgery. Biophotonics: Photonic Solutions for Better Health Care VI 2018; : 171 doi: 10.1117/12.2290037
|
| 468 |
Yuan He, Yaxing Liu, Dongkai Wu, Luyao Chen, Zhonglin Luo, Xingsong Shi, Keyan Li, Hao Hu, Gexi Qu, Qiang Zhao, Changhong Lian. Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells. Translational Oncology 2023; 27: 101583 doi: 10.1016/j.tranon.2022.101583
|
| 469 |
Jillian M Gallegos, Alexandra Taylor, Victoria Vardell, Peter T Silberstein. Socioeconomic Factors Associated With a Late-Stage Pancreatic Cancer Diagnosis: An Analysis of the National Cancer Database. Cureus 2023; doi: 10.7759/cureus.35857
|
| 470 |
Lei Wang, Rongrong Bi, Lei Li, Kun Zhou, Hang Yin. lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy. Aging 2021; 13(15): 19272 doi: 10.18632/aging.203251
|
| 471 |
Valerie Jentzsch, James Davis, Mustafa Djamgoz. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers 2020; 12(11): 3096 doi: 10.3390/cancers12113096
|
| 472 |
Ozden Oz, Asuman Argon, TuluAyata Kebat, Ozlem Ozdemir, Savas Yakan. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas. Indian Journal of Pathology and Microbiology 2023; 66(3): 533 doi: 10.4103/ijpm.ijpm_1002_21
|
| 473 |
Teruhisa Sakamoto, Takuki Yagyu, Ei Uchinaka, Kozo Miyatani, Takehiko Hanaki, Kyoichi Kihara, Tomoyuki Matsunaga, Manabu Yamamoto, Naruo Tokuyasu, Soichiro Honjo, Yoshiyuki Fujiwara. The prognostic significance of combined geriatric nutritional risk index and psoas muscle volume in older patients with pancreatic cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08094-y
|
| 474 |
Anna Beatriz Linhares Ferreira, Cínthia Almeida Costa Leite, Hemerson Andrade Lucena, José Carlos Novais De Fonseca Junior, Wândyna Braga De Oliveira, Milena Nunes Alves de Sousa. EFEITOS DA SUPLEMENTAÇÃO DE VITAMINA D NA PREVENÇÃO E TRATAMENTO DO CÂNCER DE PÂNCREAS. Revista Contemporânea 2023; 3(3): 1913 doi: 10.56083/RCV3N3-041
|
| 475 |
Gabrielle Brown, Julie Bliss. How pancreatic cancer impacts carers in the UK: why do we know so little?. British Journal of Community Nursing 2023; 28(6): 302 doi: 10.12968/bjcn.2023.28.6.302
|
| 476 |
Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature. Journal of Clinical Medicine 2019; 8(11): 1922 doi: 10.3390/jcm8111922
|
| 477 |
Devyani S Poman, Lakshya Motwani, Nailah Asif, Apurva Patel, Deepanjali Vedantam. Pancreatic Cancer and the Obesity Epidemic: A Narrative Review. Cureus 2022; doi: 10.7759/cureus.26654
|
| 478 |
Nicole L. Goerig, Rainer Fietkau. Rolle der Radiotherapie beim Pankreaskarzinom. Wiener klinisches Magazin 2020; 23(1): 14 doi: 10.1007/s00740-020-00326-4
|
| 479 |
Jojanneke Stoof, Emily Harrold, Sarah Mariottino, Maeve A. Lowery, Naomi Walsh. DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.749490
|
| 480 |
Jing Zhou, Shuyan Qie, Hongjuan Fang, Jianing Xi. MiR-487a-3p suppresses the malignant development of pancreatic cancer by targeting SMAD7. Experimental and Molecular Pathology 2020; 116: 104489 doi: 10.1016/j.yexmp.2020.104489
|
| 481 |
Wen Xu, Bei Wang, Yuxuan Cai, Chong Guo, Kai Liu, Chengfu Yuan. DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis. Current Pharmaceutical Design 2021; 27(20): 2337 doi: 10.2174/1381612826666201026150857
|
| 482 |
Silke D. Werle, Julian D. Schwab, Marina Tatura, Sandra Kirchhoff, Robin Szekely, Ramona Diels, Nensi Ikonomi, Bence Sipos, Jan Sperveslage, Thomas M. Gress, Malte Buchholz, Hans A. Kestler. Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic Cancer. Cancers 2021; 13(4): 725 doi: 10.3390/cancers13040725
|
| 483 |
Anghela Z. Paredes, J. Madison Hyer, Diamantis I. Tsilimigras, Elizabeth Palmer, Maryam B. Lustberg, Mary E. Dillhoff, Jordan M. Cloyd, Allan Tsung, Aslam Ejaz, Sharla Wells-Di Gregorio, Timothy M. Pawlik. Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer. HPB 2021; 23(3): 451 doi: 10.1016/j.hpb.2020.08.002
|
| 484 |
Eric Pion, Julia Karnosky, Sofie Boscheck, Benedikt J. Wagner, Katharina M. Schmidt, Stefan M. Brunner, Hans J. Schlitt, Thiha Aung, Christina Hackl, Silke Haerteis. 3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model. Cancers 2022; 14(15): 3733 doi: 10.3390/cancers14153733
|
| 485 |
Danhui Ma, Sinuo Chen, Heming Wang, Jiayi Wei, Hao Wu, Hong Gao, Xinlai Cheng, Taotao Liu, Shi-Hua Luo, Yicheng Zhao, Guangqi Song. Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.653061
|
| 486 |
Chaozhi Yang, Xuebing Wang, Chenjie Qiu, Ziruo Zheng, Kai Lin, Min Tu, Kai Zhang, Kuirong Jiang, Wentao Gao. Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma. PeerJ 2022; 9: e12736 doi: 10.7717/peerj.12736
|
| 487 |
Yalcin Erzurumlu, Deniz Catakli, Hatice Kubra Dogan. Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells. Journal of Natural Medicines 2023; 77(3): 572 doi: 10.1007/s11418-023-01701-1
|
| 488 |
Christina Baum, Amr S. Soliman, Heidi E. Brown, Ibrahim A. Seifeldin, Mohamed Ramadan, Breanne Lott, An Nguyen, Ahmed El-Ghawalby, Ahmed Hablas. Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period. Journal of Cancer Epidemiology 2020; 2020: 1 doi: 10.1155/2020/6031708
|
| 489 |
John W. Birk. Commentary on “postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis”. International Journal of Surgery 2019; 72: 57 doi: 10.1016/j.ijsu.2019.10.014
|
| 490 |
Ananda Guha Majumdar, Mahesh Subramanian. Hydroxychavicol from Piper betle induces apoptosis, cell cycle arrest, and inhibits epithelial-mesenchymal transition in pancreatic cancer cells. Biochemical Pharmacology 2019; 166: 274 doi: 10.1016/j.bcp.2019.05.025
|
| 491 |
Friedrich Anger, Anna Döring, Jacob van Dam, Johan Friso Lock, Ingo Klein, Max Bittrich, Christoph-Thomas Germer, Armin Wiegering, Volker Kunzmann, Casper van Eijck, Stefan Löb. Impact of Borderline Resectability in Pancreatic Head Cancer on Patient Survival: Biology Matters According to the New International Consensus Criteria. Annals of Surgical Oncology 2021; 28(4): 2325 doi: 10.1245/s10434-020-09100-6
|
| 492 |
Erbo Liang, Yishi Lu, Yanqiang Shi, Qian Zhou, Fachao Zhi. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. Oncogene 2020; 39(41): 6437 doi: 10.1038/s41388-020-01443-4
|
| 493 |
Abolfazl Akbari, Meghdad Sedaghat, Javad Heshmati, Seidamir Pasha Tabaeian, Sadegh Dehghani, Ana Beatriz Pizarro, Zahra Rostami, Shahram Agah. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers. Biomedicine & Pharmacotherapy 2021; 141: 111849 doi: 10.1016/j.biopha.2021.111849
|
| 494 |
Min Ren, Jianing Zhang, Rongrong Zong, Huiru Sun. A Novel Pancreatic Cancer Hypoxia Status Related Gene Signature for Prognosis and Therapeutic Responses. Molecular Biotechnology 2023; doi: 10.1007/s12033-023-00807-x
|
| 495 |
Faysal Dane, Nazim Can Demircan. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 193 doi: 10.1007/978-981-19-0063-1_23
|
| 496 |
Michele Ghidini, Andrea Lampis, Milko B. Mirchev, Ali Fuat Okuducu, Margherita Ratti, Nicola Valeri, Jens C. Hahne. Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer. Genes 2020; 12(1): 33 doi: 10.3390/genes12010033
|
| 497 |
Isabelle Ribeiro BARBOSA, Camila Alves dos SANTOS, Dyego Leandro Bezerra de SOUZA. PANCREATIC CANCER IN BRAZIL: MORTALITY TRENDS AND PROJECTIONS UNTIL 2029. Arquivos de Gastroenterologia 2018; 55(3): 230 doi: 10.1590/s0004-2803.201800000-59
|
| 498 |
Toshiaki Suzuki, Sayo Kawai, Makoto Ueno, Yingsong Lin, Shogo Kikuchi. Treatment patterns in pancreatic cancer patients based on a hospital claims database in Japan. Japanese Journal of Clinical Oncology 2021; 51(2): 228 doi: 10.1093/jjco/hyaa183
|
| 499 |
Xiaohong Jiang, Dongxia Hou, Zhe Wei, Shasha Zheng, Yujing Zhang, Jing Li. Extracellular and intracellular microRNAs in pancreatic cancer: from early diagnosis to reducing chemoresistance. ExRNA 2019; 1(1) doi: 10.1186/s41544-019-0014-0
|
| 500 |
Asmi Chakraborty, Kaitlyn A. Dorsett, Hoa Q. Trummell, Eddy S. Yang, Patsy G. Oliver, James A. Bonner, Donald J. Buchsbaum, Susan L. Bellis. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. Journal of Biological Chemistry 2018; 293(3): 984 doi: 10.1074/jbc.M117.808584
|
| 501 |
Aida Cristina Rahy-Martín, Francisco Cruz-Benavides, Mar Sánchez-Lauro, Álvaro Rodríguez-Méndez, Íñigo San Miguel, Pedro Lara, Joaquín Marchena-Gómez. Radioterapia intraoperatoria con Intrabeam® para el tratamiento del adenocarcinoma de páncreas resecable. Cirugía Española 2018; 96(8): 482 doi: 10.1016/j.ciresp.2018.04.014
|
| 502 |
Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Ines Barquero-Pozanco, Laura del Hierro-Marlasca, Patricia de Castro Martinez, Adoración Romero-Bazán, Miguel A. Alvarez-Mon, Jorge Monserrat, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Luis G. Guijarro, Miguel A. Ortega. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer. Cancers 2022; 14(8): 1866 doi: 10.3390/cancers14081866
|
| 503 |
Min Young Park, Woohyung Lee, Jaewoo Kwon, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Song Cheol Kim. Comparison of perioperative outcomes in pancreatic head cancer patients following either a laparoscopic or open pancreaticoduodenectomy with a superior mesenteric artery first approach. Annals of Hepato-Biliary-Pancreatic Surgery 2021; 25(3): 358 doi: 10.14701/ahbps.2021.25.3.358
|
| 504 |
Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa, Sachiko Yamamoto, Toru Wakamatsu, Takuji Hayashi, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Tomoyuki Yamasaki, Keiichiro Honma, Kazuyoshi Ohkawa. Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 2023; 15(3): 970 doi: 10.3390/cancers15030970
|
| 505 |
Andrea Pretta, Pina Ziranu, Riccardo Giampieri, Clelia Donisi, Erika Cimbro, Dario Spanu, Eleonora Lai, Federica Pecci, Francesca Balconi, Alessio Lupi, Marta Pozzari, Mara Persano, Sara Murgia, Valeria Pusceddu, Marco Puzzoni, Rossana Berardi, Mario Scartozzi. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Digestive and Liver Disease 2023; 55(5): 655 doi: 10.1016/j.dld.2022.11.012
|
| 506 |
Muaz Aijazi, Kenneth E. Fasanella, Kevin McGrath, Lynette M. Smith, Aatur D. Singhi, Randall E. Brand. Pancreatic Cysts Greater Than 1 cm Are Associated With an Increased Risk for Developing Pancreatic Cancer in Individuals From Pancreatic-Cancer Prone Kindreds Undergoing Surveillance. Pancreas 2024; 53(4): e350 doi: 10.1097/MPA.0000000000002312
|
| 507 |
Zhenshan Guo, Jun Zhen, Zhoujia Yao, Yemeng Wang, Chenlu Jin. A new 2D → 3D interdigitated supramolecular compound as luminescent sensor for detection of Hg2+ and treatment activity on pancreatic cancer. Chemical Papers 2021; 75(9): 4741 doi: 10.1007/s11696-021-01706-8
|
| 508 |
CN Ekwunife, SE Enendu, C Okorie, S Lemchi, IG Nnadi, OC Iwuagwu. Prolonged complete response after neoadjuvant capecitabine-gemcitabine for a locally advanced pancreatic adenocarcinoma: A case report. Nigerian Journal of Clinical Practice 2022; 25(11): 1945 doi: 10.4103/njcp.njcp_369_22
|
| 509 |
Danijela Ćirić, Tamara Stanulović, Dragana Mitrović, Milan Stojanović, Tanja Mladenović. Pancreatic carcinoma in a patient with chronic B hepatitis: Case report. Timocki medicinski glasnik 2019; 44(2): 81 doi: 10.5937/tmg1902081Q
|
| 510 |
Yumi Harano, Akira Babazono, Takako Fujita, Peng Jiang. Efficacy of S-1 monotherapy for older patients with unresectable pancreatic cancer: A retrospective cohort study. Journal of Geriatric Oncology 2019; 10(3): 420 doi: 10.1016/j.jgo.2018.09.004
|
| 511 |
Alberto Meyer, Bárbara J Carvalho, Kayo AA Medeiros, Leonardo Z Pipek, Fernanda S Nascimento, Milena O Suzuki, João VT Munhoz, Leandro R Iuamoto, Luiz A Carneiro-D'Alburquerque, Wellington Andraus. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report. World Journal of Clinical Cases 2021; 9(14): 3418-3423 doi: 10.12998/wjcc.v9.i14.3418
|
| 512 |
Leifeng Chen, Rongfa Yuan, Chongyu Wen, Tiande Liu, Qian Feng, Xueqiang Deng, Yunyan Du, Xiaogang Peng. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα. Oncogene 2021; 40(2): 262 doi: 10.1038/s41388-020-01527-1
|
| 513 |
Wei Wang, Haibo Xing, Changxin Huang, Hong Pan, Da Li. Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-1339-0
|
| 514 |
Jakob M. Riedl, Florian Posch, Lena Horvath, Antonia Gantschnigg, Felix Renneberg, Esther Schwarzenbacher, Florian Moik, Dominik A. Barth, Christopher H. Rossmann, Michael Stotz, Renate Schaberl-Moser, Martin Pichler, Herbert Stöger, Richard Greil, Angela Djanani, Konstantin Schlick, Armin Gerger. Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. European Journal of Cancer 2021; 151: 3 doi: 10.1016/j.ejca.2021.03.040
|
| 515 |
Shivang Dhoundiyal, Md. Aftab Alam. Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic
Cancer using Nanotechnology. Current Cancer Drug Targets 2023; 23(9): 697 doi: 10.2174/1568009623666230329085618
|
| 516 |
Daniel Maier, Jörg Janne Vehreschild, Barbara Uhl, Sandra Meyer, Karin Berger-Thürmel, Melanie Boerries, Rickmer Braren, Viktor Grünwald, Boris Hadaschik, Stefan Palm, Susanne Singer, Martin Stuschke, David Juárez, Pierre Delpy, Mohamed Lambarki, Michael Hummel, Cäcilia Engels, Stefanie Andreas, Nicola Gökbuget, Kristina Ihrig, Susen Burock, Dietmar Keune, Angelika Eggert, Ulrich Keilholz, Hagen Schulz, Daniel Büttner, Steffen Löck, Mechthild Krause, Mirko Esins, Frank Ressing, Martin Schuler, Christian Brandts, Daniel P. Brucker, Gabriele Husmann, Thomas Oellerich, Patrick Metzger, Frederik Voigt, Anna L. Illert, Matthias Theobald, Thomas Kindler, Ursula Sudhof, Achim Reckmann, Felix Schwinghammer, Daniel Nasseh, Wilko Weichert, Michael von Bergwelt-Baildon, Michael Bitzer, Nisar Malek, Öznur Öner, Klaus Schulze-Osthoff, Stefan Bartels, Jörg Haier, Raimund Ammann, Anja Franziska Schmidt, Bernd Guenther, Melanie Janning, Bernd Kasper, Sonja Loges, Stephan Stilgenbauer, Peter Kuhn, Eugen Tausch, Silvana Runow, Alexander Kerscher, Michael Neumann, Martin Breu, Martin Lablans, Hubert Serve. Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform. European Journal of Epidemiology 2023; 38(5): 573 doi: 10.1007/s10654-023-00990-w
|
| 517 |
Xin Luo, Bo Yu, Nan Jiang, Qiong Du, Xuan Ye, Huan Li, Wen-Quan Wang, Qing Zhai. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis. Cancer Control 2020; 27(1): 107327482097713 doi: 10.1177/1073274820977135
|
| 518 |
Kui Long, Qingbin Zeng, Wenzhi Dong. The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions. Bioengineered 2021; 12(1): 4633 doi: 10.1080/21655979.2021.1956404
|
| 519 |
Arif Mermer, Muhammet Volkan Bulbul, Semiha Mervenur Kalender, Ilknur Keskin, Burak Tuzun, Ozan Emre Eyupoglu. Benzotriazole-oxadiazole hybrid Compounds: Synthesis, anticancer Activity, molecular docking and ADME profiling studies. Journal of Molecular Liquids 2022; 359: 119264 doi: 10.1016/j.molliq.2022.119264
|
| 520 |
Matthew R. Woeste, Khaleel D. Wilson, Edward J. Kruse, Matthew J. Weiss, John D. Christein, Rebekah R. White, Robert C. G. Martin. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.817220
|
| 521 |
David Martin, Piero Alberti, Stephen J. Wigmore, Nicolas Demartines, Gaëtan-Romain Joliat. Pancreatic Cancer Surgery: What Matters to Patients?. Journal of Clinical Medicine 2023; 12(14): 4611 doi: 10.3390/jcm12144611
|
| 522 |
Alexander S. Rosemurgy, Sharona Ross, Kenneth Luberice, Harrison Browning, Iswanto Sucandy. Robotic Pancreatic Surgery for Solid, Cystic, and Mixed Lesions. Surgical Clinics of North America 2020; 100(2): 303 doi: 10.1016/j.suc.2019.12.006
|
| 523 |
Steffen M. Heckl, Lukas Kercher, Samir Abdullazade, Carolin Schneider, Sandra Krüger, Hans-Michael Behrens, Susanne Sebens, Heiner Schäfer, Stefan Schreiber, Christoph Röcken. Insulin Receptor in Pancreatic Cancer—Crown Witness in Cross Examination. Cancers 2021; 13(19): 4988 doi: 10.3390/cancers13194988
|
| 524 |
Shinichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saito, Katsuki Miyazaki, Takuya Tokunaga, Masaaki Nishi. Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02205-6
|
| 525 |
Yosuke Mukai, Daisaku Yamada, Hidetoshi Eguchi, Yoshifumi Iwagami, Tadafumi Asaoka, Takehiro Noda, Koichi Kawamoto, Kunihito Gotoh, Shogo Kobayashi, Yutaka Takeda, Masahiro Tanemura, Masaki Mori, Yuichiro Doki. Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy. Annals of Surgical Oncology 2018; 25(7): 1868 doi: 10.1245/s10434-018-6431-8
|
| 526 |
Hao Hua, Chenglong Zheng, Jiling Fan, Xiushen Li, Wenfeng Xie, Jinxin Chen, Chao Yu, FJ Snchez Garca. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/1916787
|
| 527 |
Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Kaio Murilo Monteiro Espíndola, Amanda Caroline R. S. Rosario, Wenddy Graziela N. Lima, Marta Chagas Monteiro. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594917
|
| 528 |
Milena Ilic, Biljana Milicic, Irena Ilic. Association between oral contraceptive use and pancreatic cancer risk: A systematic review and meta-analysis . World Journal of Gastroenterology 2021; 27(20): 2643-2656 doi: 10.3748/wjg.v27.i20.2643
|
| 529 |
Anne Cowppli-Bony, Marc Colonna, Karine Ligier, Valérie Jooste, Gautier Defossez, Alain Monnereau, Brice Amadeo, Patrick Arveux, Isabelle Baldi, Simona Bara, Anne-Marie Bouvier, Véronique Bouvier, Jacqueline Clavel, Marc Colonna, Gaëlle Coureau, Anne Cowppli-Bony, Tania Dalmeida, Laetitia Daubisse-Marliac, Gautier Defossez, Patricia Delafosse, Jacqueline Deloumeaux, Pascale Grosclaude, Anne-Valérie Guizard, Clarisse Joachim, Brigitte Lacour, Bénédicte Lapôtre-Ledoux, Emilie Marrer, Marc Maynadié, Florence Molinié, Alain Monnereau, Jean-Baptiste Nousbaum, Juliette Plenet, Sandrine Plouvier, Camille Pouchieu, Michel Robaszkiewicz, Claire Schvartz, Brigitte Trétarre, Xavier Troussard, Michel Velten, Anne-Sophie Woronoff. Épidémiologie descriptive des cancers en France métropolitaine : incidence, survie et prévalence. Bulletin du Cancer 2019; 106(7-8): 617 doi: 10.1016/j.bulcan.2018.11.016
|
| 530 |
Lianyuan Tao, Lijun Zhong, Yang Li, Deyu Li, Dianrong Xiu, Juntuo Zhou. Integrated proteomics and phosphoproteomics reveal perturbed regulative pathways in pancreatic ductal adenocarcinoma. Molecular Omics 2021; 17(2): 230 doi: 10.1039/D0MO00125B
|
| 531 |
Ki Jin Kwon, Su Jin Jeong, Young-Gyu Eun, In Hwan Oh, Young Chan Lee. Risk of cancer in patients with recurrent aphthous stomatitis in Korea. Medicine 2021; 100(16): e25628 doi: 10.1097/MD.0000000000025628
|
| 532 |
Mei Tao, Ming Zheng, Yanhua Xu, Shuo Ma, Weiwei Zhang, Shaoqing Ju. CircRNAs and their regulatory roles in cancers. Molecular Medicine 2021; 27(1) doi: 10.1186/s10020-021-00359-3
|
| 533 |
Raj Kumar Thapa, Hanh Thuy Nguyen, Milan Gautam, Aarajana Shrestha, Eung Seok Lee, Sae Kwang Ku, Han-Gon Choi, Chul Soon Yong, Jong Oh Kim. Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer. Drug Delivery 2017; 24(1): 1690 doi: 10.1080/10717544.2017.1396382
|
| 534 |
Hongcheng Wang, Jiazhe Liu, Guanggai Xia, Shizhou Lei, Xiuyan Huang, Xinyu Huang. Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64068-3
|
| 535 |
Se Jun Park, Hyunho Kim, Kabsoo Shin, Myung Ah Lee, Tae Ho Hong. Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. World Journal of Gastrointestinal Oncology 2019; 11(11): 1021-1030 doi: 10.4251/wjgo.v11.i11.1021
|
| 536 |
Zi Yin, Yu Zhou, Tingting Ma, Sheng Chen, Ning Shi, Yiping Zou, Baohua Hou, Chuanzhao Zhang. Down‐regulated lncRNA SBF2‐AS1 in M2 macrophage‐derived exosomes elevates miR‐122‐5p to restrict XIAP, thereby limiting pancreatic cancer development. Journal of Cellular and Molecular Medicine 2020; 24(9): 5028 doi: 10.1111/jcmm.15125
|
| 537 |
Mohsin Amin, Shiying Tang, Liliana Shalamanova, Rebecca L. Taylor, Stephen Wylie, Badr M. Abdullah, Kathryn A. Whitehead. Polyamine biomarkers as indicators of human disease. Biomarkers 2021; 26(2): 77 doi: 10.1080/1354750X.2021.1875506
|
| 538 |
Moudhi Almutlaq, Abir Abdullah Alamro, Hassan S. Alamri, Amani Ahmed Alghamdi, Tlili Barhoumi. The Effect of Local Renin Angiotensin System in the Common Types of Cancer. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.736361
|
| 539 |
Nicole L. Goerig, Rainer Fietkau. Rolle der Radiotherapie beim Pankreaskarzinom. Der Onkologe 2019; 25(8): 678 doi: 10.1007/s00761-019-0546-9
|
| 540 |
Juan Lu, Danhua Zhu, Lanjuan Li. Biological Functions and Molecular Mechanisms of MiR-608 in Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.870983
|
| 541 |
Houda Abrini, Mounia Amzerin, Aicha El Baaboua, Sara Aboulaghras, Alia Bouhda, Fatima Zahra El Mrabet. Comparison of different Pancreatic cancer treatments: a three-year retrospective study in the oncology center of Tangier university hospital, Morocco. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03071-0
|
| 542 |
Majid A. Almadi, Timothy B. Gardner, Yen-I Chen, Viviane Adam, Jeffrey Barkun, Alan Barkun. Use of stents in patients undergoing chemotherapy for borderline resectable pancreatic cancer-causing biliary obstruction while awaiting surgery: A cost-effectiveness analysis. Endoscopy International Open 2021; 9(09): E1413 doi: 10.1055/a-1497-1562
|
| 543 |
Louisa Bolm, Sergii Zemskov, Maria Zeller, Taisuke Baba, Jorge Roldan, Jon M. Harrison, Natalie Petruch, Hiroki Sato, Ekaterina Petrova, Hryhoriy Lapshyn, Ruediger Braun, Kim C. Honselmann, Richard Hummel, Oleksii Dronov, Alexander V. Kirichenko, Monika Klinkhammer-Schalke, Kees Kleihues-van Tol, Sylke R. Zeissig, Dirk Rades, Tobias Keck, Carlos Fernandez-del Castillo, Ulrich F. Wellner, Rodney E. Wegner. Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer—A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT). Cancers 2022; 14(4): 868 doi: 10.3390/cancers14040868
|
| 544 |
Sijia Sun, Min Jo Kim, Ashraf M. Omar, Nguyen Duy Phan, Suresh Awale. (+)-Panduratin A induces PANC-1 human pancreatic cancer cell death preferentially under nutrient starvation by inhibiting PI3K/Akt/mTOR/autophagy signaling pathway. Phytomedicine Plus 2021; 1(4): 100101 doi: 10.1016/j.phyplu.2021.100101
|
| 545 |
Neda Ghamarzad Shishavan, Sahar Masoudi, Ashraf Mohamadkhani, Sadaf G. Sepanlou, Maryam Sharafkhah, Hossein Poustchi, Mehdi Mohamadnejad, Azita Hekmatdoost, Akram Pourshams. Dietary intake of fatty acids and risk of pancreatic cancer: Golestan cohort study. Nutrition Journal 2021; 20(1) doi: 10.1186/s12937-021-00723-3
|
| 546 |
Povilas Kavaliauskas, Audrius Dulskas, Inga Kildusiene, Rokas Arlauskas, Rimantas Stukas, Giedre Smailyte. Trends in Pancreatic Cancer Incidence and Mortality in Lithuania, 1998–2015. International Journal of Environmental Research and Public Health 2022; 19(2): 949 doi: 10.3390/ijerph19020949
|
| 547 |
Bo Chen, Tuo Deng, Liming Deng, Haitao Yu, Bangjie He, Kaiyu Chen, Chongming Zheng, Daojie Wang, Yi Wang, Gang Chen. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08962-7
|
| 548 |
Piera Filomena Fiore, Anna Laura Di Pace, Libenzio Adrian Conti, Nicola Tumino, Francesca Besi, Silvia Scaglione, Enrico Munari, Lorenzo Moretta, Paola Vacca. Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers. Cancer Immunology, Immunotherapy 2023; 72(6): 1417 doi: 10.1007/s00262-022-03340-z
|
| 549 |
Teresa Macarulla, Jean-Frédéric Blanc, Andrea Wang-Gillam, Li-Tzong Chen, Jens T. Siveke, Beloo Mirakhur, Jie Chen, Floris A. de Jong. Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer – A subgroup analysis of the pivotal NAPOLI-1 trial. Journal of Geriatric Oncology 2019; 10(3): 427 doi: 10.1016/j.jgo.2019.02.011
|
| 550 |
Xiutian Zhang, Peng Tan, Yuan Zhuang, Lei Du. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(6): G703 doi: 10.1152/ajpgi.00118.2020
|
| 551 |
Bogdan Silviu Ungureanu, Daniel Pirici, Simona Olimpia Dima, Irinel Popescu, Gheorghe Hundorfean, Valeriu Surlin, Adrian Saftoiu. Morphometric Assessment of Confocal Laser Endomicroscopy for Pancreatic Ductal Adenocarcinoma, an Ex-Vivo Pilot Study. Diagnostics 2020; 10(11): 923 doi: 10.3390/diagnostics10110923
|
| 552 |
Mengwei Wu, Jiashu Han, Hao Wu, Ziwen Liu. Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1216376
|
| 553 |
Alejandro Speck-Planche. Multicellular Target QSAR Model for Simultaneous Prediction and Design of Anti-Pancreatic Cancer Agents. ACS Omega 2019; 4(2): 3122 doi: 10.1021/acsomega.8b03693
|
| 554 |
Maria Kalli, Panagiotis Papageorgis, Vasiliki Gkretsi, Triantafyllos Stylianopoulos. Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration. Annals of Biomedical Engineering 2018; 46(5): 657 doi: 10.1007/s10439-018-1997-7
|
| 555 |
Ahmad Ali, Ugo Chianese, Chiara Papulino, Antonella Toraldo, Mawada Elmagboul Abdalla Abakar, Eugenia Passaro, Rosario Cennamo, Nunzio Del Gaudio, Lucia Altucci, Rosaria Benedetti. Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(15): 3799 doi: 10.3390/cancers14153799
|
| 556 |
Casandra Teodorescu, Marcel Gheorghiu, Teodor Zaharie, Ioana Rusu, Cristina Pojoga, Sorana D. Bolboacă, Radu Seicean, Livia Petrusel, Andrada Seicean. Endoscopic ultrasonography‐fine needle aspiration of solid pancreatic masses: Do we need the fourth pass? A prospective study. Diagnostic Cytopathology 2021; 49(3): 395 doi: 10.1002/dc.24669
|
| 557 |
Silvia De Francia, Daniele Mancardi, Paola Berchialla, Tiziana Armando, Silvana Storto, Sarah Allegra, Giulia Soave, Silvia Racca, Francesco Chiara, Jennifer Carnovale, Libero Ciuffreda, Maria Valentina Mussa. Gender-specific side effects of chemotherapy in pancreatic cancer patients. Canadian Journal of Physiology and Pharmacology 2022; 100(4): 371 doi: 10.1139/cjpp-2021-0622
|
| 558 |
Naoto Iwai, Takashi Okuda, Junichi Sakagami, Taishi Harada, Tomoya Ohara, Masashi Taniguchi, Hiroaki Sakai, Kohei Oka, Tasuku Hara, Toshifumi Tsuji, Toshiyuki Komaki, Keizo Kagawa, Hiroaki Yasuda, Yuji Naito, Yoshito Itoh. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75745-8
|
| 559 |
Cihat Ediz Akbaba, Adem Polat, Dilek Göktürk. Tracing 2D Growth of Pancreatic Tumoroids Using the Combination of Image Processing Techniques and Mini-Opto Tomography Imaging System. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231164267
|
| 560 |
Tajana Pavić, Dominik Kralj, Jelena Forgač, Davor Hrabar, Doris Ogresta, Vedran Tomašić, Ivan Lerotić. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; : 213 doi: 10.1007/978-3-319-75856-5_17
|
| 561 |
Philip I. Chow, Devin G. Roller, Mehdi Boukhechba, Kelly M. Shaffer, Lee M. Ritterband, Matthew J. Reilley, Tri M. Le, Paul R. Kunk, Todd W. Bauer, Daniel G. Gioeli. Mobile sensing to advance tumor modeling in cancer patients: A conceptual framework. Internet Interventions 2023; 34: 100644 doi: 10.1016/j.invent.2023.100644
|
| 562 |
Shweta Subhash Giri, Alok Shiomurti Tripathi, Pınar Erkekoğlu, Magdi E. A. Zaki. Molecular pathway of pancreatic cancer‐associated neuropathic pain. Journal of Biochemical and Molecular Toxicology 2024; 38(4) doi: 10.1002/jbt.23638
|
| 563 |
Guoqing Ouyang, Yongrong Wu, Zhen Liu, Wuchang Lu, Shuai Li, Shuqing Hao, Guangdong Pan. Efficacy and safety of gemcitabine-capecitabine combination therapy for pancreatic cancer. Medicine 2021; 100(48): e27870 doi: 10.1097/MD.0000000000027870
|
| 564 |
Akira Kurita, Yoshiharu Mori, Yuko Someya, Shigeto Kubo, Shunjiro Azuma, Kosuke Iwano, Satoshi Ikeda, Ryosuke Okumura, Shujiro Yazumi. High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer. Abdominal Radiology 2021; 46(10): 4817 doi: 10.1007/s00261-021-03199-1
|
| 565 |
Feng Zhu, Shang-Nan Dai, Da-Lai Xu, Chao-Qun Hou, Tong-Tai Liu, Qiu-Yang Chen, Jun-Li Wu, Yi Miao. EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT. Biomedicine & Pharmacotherapy 2020; 125: 109972 doi: 10.1016/j.biopha.2020.109972
|
| 566 |
Michelle R. Ju, Subhadeep Paul, Patricio Polanco, Mathew Augustine, John Mansour, Sam Wang, Matthew R. Porembka. Underutilization of Palliative Care in Metastatic Foregut Cancer Patients Is Associated with Socioeconomic Disparities. Journal of Gastrointestinal Surgery 2021; 25(6): 1404 doi: 10.1007/s11605-020-04742-z
|
| 567 |
Jeffrey S. Chang, Li‐Tzong Chen, Yan‐Shen Shan, Pei‐Yi Chu, Chia‐Rung Tsai, Hui‐Jen Tsai. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation‐wide cancer registry‐based study from Taiwan. Cancer Medicine 2018; 7(11): 5775 doi: 10.1002/cam4.1795
|
| 568 |
Priti Gupta, Charles F. Hodgman, Claudia Alvarez-Florez, Keri L. Schadler, Melissa M. Markofski, Daniel P. O’Connor, Emily C. LaVoy. Comparison of three exercise interventions with and without gemcitabine treatment on pancreatic tumor growth in mice: No impact on tumor infiltrating lymphocytes. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1039988
|
| 569 |
Jing Xue, Shengjiang Chen, Dongfeng Ge, Xiaozhi Yuan. Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer. Human Cell 2022; 35(4): 1174 doi: 10.1007/s13577-022-00700-w
|
| 570 |
Yizhao Zhou, Yi Zhu, Xin Dong, Guodong Cao, Yongzhou Li, Yiqun Fan, Qing Chen, Haolei Cai, Yulian Wu. Exosomes Derived from Pancreatic Cancer Cells Induce Osteoclast Differentiation Through the miR125a-5p/TNFRSF1B Pathway. OncoTargets and Therapy 2021; : 2727 doi: 10.2147/OTT.S282319
|
| 571 |
Susan Kuo, Marco Ventin, Hiroki Sato, Jon M. Harrison, Yusuke Okuda, Motaz Qadan, Cristina R. Ferrone, Keith D. Lillemoe, Carlos Fernandez-del Castillo. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival. Journal of Gastrointestinal Surgery 2024; doi: 10.1016/j.gassur.2024.02.018
|
| 572 |
Urushi Rehman, Mohammed A.S. Abourehab, Amit Alexander, Prashant Kesharwani. Polymeric micelles assisted combinatorial therapy: Is it new hope for pancreatic cancer?. European Polymer Journal 2023; 184: 111784 doi: 10.1016/j.eurpolymj.2022.111784
|
| 573 |
Thomas J. George, Azka Ali, Yu Wang, Ji-Hyun Lee, Alison M. Ivey, David DeRemer, Karen C. Daily, Carmen J. Allegra, Steven J. Hughes, Z. Hugh Fan, Miles E. Cameron, Andrew R. Judge, Jose G. Trevino. Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma. The Oncologist 2021; 26(10): 825 doi: 10.1002/onco.13853
|
| 574 |
Kangchun Wang, Xin Wang, Qi Pan, Bei Zhao. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01870-3
|
| 575 |
Shangnan Dai, Yunpeng Peng, Yi Zhu, Dalai Xu, Feng Zhu, Wenbin Xu, Qiuyang Chen, Xiaole Zhu, Tongtai Liu, Chaoqun Hou, Junli Wu, Yi Miao. Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. Biomedicine & Pharmacotherapy 2020; 121: 109521 doi: 10.1016/j.biopha.2019.109521
|
| 576 |
Edward Hammond, Keith Dredge. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 539 doi: 10.1007/978-3-030-34521-1_22
|
| 577 |
Junko Morishita, Tomoko Inoue. Determining desire to live among patients with advanced hepatobiliary-pancreatic cancer for whom curative treatment is not indicated. Global Health & Medicine 2021; 3(3): 163 doi: 10.35772/ghm.2021.01017
|
| 578 |
Bo Zhu, Xiaomei Wu, Tianyu Guo, Ning Guan, Yefu Liu. Epidemiological Characteristics of Pancreatic Cancer in China From 1990 to 2019. Cancer Control 2021; 28: 107327482110515 doi: 10.1177/10732748211051536
|
| 579 |
Eri Munekage, Satoshi Serada, Shigehiro Tsujii, Keiichiro Yokota, Keita Kiuchi, Kenji Tominaga, Minoru Fujimoto, Mizuki Kanda, Sunao Uemura, Tsutomu Namikawa, Taisei Nomura, Ichiro Murakami, Kazuhiro Hanazaki, Tetsuji Naka. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma. Neoplasia 2021; 23(9): 939 doi: 10.1016/j.neo.2021.07.006
|
| 580 |
Subinuer Abudukelimu, Gang Wei, Jia Huang, Gang Zhao, Li Wei, Wenguo Cui, Min Lu, Weiyan Yao. Polyhedral oligomeric silsesquioxane (POSS)-based hybrid nanocomposite for synergistic chemo-photothermal therapy against pancreatic cancer. Chemical Engineering Journal 2022; 442: 136124 doi: 10.1016/j.cej.2022.136124
|
| 581 |
Min Zhang, Luyang Zhang, Minghe Zhou, Enze Wang, Bo Meng, Qingjun Li, Xiaoqian Wang, Yunjian Wang, Qiong Li. Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc. International Journal of Oncology 2022; 62(1) doi: 10.3892/ijo.2022.5456
|
| 582 |
Zhile Bai, Mengyu Feng, Yang Du, Lin Cong, Yong Cheng. Carboxypeptidase E down-regulation regulates transcriptional and epigenetic profiles in pancreatic cancer cell line: A network analysis. Cancer Biomarkers 2020; 29(1): 79 doi: 10.3233/CBM-191163
|
| 583 |
Jing Lin, Shasha Liao, Zewa Liu, E Li, Xiaohua Wu, Wanting Zeng. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis. Cancer Biology & Therapy 2021; 22(3): 257 doi: 10.1080/15384047.2021.1883184
|
| 584 |
Min-Yue Yin, Li-Ting Xi, Lu Liu, Jin-Zhou Zhu, Li-Juan Qian, Chun-Fang Xu. Pancreatic cancer incidence and mortality patterns in 2006-2015 and prediction of the epidemiological trend to 2025 in China. World Journal of Clinical Cases 2022; 10(14): 4404-4413 doi: 10.12998/wjcc.v10.i14.4404
|
| 585 |
Sini Vehviläinen, Antti Kuuliala, Marianne Udd, Anna Nurmi, Katriina Peltola, Caj Haglund, Leena Kylänpää, Hanna Seppänen. Cholangitis and Interruptions of Neoadjuvant Chemotherapy Associate with Reduced Overall and Progression-Free Survival in Pancreatic Cancer. Annals of Surgical Oncology 2024; 31(4): 2621 doi: 10.1245/s10434-023-14793-6
|
| 586 |
Hye-Su Shin, Sang Baek Jung, Sungho Park, Pooja Dua, Dong ki Lee. ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles. Molecular Therapy - Methods & Clinical Development 2019; 15: 204 doi: 10.1016/j.omtm.2019.08.016
|
| 587 |
Mohaddeseh Hedayat, Reza Jafari, Naime Majidi Zolbanin. Selumetinib: a selective MEK1 inhibitor for solid tumor treatment. Clinical and Experimental Medicine 2022; 23(2): 229 doi: 10.1007/s10238-021-00783-z
|
| 588 |
Yukie Yoshii, Hiroki Matsumoto, Chika Igarashi, Tomoko Tachibana, Fukiko Hihara, Mitsuhiro Shinada, Atsuo Waki, Sei Yoshida, Kenichiro Naito, Kimiteru Ito, Tatsuya Higashi, Hiroaki Kurihara, Makoto Ueno. Process to Remove the Size Variants Contained in the Antibody–Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64. Pharmaceuticals 2023; 16(10): 1341 doi: 10.3390/ph16101341
|
| 589 |
Kumi Ozaki, Hiroshi Ikeno, Yasuharu Kaizaki, Kazuya Maeda, Shohei Higuchi, Nobuyuki Kosaka, Hirohiko Kimura, Toshifumi Gabata. Pearls and pitfalls of imaging features of pancreatic cystic lesions: a case-based approach with imaging–pathologic correlation. Japanese Journal of Radiology 2021; 39(2): 118 doi: 10.1007/s11604-020-01032-1
|
| 590 |
Yongdong Guo, Ronglin Wang, Junqiang Li, Yang Song, Jie Min, Ting Zhao, Lei Hua, Jingjie Shi, Chao Zhang, Peixiang Ma, Cheng Yang, Liaoliao Zhu, Dongxue Gan, Shanshan Li, Xiaonan Liu, Haichuan Su. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.769425
|
| 591 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
|
| 592 |
Chao Li, Juanjuan Cai, Weifeng Liu, Zhenzhen Gao, Guogang Li. Downregulation of circ-STK39 suppresses pancreatic cancer progression by sponging mir-140-3p and regulating TRAM2-mediated epithelial-mesenchymal transition. Apoptosis 2023; 28(7-8): 1024 doi: 10.1007/s10495-023-01813-9
|
| 593 |
Abdella M Ahmed, Maegan Gargett, Levi Madden, Adam Mylonas, Danielle Chrystall, Ryan Brown, Adam Briggs, Trang Nguyen, Paul Keall, Andrew Kneebone, George Hruby, Jeremy Booth. Evaluation of deep learning based implanted fiducial markers tracking in pancreatic cancer patients. Biomedical Physics & Engineering Express 2023; 9(3): 035008 doi: 10.1088/2057-1976/acb550
|
| 594 |
Ming Jia, Dan Zhang, Chunxiang Zhang, Chunhong Li. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01134-6
|
| 595 |
Monireh Rezaei, Zinat Shams, Bahareh Sadat Rasouli, Katayoun Dadeh Amirfard, Mohadeseh Soleymani Sadrabadi, Ali Gheysarzadeh, Karimeh Haghani, Salar Bakhtiyari. New Association Between Diabetes Mellitus and Pancreatic Cancer. Current Diabetes Reviews 2023; 19(1) doi: 10.2174/1573399818666220118095952
|
| 596 |
Mobina Shameli Rajiri, Mahsa Aminsalehi, Mahsa Shahbandeh, Ali Maleki, Parissa Jonoubi, Abdolkarim Chehregani Rad. Anticancer and therapeutic potential of Delonix regia extract and silver nanoparticles (AgNPs) against pancreatic (Panc-1) and breast (MCF-7) cancer cell. Toxicology and Environmental Health Sciences 2021; 13(1): 45 doi: 10.1007/s13530-020-00067-1
|
| 597 |
Sophia G. Kisling, Gopalakrishnan Natarajan, Ramesh Pothuraju, Ashu Shah, Surinder K. Batra, Sukhwinder Kaur. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics. Cancer and Metastasis Reviews 2021; 40(3): 721 doi: 10.1007/s10555-021-09991-1
|
| 598 |
Jing Wang, Liping Zheng, Chundong Hu, Demiao Kong, Zhongcheng Zhou, Bin Wu, Shaohan Wu, Famin Fei, Yiyu Shen. CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Cellular Signalling 2023; 107: 110661 doi: 10.1016/j.cellsig.2023.110661
|
| 599 |
Sai-Li Duan, Yingke Jiang, Guo-Qing Li, Weijie Fu, Zewen Song, Li-Nan Li, Jia Li. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors. PeerJ 2024; 12: e16757 doi: 10.7717/peerj.16757
|
| 600 |
Se Jun Park, Hyunho Kim, Kabsoo Shin, Tae Ho Hong, Ja Hee Suh, Myung Ah Lee. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08887-1
|
| 601 |
Silke Hermann, Klaus Kraywinkel. Epidemiologie des Pankreaskarzinoms in Deutschland. Der Onkologe 2019; 25(8): 647 doi: 10.1007/s00761-019-0623-0
|
| 602 |
Josiah McAllister, Saber Amin, Chi Lin. Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer. Future Oncology 2022; 18(10): 1273 doi: 10.2217/fon-2021-0986
|
| 603 |
Mengyu Zhao, Rongyang Dai. HIST3H2A is a potential biomarker for pancreatic cancer. Medicine 2021; 100(46): e27598 doi: 10.1097/MD.0000000000027598
|
| 604 |
Tanya Odisho, Stephanie Joseph, Awni Shahait, Lydia Choi-Kim, Jessica McGee, Steve Kim. Potentially curative resection of an abdominal wall metastasis from pancreatic adenocarcinoma: a case report. Journal of Surgical Case Reports 2022; 2022(4) doi: 10.1093/jscr/rjac138
|
| 605 |
Yadong Han, Xu Qian, Teng Xu, Yang Shi. Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis. Cancer Biology & Therapy 2022; 23(1): 378 doi: 10.1080/15384047.2022.2041961
|
| 606 |
Louisa Bolm, Ekaterina Petrova, Lukas Woehrmann, Jens Werner, Waldemar Uhl, Natascha Nuessler, Michael Ghadimi, Dirk Bausch, Hryhoriy Lapshyn, Jochen Gaedcke, Orlin Belyaev, Jan G. D'Haese, Thomas Klier, Tobias Keck, Ulrich F. Wellner. The impact of preoperative biliary stenting in pancreatic cancer: A case-matched study from the German nationwide pancreatic surgery registry (DGAV StuDoQ|Pancreas). Pancreatology 2019; 19(7): 985 doi: 10.1016/j.pan.2019.09.007
|
| 607 |
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
|
| 608 |
Shanshan Hu, Xiao Chen, Xiangxiang Xu, Chenlei Zheng, Wenqian Huang, Yi Zhou, Percy David Papa Akuetteh, Hongbao Yang, Keqing Shi, Bicheng Chen, Qiyu Zhang. STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.594224
|
| 609 |
Dawei Jiang, Xiangfei Yuan, Jianqi Ni, Lan Shen, Min Cai, Liu Xu, Antonio Giovanni Solimando. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8882129
|
| 610 |
Roshan Kumar, Prachi Sood, Rahaman Shaik, Harjeet Kumar Singh, Ayush Verma. A Brief Description of Different Types of Cancers and Role of Some Herbs & Bioactive Compounds in Lung Cancer Management. Journal for Research in Applied Sciences and Biotechnology 2023; 2(4): 32 doi: 10.55544/jrasb.2.4.5
|
| 611 |
Marta Gómez de Cedrón, Lamia Mouhid, Elena García-Carrascosa, Tiziana Fornari, Guillermo Reglero, Ana Ramírez de Molina. Marigold Supercritical Extract as Potential Co-adjuvant in Pancreatic Cancer: The Energetic Catastrophe Induced via BMP8B Ends Up With Autophagy-Induced Cell Death. Frontiers in Bioengineering and Biotechnology 2020; 7 doi: 10.3389/fbioe.2019.00455
|
| 612 |
Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, Tsuyoshi Takeda, Chinatsu Mori, Takaaki Furukawa, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira. Treatment outcomes of nanoliposomal irinotecan as second-line chemotherapy after gemcitabine and nab-paclitaxel in metastatic and recurrent pancreatic cancer. Japanese Journal of Clinical Oncology 2022; 52(12): 1399 doi: 10.1093/jjco/hyac145
|
| 613 |
Laia Gorchs, Carlos Fernández Moro, Peter Bankhead, Katharina P. Kern, Imrul Sadeak, Qingda Meng, Elena Rangelova, Helen Kaipe. Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00847
|
| 614 |
Muhammad Attique Khan, Tallha Akram, Yu-Dong Zhang, Muhammad Sharif. Attributes based skin lesion detection and recognition: A mask RCNN and transfer learning-based deep learning framework. Pattern Recognition Letters 2021; 143: 58 doi: 10.1016/j.patrec.2020.12.015
|
| 615 |
Qi Liu, Hongyu Zhao, Yu Guo, Kai Zhang, Fengjia Shang, Tongjun Liu, Mihajlo Jakovljevic. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/7904982
|
| 616 |
M. Jesús Fernández Aceñero, M. Vázquez, J.M. Esteban, Guillermo García Diego, Cristina Díaz del Arco. Influence of the Histopathological Features of the Lesion on the Diagnostic Yield of Fine-Needle Aspiration Cytology of Pancreatic Solid Lesions. Acta Cytologica 2018; 62(4): 259 doi: 10.1159/000488383
|
| 617 |
Ashika D. Maharaj, Liane Ioannou, Daniel Croagh, John Zalcberg, Rachel E. Neale, David Goldstein, Neil Merrett, James G. Kench, Kate White, Charles H.C. Pilgrim, Lorraine Chantrill, Peter Cosman, Andrew Kneebone, Lara Lipton, Mehrdad Nikfarjam, Jennifer Philip, Charbel Sandroussi, Peter Tagkalidis, Richard Chye, Koroush S. Haghighi, Jaswinder Samra, Sue M. Evans. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. HPB 2019; 21(4): 444 doi: 10.1016/j.hpb.2018.08.016
|
| 618 |
Keiichi Yonemori, Naohiko Seki, Tetsuya Idichi, Hiroshi Kurahara, Yusaku Osako, Keiichi Koshizuka, Takayuki Arai, Atsushi Okato, Yoshiaki Kita, Takaaki Arigami, Yuko Mataki, Yuko Kijima, Kosei Maemura, Shoji Natsugoe. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster. Oncotarget 2017; 8(41): 70097 doi: 10.18632/oncotarget.19591
|
| 619 |
L. Gutierrez-Sainz, D. Viñal, J. Villamayor, D. Martinez-Perez, J. A. Garcia-Cuesta, I. Ghanem, A. Custodio, J. Feliu. Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience. Clinical and Translational Oncology 2021; 23(9): 1838 doi: 10.1007/s12094-021-02589-7
|
| 620 |
Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World Journal of Gastroenterology 2017; 23(32): 5875-5886 doi: 10.3748/wjg.v23.i32.5875
|
| 621 |
Li Zhang, Shuangni Yu, Cuiping Wang, Congwei Jia, Zhaohui Lu, Jie Chen. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4560
|
| 622 |
Thomas Chaigneau, Lina Aguilera Munoz, Caroline Oger, Clémence Gourdeau, Olivia Hentic, Lucie Laurent, Nelly Muller, Marco Dioguardi Burgio, Marie-Pauline Gagaille, Philippe Lévy, Vinciane Rebours, Pascal Hammel, Louis de Mestier. Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens. Therapeutic Advances in Medical Oncology 2023; 15: 175883592311637 doi: 10.1177/17588359231163776
|
| 623 |
Y. Veisani, E. Jenabi, S. Khazaei, Sh. Nematollahi. Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health 2018; 156: 87 doi: 10.1016/j.puhe.2017.12.015
|
| 624 |
Robert Memba, Donal B. O’Connor, Kevin C. Conlon. Minimally Invasive Surgery of the Pancreas. Updates in Surgery 2018; : 75 doi: 10.1007/978-88-470-3958-2_8
|
| 625 |
Ines Batista, Sonia Melo. Exosomes and the Future of Immunotherapy in Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(3): 567 doi: 10.3390/ijms20030567
|
| 626 |
Emmanuel Briones, Angelyn Lao, Geoffrey A. Solano. A Pancreatic Cancer Detection Support Tool Using Mass Spectrometry Data and Support Vector Machines. 2020 International Conference on Artificial Intelligence and Signal Processing (AISP) 2020; : 1 doi: 10.1109/AISP48273.2020.9073503
|
| 627 |
Zhi Zheng, Ang Li, Feng Cao, Fei Li. Laparoscopic advanced intraoperative restaging for radiographic non-metastasis pancreatic cancer. Medicine 2020; 99(36): e22090 doi: 10.1097/MD.0000000000022090
|
| 628 |
Ines de Santiago, Christopher Yau, Lara Heij, Mark R. Middleton, Florian Markowetz, Heike I. Grabsch, Michael L. Dustin, Shivan Sivakumar. Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes. International Journal of Cancer 2019; 145(4): 1125 doi: 10.1002/ijc.32186
|
| 629 |
Hannah Jonescheit, Hans-Heinrich Oberg, Daniel Gonnermann, Martin Hermes, Vjola Sulaj, Christian Peters, Dieter Kabelitz, Daniela Wesch. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells. Cells 2020; 9(5): 1140 doi: 10.3390/cells9051140
|
| 630 |
Hanzhang Dong, Mingjian Luo, Shaobiao Ke, Jiulin Zhan, Xi Liu, Zhiwei Li. Application of intraoperative navigation in 3D laparoscopic pancreaticoduodenectomy: A case report. Experimental and Therapeutic Medicine 2022; 24(1) doi: 10.3892/etm.2022.11380
|
| 631 |
Hani M Babiker, Michael Karass, Alejandro Recio-Boiles, Sreenivasa R Chandana, Ali McBride, Daruka Mahadevan. Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC). Expert Opinion on Investigational Drugs 2019; 28(7): 583 doi: 10.1080/13543784.2019.1632289
|
| 632 |
Gitika Thakur, Raj Kumar, Saet-Byul Kim, Sang-Yeob Lee, Sung-Lim Lee, Gyu-Jin Rho. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma. Biomedicines 2021; 9(2): 178 doi: 10.3390/biomedicines9020178
|
| 633 |
Jagoda Oliwia Rogowska, Łukasz Durko, Ewa Malecka-Wojciesko. The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions. Journal of Clinical Medicine 2023; 12(14): 4630 doi: 10.3390/jcm12144630
|
| 634 |
Papitchaya Watcharanurak, Apiwat Mutirangura, Vitavat Aksornkitti, Narumol Bhummaphan, Charoenchai Puttipanyalears. The high FKBP1A expression in WBCs as a potential screening biomarker for pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58324-z
|
| 635 |
Jeffrey M Peters, Frank J Gonzalez. The Evolution of Carcinogenesis. Toxicological Sciences 2018; 165(2): 272 doi: 10.1093/toxsci/kfy184
|
| 636 |
Angelica Petrillo, Annalisa Pappalardo, Luca Pompella, Giuseppe Tirino, Filomena Calabrese, Maria Maddalena Laterza, Marianna Caterino, Anna Ventriglia, Michele Orditura, Giovanni Conzo, Carlo Molino, Fortunato Ciardiello, Maria Biglietto, Ferdinando De Vita. Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment. Medical Oncology 2019; 36(10) doi: 10.1007/s12032-019-1306-9
|
| 637 |
Pengfei Zhang, Weiwei Tao, Cai Lu, Lu Fan, Qihang Jiang, Chengbin Yang, Erxin Shang, Haibo Cheng, Chuntao Che, Jinao Duan, Ming Zhao. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer. Pharmacological Research 2021; 169: 105658 doi: 10.1016/j.phrs.2021.105658
|
| 638 |
Amin Ghareyazi, Amir Mohseni, Hamed Dashti, Amin Beheshti, Abdollah Dehzangi, Hamid R. Rabiee, Hamid Alinejad-Rokny. Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer. Cancers 2021; 13(17): 4376 doi: 10.3390/cancers13174376
|
| 639 |
Vladimir Davidyuk, Neal Bhutiani, Maks K. Gold, Garrett F. Mortensen, Timothy Trestrail, Amber N Brown, Rebecca J. Vitale, Stephen A. McClave, Gary C. Vitale. Surgical Diagnoses of Pancreatic Adenocarcinoma Not Found on Previous Endoscopic Ultrasound: A Case Series and Review of the Literature. The American Surgeon™ 2023; 89(4): 990 doi: 10.1177/00031348211054531
|
| 640 |
Irem Guvendir, Itir Ebru Zemheri, Kamil Ozdil. Impact of rapid on-site evaluation on diagnostic accuracy of EUS-guided fine-needle aspiration of solid pancreatic lesions: experience from a single center. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02330-w
|
| 641 |
Neda Ghamarzad Shishavan, Ashraf Mohamadkhani, Sadaf Ghajarieh Sepanlou, Sahar Masoudi, Maryam Sharafkhah, Hossein Poustchi, Azita Hekmatdoost, Akram Pourshams. Circulating plasma fatty acids and risk of pancreatic cancer: Results from the Golestan Cohort Study. Clinical Nutrition 2021; 40(4): 1897 doi: 10.1016/j.clnu.2020.09.002
|
| 642 |
Rafique Umer Harvitkar, Harish Peri, Sri Nikhil Zallipalli, Suneet John Joseph, Giri Babu Gattupalli, Khursheed Ansari. Non-Cancer Causes of Death in Patients With Pancreatic Adenocarcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Based Study. Cureus 2021; doi: 10.7759/cureus.20289
|
| 643 |
Liang Xue, Yan Shen, Zhenglong Zhai, Shusen Zheng. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1. International Journal of Molecular Medicine 2020; doi: 10.3892/ijmm.2020.4561
|
| 644 |
Chao Chen, Ying Wang, Qing Zhao, Guo-dong Li, Yao-hui Wang, Li-chao Xu, Hao-zhe Huang, Ge Song, Wen-tao Li, Xin-hong He. E3 Ubiquitin Ligase MARCH8 Promotes Pancreatic Cancer Growth and Metastasis by Activating STAT3 via Degradation of PTPN4. Pancreas 2023; 52(4): e224 doi: 10.1097/MPA.0000000000002244
|
| 645 |
Megha Pratapwar, Ashley E. Stenzel, Janine M. Joseph, Christos Fountzilas, John Lewis Etter, Jennifer M. Mongiovi, Rikki Cannioto, Kirsten B. Moysich. Physical Inactivity and Pancreatic Cancer Mortality. Journal of Gastrointestinal Cancer 2020; 51(3): 1088 doi: 10.1007/s12029-020-00441-9
|
| 646 |
V. I. Orelkin, E. A. Toneev, A. V. Zhinov, S. V. Gorodnov, B. V. Abroskin, Y. D. Orelkina. EXPERIENCE OF GASTROPANCREATODUODENAL RESECTION WITH CIRCULAR RESECTION OF MAJOR VENOUS VESSELS. Surgical practice 2021; (4): 40 doi: 10.38181/2223-2427-2020-4-40-47
|
| 647 |
Samuli I. Nissinen, Markus Venäläinen, Pekka Kumpulainen, Antti Roine, Merja R. Häkkinen, Jouko Vepsäläinen, Niku Oksala, Tuomo Rantanen. Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel. Cancer Control 2021; 28: 107327482110397 doi: 10.1177/10732748211039762
|
| 648 |
Jiaqi Wu, Liang Tang, Feng Zheng, Xun Chen, Lei Li. A review of the last decade: pancreatic cancer and type 2 diabetes. Archives of Physiology and Biochemistry 2023; : 1 doi: 10.1080/13813455.2023.2252204
|
| 649 |
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
|
| 650 |
Samaneh Tokhanbigli, Ali Asadirad, Kaveh Baghaei, Andrea Piccin, Fatemeh Yarian, Gilda Parsamanesh, Seyed Mahmoud Hashemi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. <p>Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer</p>. ImmunoTargets and Therapy 2020; : 95 doi: 10.2147/ITT.S245913
|
| 651 |
Carlos Marra-López Valenciano. Factors associated with pancreatic cancer in Spain. What can we learn from epidemiological studies?. Revista Española de Enfermedades Digestivas 2022; 114 doi: 10.17235/reed.2022.8927/2022
|
| 652 |
Edyta Barańska, Olga Wiecheć-Cudak, Monika Rak, Aleksandra Bienia, Anna Mrozek-Wilczkiewicz, Martyna Krzykawska-Serda, Maciej Serda. Interactions of a Water-Soluble Glycofullerene with Glucose Transporter 1. Analysis of the Cellular Effects on a Pancreatic Tumor Model. Nanomaterials 2021; 11(2): 513 doi: 10.3390/nano11020513
|
| 653 |
Peng Dong, Yu Yan, Yujun Fan, Hui Wang, Danzhu Wu, Liyuan Yang, Junpeng Zhang, Xiaoyang Yin, Yajuan Lv, Jiandong Zhang, Yuzhu Hou, Fengjun Liu, Xinshuang Yu. The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. Technology in Cancer Research & Treatment 2022; 21: 153303382211424 doi: 10.1177/15330338221142472
|
| 654 |
Takafumi Mie, Takashi Sasaki, Tsuyoshi Takeda, Takeshi Okamoto, Chinatsu Mori, Takaaki Furukawa, Yuto Yamada, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira. Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer. Japanese Journal of Clinical Oncology 2021; 51(9): 1416 doi: 10.1093/jjco/hyab091
|
| 655 |
Wenqi Huang, LiFeng Xue, Haoming Xu, Zhiqian Kong, Jing Xu, Hailan Zhao, Yuqiang Nie. Diagnostic value of neuronal pentraxin II methylation in patients with pancreatic cancer: Meta‐analysis. International Journal of Clinical Practice 2021; 75(9) doi: 10.1111/ijcp.14443
|
| 656 |
Siqi Guo, Niculina I. Burcus, Chelsea M. Edelblute, James Hornef, Chunqi Jiang, Karl Schoenbach, Richard Heller, Stephen J. Beebe. Advances in Pancreatic Cancer. 2018; doi: 10.5772/intechopen.75196
|
| 657 |
Krishna Sriram, Cristina Salmerón, Shu Z. Wiley, Paul A. Insel. GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets. British Journal of Pharmacology 2020; 177(11): 2434 doi: 10.1111/bph.15028
|
| 658 |
Yoshiyasu Kato, Suguru Yamada, Masaya Suenaga, Hideki Takami, Yukiko Niwa, Masamichi Hayashi, Naoki Iwata, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma. Pancreas 2018; 47(7): 823 doi: 10.1097/MPA.0000000000001105
|
| 659 |
Hsuan-Ju Kuo, Yu-Wen Tien, Nien-Tzu Chang, Yun-Jen Chou, Shiow-Ching Shun. Comparison of Fatigue and Quality of Life in Individuals With Pancreatogenic Diabetes After Total or Partial Pancreatectomy. Oncology Nursing Forum 2019; 46(5): E159 doi: 10.1188/19.ONF.E159-E170
|
| 660 |
Juan Zhao, Madi Guo, Yushuai Song, Shan Liu, Ran Liao, Yu Zhang, Yumin Zhang, Qi Yang, Yuanlong Gu, Xiaoyi Huang. Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.992929
|
| 661 |
Deep Jyoti Bhuyan, Quan V. Vuong, Anita C. Chalmers, Michael C. Bowyer, Christopher J. Scarlett. An Array of Bioactive Compounds From Australian Eucalypts and Their Relevance in Pancreatic Cancer Therapeutics. Pancreas 2018; 47(6): 690 doi: 10.1097/MPA.0000000000001074
|
| 662 |
Panagiotis Ntellas, Katerina Dadouli, Konstantinos Perivoliotis, Eleni Sogka, Georgios Pentheroudakis, Maria Ioannou, Christos Hadjichristodoulou, Konstantinos Tepetes, Davide Mauri. Microvessel Density and Impact of Angiogenesis on Survival of Resected Pancreatic Cancer Patients. Pancreas 2019; 48(2): 233 doi: 10.1097/MPA.0000000000001237
|
| 663 |
Natalia Khalaf, Hashem B. El-Serag, Hannah R. Abrams, Aaron P. Thrift. Burden of Pancreatic Cancer: From Epidemiology to Practice. Clinical Gastroenterology and Hepatology 2021; 19(5): 876 doi: 10.1016/j.cgh.2020.02.054
|
| 664 |
Urszula Religioni, Aleksandra Czerw, Anna M. Badowska-Kozakiewicz, Michał Budzik, Andrzej Deptała. Health-Related Quality of Life - Measurement Tools, Predictors and Modifiers. 2022; doi: 10.5772/intechopen.97325
|
| 665 |
Andrea Zironda, Chi Zhang, Courtney Day, Robert R. McWilliams, Patrick Starlinger, Susanne G. Warner, Rory L. Smoot, Sean P. Cleary, Micheal L. Kendrick, Mark J. Truty, Cornelius A. Thiels. Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection. HPB 2024; 26(1): 145 doi: 10.1016/j.hpb.2023.09.010
|
| 666 |
Victoria Katie Xie, Jie He, Keping Xie. Protein arginine methylation promotes therapeutic resistance in human pancreatic cancer. Cytokine & Growth Factor Reviews 2020; 55: 58 doi: 10.1016/j.cytogfr.2020.07.011
|
| 667 |
Ruiguan Wang, Jiangbo Li, Changjian Zhang, Xin Guan, Boyu Qin, Rui Jin, Lingmei Qin, Shanrong Xu, Xiaona Zhang, Rong Liu, Qinong Ye, Long Cheng. Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.821620
|
| 668 |
Mohini Singh, Paulami Pal, Rajat Subhra Dutta, Daphisha Marbaniang, Subhabrata Ray, Bhaskar Mazumder. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma:
Disrupting the Tumor-stromal Cross-talk, Next Hope on the
Horizon?. Current Cancer Drug Targets 2023; 23(8): 620 doi: 10.2174/1568009623666230227120837
|
| 669 |
Lili Zhu, Botai Li, Rongkun Li, Lipeng Hu, Yanli Zhang, Zhigang Zhang, Shuheng Jiang, Xueli Zhang. METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity. Cellular Oncology 2023; 46(5): 1529 doi: 10.1007/s13402-023-00829-2
|
| 670 |
Paulina Paciej-Gołębiowska, Małgorzata Pikala, Irena Maniecka-Bryła. Years of life lost due to malignant neoplasms of the digestive system in Poland in the years 2000–2014. United European Gastroenterology Journal 2018; 6(6): 943 doi: 10.1177/2050640618764714
|
| 671 |
Sunkai Ling, Yanru He, Xiaoxue Li, Mingyue Hu, Yu Ma, Yuan Li, Zipeng Lu, Shanshan Shen, Bo Kong, Xiaoping Zou, Kuirong Jiang, Peilin Huang. CircRHOT1 mediated cell proliferation, apoptosis and invasion of pancreatic cancer cells by sponging miR‐125a‐3p. Journal of Cellular and Molecular Medicine 2020; 24(17): 9881 doi: 10.1111/jcmm.15572
|
| 672 |
Ida Micaily, Edik M. Blais, Randi Carhart, Sophia Lam, Steven J. Cohen, Shawna J. Cannaday, David Halverson, Lynn M. Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J. Pishvaian, Harish Lavu, Charles J. Yeo, Atrayee Basu Mallick. Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.22.00648
|
| 673 |
Kohji Takagi, Johji Imura, Akiko Shimomura, Akira Noguchi, Takashi Minamisaka, Shinichi Tanaka, Takeshi Nishida, Hideki Hatta, Takahiko Nakajima. Establishment of highly invasive pancreatic cancer cell lines and the expression of IL‑32. Oncology Letters 2020; 20(3): 2888 doi: 10.3892/ol.2020.11825
|
| 674 |
Ingar Olsen, Özlem Yilmaz. Possible role of Porphyromonas gingivalis in orodigestive cancers. Journal of Oral Microbiology 2019; 11(1): 1563410 doi: 10.1080/20002297.2018.1563410
|
| 675 |
Gerardo A. Vitiello, Deirdre J. Cohen, George Miller. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy. Trends in Cancer 2019; 5(11): 670 doi: 10.1016/j.trecan.2019.10.005
|
| 676 |
Dimitrios Schizas, Nikolaos Charalampakis, Christo Kole, Panagiota Economopoulou, Evangelos Koustas, Efthymios Gkotsis, Dimitrios Ziogas, Amanda Psyrri, Michalis V. Karamouzis. Immunotherapy for pancreatic cancer: A 2020 update. Cancer Treatment Reviews 2020; 86: 102016 doi: 10.1016/j.ctrv.2020.102016
|
| 677 |
Akanksha Malaiya, Dolly Jain, Awesh K. Yadav. Nano Drug Delivery Strategies for the Treatment of Cancers. 2021; : 145 doi: 10.1016/B978-0-12-819793-6.00007-2
|
| 678 |
Cheng-Fang Wang, Xian-Jie Shi. Generation and application of patient-derived xenograft models in pancreatic cancer research. Chinese Medical Journal 2019; 132(22): 2729 doi: 10.1097/CM9.0000000000000524
|
| 679 |
Yuli Zhang, Haohong Zhang, Bingqiang Liu, Kang Ning. Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data. iScience 2024; 27(3): 109294 doi: 10.1016/j.isci.2024.109294
|
| 680 |
Chun-Man Lee, Benedetto Natalini. A Review on the Antimutagenic and Anticancer Effects of Cysteamine. Advances in Pharmacological and Pharmaceutical Sciences 2023; 2023: 1 doi: 10.1155/2023/2419444
|
| 681 |
Zhaoqing Sun, Bo Yan. Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers. Clinical Genetics 2020; 97(1): 64 doi: 10.1111/cge.13630
|
| 682 |
Magdalena Sikora-Skrabaka, Katarzyna Walkiewicz, Ewa Nowakowska-Zajdel. Adamalizyny jako potencjalne biomarkery w wybranych nowotworach złośliwych przewodu pokarmowego. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 674 doi: 10.2478/ahem-2021-0020
|
| 683 |
Nikhil Gupta, Ravi Kankotia, Ara Sahakian, Preeth Jayaram, Alex Shindel, Elizabeth Dong, Paul Korc, Mohamad Eloubeidi, James Buxbaum. Endoscopic Ultrasound Assessment of Pancreatic Duct Diameter Predicts Neuroendocrine Tumors and Other Pancreas Masses. Pancreas 2019; 48(1): 66 doi: 10.1097/MPA.0000000000001200
|
| 684 |
Daniel C. Osei-Bordom, Nikolaos Serifis, Zachary J. Brown, D. Brock Hewitt, Gbemisola Lawal, Gagandeep Sachdeva, Daniel J. Cloonan, Timothy M. Pawlik. Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies. Surgical Oncology 2022; 43: 101803 doi: 10.1016/j.suronc.2022.101803
|
| 685 |
Pablo Redruello, Gloria Perazzoli, Ana Cepero, Francisco Quiñonero, Cristina Mesas, Kevin Doello, Antonio Láinez-Ramos-Bossini, Mario Rivera-Izquierdo, Consolación Melguizo, Jose Prados. Nanomedicine in Pancreatic Cancer: A New Hope for Treatment. Current Drug Targets 2020; 21(15): 1580 doi: 10.2174/1389450121666200703195229
|
| 686 |
Ulf Gyllensten, Sofia Bosdotter Enroth, Karin Stålberg, Karin Sundfeldt, Stefan Enroth. Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome. Cancers 2020; 12(9): 2439 doi: 10.3390/cancers12092439
|
| 687 |
Shiow-Ching Shun. Proposing a Comprehensive Prehabilitation Model for Individuals with Operable Pancreatic Cancer. Asia-Pacific Journal of Oncology Nursing 2020; 7(3): 255 doi: 10.4103/apjon.apjon_18_20
|
| 688 |
Rittal Mehta, Diamantis I. Tsilimigras, Anghela Z. Paredes, Madison Hyer, Mary Dillhoff, Jordan M. Cloyd, Aslam Ejaz, Allan Tsung, Timothy M. Pawlik. County-Level Variation in Utilization of Surgical Resection for Early-Stage Hepatopancreatic Cancer Among Medicare Beneficiaries in the USA. Journal of Gastrointestinal Surgery 2021; 25(7): 1736 doi: 10.1007/s11605-020-04778-1
|
| 689 |
Xiaomin Li, Ning Qiu, Qijuan Li. Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.758725
|
| 690 |
Yazan H Nofal, Yaser Abu Dail, Yazan Assaf, Hayan Abo Samra, Fatima Abbas, Ammar Hamzeh, Nahla Alhaj Hasan. Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD012952
|
| 691 |
Omer Gersten, Magali Barbieri. Evaluation of the Cancer Transition Theory in the US, Select European Nations, and Japan by Investigating Mortality of Infectious- and Noninfectious-Related Cancers, 1950-2018. JAMA Network Open 2021; 4(4): e215322 doi: 10.1001/jamanetworkopen.2021.5322
|
| 692 |
Venkatesh Panthangi, Adrienne R Cyril Kurupp, Anjumol Raju, Gaurav Luthra, Mahrukh Shahbaz, Halah Almatooq, Paul Foucambert, Faith D Esbrand, Sana Zafar, Safeera Khan. Association Between Helicobacter pylori Infection and the Risk of Pancreatic Cancer: A Systematic Review Based on Observational Studies. Cureus 2022; doi: 10.7759/cureus.28543
|
| 693 |
Wei Fang Dai, Jaclyn Beca, Helen Guo, Wanrudee Isaranawatchai, Deborah Schwartz, Rohini Naipaul, Jessica Arias, Yao Qiao, Scott Gavura, Ruby Redmond‐Misner, Zahra Ismail, Lisa Barbera, Kelvin Chan. Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?. Cancer Medicine 2020; 9(1): 215 doi: 10.1002/cam4.2704
|
| 694 |
Mengqi Song, Bin Zhou, Bilu Li, Lantian Tian. PMEPA1 Stimulates the Proliferation, Colony Formation of Pancreatic Cancer Cells via the MAPK Signaling Pathway. The American Journal of the Medical Sciences 2021; 362(3): 291 doi: 10.1016/j.amjms.2021.04.002
|
| 695 |
Jie Chen, Jada C. Domingue, Cynthia L. Sears. Microbiota dysbiosis in select human cancers: Evidence of association and causality. Seminars in Immunology 2017; 32: 25 doi: 10.1016/j.smim.2017.08.001
|
| 696 |
Ye Tian, Huanli Xu, Ammad Ahmad Farooq, Baozeng Nie, Xiaoliang Chen, Shuonan Su, Ru Yuan, Gan Qiao, Cong Li, Xiao Li, Xiaohui Liu, Xiukun Lin. Maslinic acid induces autophagy by down‐regulating HSPA8 in pancreatic cancer cells. Phytotherapy Research 2018; 32(7): 1320 doi: 10.1002/ptr.6064
|
| 697 |
Yihui Ma, Peiyi Xia, Zhengyang Wang, Jingjing Xu, Lan Zhang, Yanan Jiang. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1. Neoplasia 2021; 23(9): 912 doi: 10.1016/j.neo.2021.07.004
|
| 698 |
Ao Liu, Hui Jiang, Weiwei Cao, Wenju Cui, Dehui Xiang, Chengwei Shao, Zhaobang Liu, Yun Bian, Jian Zheng. MLAGG-Net: Multi-level aggregation and global guidance network for pancreatic lesion segmentation in histopathological images. Biomedical Signal Processing and Control 2023; 86: 105303 doi: 10.1016/j.bspc.2023.105303
|
| 699 |
Ashiat Ashake Adeogun, Misagh Faezipour. Exploring Risk Factors in PDAC Using System Dynamics. 2023 Congress in Computer Science, Computer Engineering, & Applied Computing (CSCE) 2023; : 1368 doi: 10.1109/CSCE60160.2023.00229
|
| 700 |
Sergey Batskikh, Sergey Morozov, Dmitry Kostyushev. Hepatitis B virus markers in hepatitis B surface antigen negative patients with pancreatic cancer: Two case reports . World Journal of Hepatology 2022; 14(7): 1512-1519 doi: 10.4254/wjh.v14.i7.1512
|
| 701 |
Amanda R. Muñoz, Divya Chakravarthy, Jingjing Gong, Glenn A. Halff, Rita Ghosh, Addanki P. Kumar. Pancreatic Cancer: Current Status and Challenges. Current Pharmacology Reports 2017; 3(6): 396 doi: 10.1007/s40495-017-0112-3
|
| 702 |
Vidhura Ratnasekara, Laurence Weinberg, Samuel Anthony Johnston, Luke Fletcher, Patrick Nugraha, Daniel Robert Anthony Cox, Raymond Hu, Ilonka Meyer, Osamu Yoshino, Marcos Vinius Perini, Vijayaragavan Muralidharan, Mehrdad Nikfarjam, Dong-Kyu Lee, Young-Kug Kim. Multimodal intrathecal analgesia (MITA) with morphine for reducing postoperative opioid use and acute pain following hepato-pancreato-biliary surgery: A multicenter retrospective study. PLOS ONE 2023; 18(9): e0291108 doi: 10.1371/journal.pone.0291108
|
| 703 |
Hassam Ali, Rahul Pamarthy, Meghana Vallabhaneni, Shiza Sarfraz, Hadiqa Ali, Hamza Rafique. Pancreatic cancer incidence trends in the United States from 2000-2017: Analysis of Surveillance, Epidemiology and End Results (SEER) database. F1000Research 2021; 10: 529 doi: 10.12688/f1000research.54390.1
|
| 704 |
Matthew B. O'Rourke, Sumit Sahni, Jaswinder Samra, Anubhav Mittal, Mark P. Molloy. Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma. Journal of Proteomics 2021; 231: 103998 doi: 10.1016/j.jprot.2020.103998
|
| 705 |
Victor R. Lincha, Jun Zhao, Xiaoxia Wen, Chiyi Xiong, Diana S-L Chow, Chun Li. A polymeric micellar drug delivery system developed through a design of Experiment approach improves pancreatic tumor accumulation of calcipotriol and paclitaxel. International Journal of Pharmaceutics 2021; 601: 120523 doi: 10.1016/j.ijpharm.2021.120523
|
| 706 |
Mohammad Khan, Shafquat Azim, Haseeb Zubair, Arun Bhardwaj, Girijesh Patel, Moh’d Khushman, Seema Singh, Ajay Singh. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. International Journal of Molecular Sciences 2017; 18(4): 779 doi: 10.3390/ijms18040779
|
| 707 |
Ding Li, Xiao-Feng Ni, Hengjie Tang, Jiecheng Zhang, Chenlei Zheng, Jianhu Lin, Cheng Wang, Linxiao Sun, Bicheng Chen. <p>KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway</p>. Cancer Management and Research 2020; : 2087 doi: 10.2147/CMAR.S243129
|
| 708 |
Sumit Sahni, Elizabeth A. Moon, Viive M. Howell, Shreya Mehta, Nick Pavlakis, David Chan, Mahsa S. Ahadi, Anthony J. Gill, Jaswinder Samra, Anubhav Mittal. Tissue biomarker panel as a surrogate marker for squamous subtype of pancreatic cancer. European Journal of Surgical Oncology 2020; 46(8): 1539 doi: 10.1016/j.ejso.2020.02.001
|
| 709 |
Miles W. Grunvald, Richard A. Jacobson, Timothy M. Kuzel, Sam G. Pappas, Ashiq Masood. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer. International Journal of Molecular Sciences 2020; 21(20): 7651 doi: 10.3390/ijms21207651
|
| 710 |
Peng Li, Hongsheng Wang, Ying Tang, Shuo Sun, Yue Ma, Yansong Xu, Guangyu Chen. Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR‑520h/CKS1B axis. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10576
|
| 711 |
Ziba Lotfi, Shiva Najjary, Fariba Lotfi, Mohammad Amini, Amir Baghbanzadeh, Darya Javad Rashid, Elmira Roshani Asl, Behzad Baradaran, Ahad Mokhtarzadeh. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma. European Journal of Pharmacology 2021; 901: 174006 doi: 10.1016/j.ejphar.2021.174006
|
| 712 |
Qingqing Yu, Xin Wang, Xinyu Li, Xue Bai, Ronglan Zhao, Xiaoxiang Peng. Purinergic P2X7R as a potential target for pancreatic cancer. Clinical and Translational Oncology 2023; 25(8): 2297 doi: 10.1007/s12094-023-03123-7
|
| 713 |
Konstantinos K Tsilidis, James Y Dai, Ulrike Peters. Editorial: Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk. JNCI: Journal of the National Cancer Institute 2017; 109(9) doi: 10.1093/jnci/djx043
|
| 714 |
Diana Pinkert-Leetsch, Jasper Frohn, Philipp Ströbel, Frauke Alves, Tim Salditt, Jeannine Missbach-Guentner. Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography – the next dimension of diagnosis. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00559-6
|
| 715 |
Amelia Barcellini, Andrea Peloso, Luigi Pugliese, Viviana Vitolo, Lorenzo Cobianchi. <p>Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress</p>. OncoTargets and Therapy 2020; : 12705 doi: 10.2147/OTT.S220971
|
| 716 |
Tommaso Schepis, Sara S. De Lucia, Enrico C. Nista, Vittoria Manilla, Giulia Pignataro, Veronica Ojetti, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli. Microbiota in Pancreatic Diseases: A Review of the Literature. Journal of Clinical Medicine 2021; 10(24): 5920 doi: 10.3390/jcm10245920
|
| 717 |
Norihiro Ishii, Kenichiro Araki, Takehiko Yokobori, Dorgormaa Gantumur, Takahiro Yamanaka, Bolag Altan, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Yasuo Hosouchi, Hiroyuki Kuwano, Ken Shirabe. Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1. Oncotarget 2017; 8(68): 112636 doi: 10.18632/oncotarget.22634
|
| 718 |
Ruiming Li, Xia Wang, Chunming Zhu, Kefeng Wang. lncRNA PVT1: a novel oncogene in multiple cancers. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00385-x
|
| 719 |
Hrvoje Kaučić, Domagoj Kosmina, Dragan Schwarz, Andreas Mack, Hrvoje Šobat, Adlan Čehobašić, Vanda Leipold, Iva Andrašek, Asmir Avdičević, Mihaela Mlinarić. Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study. Cancers 2022; 14(11): 2688 doi: 10.3390/cancers14112688
|
| 720 |
Rohit Mundel, Sunidhi Dhadwal, Saumya Bharti, Mary Chatterjee. Handbook of Oncobiology: From Basic to Clinical Sciences. 2023; : 1 doi: 10.1007/978-981-99-2196-6_4-1
|
| 721 |
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki, Konstantinos G. Toutouzas. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Current Issues in Molecular Biology 2024; 46(4): 2827 doi: 10.3390/cimb46040177
|
| 722 |
Kazunori Nakaoka, Senju Hashimoto, Naoto Kawabe, Takuji Nakano, Tomoki Takamura, Sayuri Miyachi, Arisa Mii, Aiko Fukui, Kentaro Yoshioka, Yoshiki Hirooka. Probe‐based confocal laser endomicroscopy for the diagnosis of pancreatic ductal structures. Journal of Gastroenterology and Hepatology 2021; 36(1): 118 doi: 10.1111/jgh.15111
|
| 723 |
Farzaneh Raeisi, Mahdieh Abolfathi, Raheleh Ahmadi-Naji, Sara Iranparast, Esmat Noshadi, Arvand Akbari, Esmaeil Mahmoudi, Mansoor Khaledi, Asghar Arshi. ARA lncRNA, is upregulated in liver and breast tumor tissues. Molecular Biology Reports 2019; 46(1): 77 doi: 10.1007/s11033-018-4447-6
|
| 724 |
Maria Montserrat Duh, Neus Torra-Ferrer, Meritxell Riera-Marín, Dídac Cumelles, Júlia Rodríguez-Comas, Javier García López, Mª Teresa Fernández Planas. Deep Learning to Detect Pancreatic Cystic Lesions on Abdominal Computed Tomography Scans: Development and Validation Study. JMIR AI 2023; 2: e40702 doi: 10.2196/40702
|
| 725 |
Siqi Guo, Niculina Burcus, James Hornef, Yu Jing, Chunqi Jiang, Richard Heller, Stephen Beebe. Nano-Pulse Stimulation for the Treatment of Pancreatic Cancer and the Changes in Immune Profile. Cancers 2018; 10(7): 217 doi: 10.3390/cancers10070217
|
| 726 |
Tai‐Tu Lin, Tong Zhang, Reta B. Kitata, Tao Liu, Richard D. Smith, Wei‐Jun Qian, Tujin Shi. Mass spectrometry‐based targeted proteomics for analysis of protein mutations. Mass Spectrometry Reviews 2023; 42(2): 796 doi: 10.1002/mas.21741
|
| 727 |
Jie Shi, Ling Zong, Peiyao Wang, Chao Li, Jianjun Yue, Xin Wang. A study of biomacromolecular changes in dandelion root extract induced PANC-1 cells apoptosis using FTIR microspectroscopy. Infrared Physics & Technology 2022; 120: 103995 doi: 10.1016/j.infrared.2021.103995
|
| 728 |
Guillaume Onyeaghala, John Lane, Nathan Pankratz, Heather H. Nelson, Bharat Thyagarajan, Bruce Walcheck, Kristin E. Anderson, Anna E. Prizment, Narasimha Reddy Parine. Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study. PLOS ONE 2019; 14(6): e0217868 doi: 10.1371/journal.pone.0217868
|
| 729 |
Xu-Sheng Liu, Yan Gao, Chao Liu, Xue-Qin Chen, Lu-Meng Zhou, Jian-Wei Yang, Xue-Yan Kui, Zhi-Jun Pei. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.606735
|
| 730 |
Lingmin Yang, Ranliang Cui, Yueguo Li, Kai Liang, Min Ni, Yajun Gu. Hypoxia-Induced TGFBI as a Serum Biomarker for Laboratory Diagnosis and Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Laboratory Medicine 2020; 51(4): 352 doi: 10.1093/labmed/lmz063
|
| 731 |
Maia E.W. Morrison, Emma G. Hobika, Janine M. Joseph, Ashley E. Stenzel, Jennifer M. Mongiovi, Li Tang, Susan E. McCann, James Marshall, Christos Fountzilas, Kirsten B. Moysich. Cruciferous vegetable consumption and pancreatic cancer: A case-control study. Cancer Epidemiology 2021; 72: 101924 doi: 10.1016/j.canep.2021.101924
|
| 732 |
Xi Wang, Cheng-Sheng Zhang, Xu-Yuan Dong, Yuan Hu, Bao-Jun Duan, Jun Bai, Yin-Ying Wu, Lin Fan, Xin-Hua Liao, Ye Kang, Peng Zhang, Meng-Yang Li, Jiao Xu, Zhi-Jun Mao, Hui-Tong Liu, Xiao-Long Zhang, Li-Fei Tian, En-Xiao Li. Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology 2022; 14(7): 1252-1264 doi: 10.4251/wjgo.v14.i7.1252
|
| 733 |
Jing Li, Yunmei Li, Chong Chen, Jiayu Guo, Mengmeng Qiao, Jun Lyu. Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: A model-based period analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1049136
|
| 734 |
Hui Zhang, Xuan Zhang, Xun Li, Wen‐Bo Meng, Zhong‐Tian Bai, Shao‐Zhen Rui, Zheng‐Feng Wang, Wen‐Ce Zhou, Xiao‐Da Jin. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Journal of Cellular Physiology 2019; 234(1): 619 doi: 10.1002/jcp.26816
|
| 735 |
Gilberto Duarte-Medrano, Iván Lopez-Méndez, Miguel Ángel Ramírez-Luna, Francisco Valdovinos-Andraca, Rodrigo Cruz-Martínez, Isabel Medina-Vera, Carlos Pérez-Monter, Félix Ignacio Téllez-Ávila. Analysis of circulating blood and tissue biopsy PDX1 and MSX2 gene expression in patients with pancreatic cancer. Medicine 2019; 98(26): e15954 doi: 10.1097/MD.0000000000015954
|
| 736 |
Sang-Heum Park, Hoo Rim Song, Sung Won Lee, Tae Hoon Lee. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?. The Korean Journal of Pancreas and Biliary Tract 2018; 23(3): 89 doi: 10.15279/kpba.2018.23.3.89
|
| 737 |
Alecia M. Blaszczak, Somashekar G. Krishna. Endoscopic diagnosis of pancreatic cysts. Current Opinion in Gastroenterology 2019; 35(5): 448 doi: 10.1097/MOG.0000000000000558
|
| 738 |
Kyriakos Papadimitriou, Daniel Kiss-Bodolay, Abderrahmane Hedjoudje, Diego San Millan, Alexandre Simonin, Jean-Yves Fournier, Karen Huscher. Late metachronous cerebral metastasis of pancreatic adenocarcinoma of the tail of the pancreas: a case report. Journal of Medical Case Reports 2022; 16(1) doi: 10.1186/s13256-022-03314-w
|
| 739 |
Guoping Ding, Xiaodong Xu, Dan Li, Yuhao Chen, Weimin Wang, Dongnan Ping, Shengnan Jia, Liping Cao. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03019-2
|
| 740 |
Valeria Tonini, Manuel Zanni. Pancreatic cancer in 2021: What you need to know to win. World Journal of Gastroenterology 2021; 27(35): 5851-5889 doi: 10.3748/wjg.v27.i35.5851
|
| 741 |
Ylberta Kajtazi, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours. Journal of Cancer Research and Clinical Oncology 2019; 145(10): 2481 doi: 10.1007/s00432-019-03011-0
|
| 742 |
Weiyu Ge, Daiyuan Shentu, Yongchao Wang, Yanling Wang, Shengbai Xue, Ming Yue, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Shumin Li, Jingyu Ma, Jiayu Yao, Jiujie Cui, Liwei Wang. A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1001606
|
| 743 |
John Silke, Lorraine Ann O’Reilly. NF-κB and Pancreatic Cancer; Chapter and Verse. Cancers 2021; 13(18): 4510 doi: 10.3390/cancers13184510
|
| 744 |
Zohar Levi, Gilad Twig. Reply to The relationship between obesity in adolescence and pancreatic cancer in adulthood. Cancer 2019; 125(12): 2132 doi: 10.1002/cncr.32019
|
| 745 |
Anne Sofie Bruun‐Sørensen, Sarannya Edamana, Frédéric H. Login, Signe Borgquist, Lene N. Nejsum. Aquaporins in pancreatic ductal adenocarcinoma. APMIS 2021; 129(12): 700 doi: 10.1111/apm.13184
|
| 746 |
Jian Xie, Yang Peng, Xiaoyu Chen, Qigang Li, Bin Jian, Zelin Wen, Shengchun Liu, Hiromu Suzuki. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis. PLOS ONE 2021; 16(1): e0245908 doi: 10.1371/journal.pone.0245908
|
| 747 |
Nadia N Khan, Harleen Basrai, Sue M Evans, Liane J Ioannou, Charles HC Pilgrim, John R Zalcberg, Gayle M Jones, Susan Hanson. Landscape of clinical trials across the pancreatic cancer care continuum: an Australian perspective. Medical Journal of Australia 2022; 217(10): 505 doi: 10.5694/mja2.51756
|
| 748 |
Anni M. Y. Zhang, Ken H. Chu, Brian F. Daly, Titine Ruiter, Yan Dou, Jenny C. C. Yang, Twan J. J. de Winter, Justin Chhuor, Su Wang, Stephane Flibotte, Yiwei Bernie Zhao, Xiaoke Hu, Hong Li, Elizabeth J. Rideout, David F. Schaeffer, James D. Johnson, Janel L. Kopp. Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics. Cancer & Metabolism 2022; 10(1) doi: 10.1186/s40170-022-00282-z
|
| 749 |
Jaime Feliu, Mónica Jorge Fernández, Teresa Macarulla, Bartomeu Massuti, Ana Albero, José Federico González González, Guillermo Quintero-Aldana, Juan Ignacio Delgado-Mingorance, Ana Fernández Montes, Carmen García Piernavieja, Manuel Valladares-Ayerbes, Ana María López Muñoz, Rebeca Mondéjar Solís, Pilar Vicente, Esther Casado Gonzalez, Irene González Cebrián, Guillermo López-Vivanco. Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study. Cancer Chemotherapy and Pharmacology 2021; 87(4): 543 doi: 10.1007/s00280-020-04214-w
|
| 750 |
Shuxia Wang, Yongli Gao. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway. International Immunopharmacology 2021; 100: 107990 doi: 10.1016/j.intimp.2021.107990
|
| 751 |
Qi Wang, Berina Šabanović, Azhar Awada, Chiara Reina, Alexandra Aicher, Jiajia Tang, Christopher Heeschen. Single-cell omics: a new perspective for early detection of pancreatic cancer?. European Journal of Cancer 2023; 190: 112940 doi: 10.1016/j.ejca.2023.112940
|
| 752 |
Wenjing Song, Xin He, Pengju Gong, Yan Yang, Sirui Huang, Yifan Zeng, Lei Wei, Jingwei Zhang. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.639246
|
| 753 |
Zekun Lu, Qiangsheng Hu, Yi Qin, Hao Yang, Bingkai Xiao, Weibo Chen, Shunrong Ji, Guangchen Zu, Zhiliang Wang, Guixiong Fan, Xiaowu Xu, Xuemin Chen. SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02899-6
|
| 754 |
Musbau Adewumi Akanji, Heritage Demilade Fatinukun, Damilare Emmanuel Rotimi, Boluwatife Lawrence Afolabi, Oluyomi Stephen Adeyemi. Antioxidants - Benefits, Sources, Mechanisms of Action. 2021; doi: 10.5772/intechopen.94988
|
| 755 |
Dongwook Oh, Jung-Soo Pyo, Byoung Kwan Son. Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9745601
|
| 756 |
Kei Hagiwara, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Dorgormaa Gantumur, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Hiroshi Tanaka, Akira Watanabe, Norio Kubo, Kenichiro Araki, Yasuo Hosouchi, Ken Shirabe. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer. Annals of Surgical Oncology 2020; 27(3): 924 doi: 10.1245/s10434-019-07708-x
|
| 757 |
Wenji Li, Shu Huang, Lihong Xie, Yilin Zhai, Fengqiu Gong. Effect of Nanoknife Ablation Therapy in Patients with Pancreatic Cancer. Journal of Biomedical Nanotechnology 2023; 19(10): 1806 doi: 10.1166/jbn.2023.3675
|
| 758 |
Zhiqing Lin, Ziru Lv, Xin Liu, Keke Huang. Palmitoyl transferases act as novel drug targets for pancreatic cancer. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04098-3
|
| 759 |
Nurbanu Demirtürk, Erem Bilensoy. Nanocarriers targeting the diseases of the pancreas. European Journal of Pharmaceutics and Biopharmaceutics 2022; 170: 10 doi: 10.1016/j.ejpb.2021.11.006
|
| 760 |
Jiaqi Chen, Hui Chen, Tongchao Zhang, Xiaolin Yin, Jinyu Man, Xiaorong Yang, Ming Lu. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. Pancreatology 2022; 22(5): 608 doi: 10.1016/j.pan.2022.04.011
|
| 761 |
Balraj Singh, Sydney Fasulo, Parminder Kaur, Beenish Faheen, Sarah Ayad, Sachin Gupta, Michael Maroules. Pancreatic cancer presenting with pulmonary cannonball lesions. Radiology Case Reports 2021; 16(5): 1179 doi: 10.1016/j.radcr.2021.02.057
|
| 762 |
Tai-Long Chien, Yao-Cheng Wu, Hsiang-Lin Lee, Wen-Wei Sung, Chia-Ying Yu, Ya-Chuan Chang, Chun-Che Lin, Chi-Chih Wang, Ming-Chang Tsai. PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer. Medicina 2023; 59(9): 1531 doi: 10.3390/medicina59091531
|
| 763 |
Wenyan Du, Chengbin Lei, Yanzhen Wang, Yiwen Ding, Peng Tian. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis. Technology in Cancer Research & Treatment 2021; 20: 153303382098852 doi: 10.1177/1533033820988525
|
| 764 |
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital center. Revista de Gastroenterología de México (English Edition) 2021; 86(2): 118 doi: 10.1016/j.rgmxen.2020.04.005
|
| 765 |
Ying Xu, Lunjie Lu, Judong Luo, Lili Wang, Qi Zhang, Jianping Cao, Yang Jiao. Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.683695
|
| 766 |
Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P. Ebert, Nicolai Haertel. A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax). BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4665-2
|
| 767 |
Hongjuan Fu, Jie Zeng, Chang Liu, Yi Gu, Yixin Zou, Hui Chang. Folate Intake and Risk of Pancreatic Cancer: A Systematic Review and Updated Meta-Analysis of Epidemiological Studies. Digestive Diseases and Sciences 2021; 66(7): 2368 doi: 10.1007/s10620-020-06525-7
|
| 768 |
Yoo Jin Choi, Woongchang Yoon, Areum Lee, Youngmin Han, Yoonhyeong Byun, Jae Seung Kang, Hongbeom Kim, Wooil Kwon, Young-Ah Suh, Yongkang Kim, Seungyeoun Lee, Junghyun Namkung, Sangjo Han, Yonghwan Choi, Jin Seok Heo, Joon Oh Park, Joo Kyung Park, Song Cheol Kim, Chang Moo Kang, Woo Jin Lee, Taesung Park, Jin-Young Jang. Diagnostic model for pancreatic cancer using a multi-biomarker panel. Annals of Surgical Treatment and Research 2021; 100(3): 144 doi: 10.4174/astr.2021.100.3.144
|
| 769 |
Wenhou Duan, Suyun Li, Xin Meng, Yanxin Sun, Chongqi Jia. Smoking and survival of breast cancer patients: A meta-analysis of cohort studies. The Breast 2017; 33: 117 doi: 10.1016/j.breast.2017.03.012
|
| 770 |
Sedrah Arif Butt, Øjvind Lidegaardi, Charlotte Skovlund, Philip C. Hannaford, Lisa Iversen, Shona Fielding, Lina Steinrud Mørch, Jung Eun Lee. Hormonal contraceptive use and risk of pancreatic cancer—A cohort study among premenopausal women. PLOS ONE 2018; 13(10): e0206358 doi: 10.1371/journal.pone.0206358
|
| 771 |
A.S. Guerard, A. Ayav, H. Busby, M. Lafitte, H. Rousseau, V. Laurent. Early liver metastases in resectable periampullary cancer: Incidence and risk factors. European Journal of Radiology 2017; 93: 265 doi: 10.1016/j.ejrad.2017.06.005
|
| 772 |
Gang Ma, Guichen Li, Wufeng Fan, Yuanhong Xu, Shaowei Song, Kejian Guo, Zhe Liu. Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Cell Death & Disease 2021; 12(7) doi: 10.1038/s41419-021-03938-8
|
| 773 |
Miguel S. Gonzalez‐Mancera, Saman S. Ahmadian, Carmen Gomez‐Fernandez, Jaylou Velez‐Torres, Merce Jorda, Monica T. García‐Buitrago. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience. Diagnostic Cytopathology 2022; 50(2): 49 doi: 10.1002/dc.24910
|
| 774 |
Yang Yang, Tao Cheng, Peng Xie, Lishan Wang, Hong Chen, Zhangjun Cheng, Jiahua Zhou. PMEPA1 interference activates PTEN/PI3K/AKT, thereby inhibiting the proliferation, invasion and migration of pancreatic cancer cells and enhancing the sensitivity to gemcitabine and cisplatin. Drug Development Research 2022; 83(1): 64 doi: 10.1002/ddr.21844
|
| 775 |
Lucy Nichols, Rachel Lawrence, Hasan Haboubi, Bilal Al-Sarireh, Shareen Doak, Gareth Jenkins. Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study. Mutagenesis 2023; 38(2): 93 doi: 10.1093/mutage/gead006
|
| 776 |
Sabine Naudin, Kuanrong Li, Tristan Jaouen, Nada Assi, Cecilie Kyrø, Anne Tjønneland, Kim Overvad, Marie‐Christine Boutron‐Ruault, Vinciane Rebours, Anne‐Laure Védié, Heiner Boeing, Rudolf Kaaks, Verena Katzke, Christina Bamia, Androniki Naska, Antonia Trichopoulou, Franco Berrino, Giovanna Tagliabue, Domenico Palli, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Petra H. Peeters, H. B(as) Bueno‐de‐Mesquita, Elisabete Weiderpass, Inger Torhild Gram, Guri Skeie, Maria‐Dolores Chirlaque, Miguel Rodríguez‐Barranco, Aurelio Barricarte, Jose Ramón Quirós, Miren Dorronsoro, Ingegerd Johansson, Malin Sund, Hanna Sternby, Kathryn E. Bradbury, Nick Wareham, Elio Riboli, Marc Gunter, Paul Brennan, Eric J. Duell, Pietro Ferrari. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. International Journal of Cancer 2018; 143(4): 801 doi: 10.1002/ijc.31367
|
| 777 |
Che‐Yi Chou, Chiz‐Tzung Chang, Chao‐Jung Chen. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry. Rapid Communications in Mass Spectrometry 2020; 34(S1) doi: 10.1002/rcm.8580
|
| 778 |
Jing Wang, Yaxing Zhang, Qiuyuan Wang, Luyao Wang, Peitong Zhang, Lu sa Mota da Silva. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/4651432
|
| 779 |
Bo Chen, Chuan Hu, Liqing Jiang, Zhouxia Xiang, Ziyi Zuo, Yangjun Lin, Chuan Liu. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma. International Immunopharmacology 2021; 92: 107359 doi: 10.1016/j.intimp.2020.107359
|
| 780 |
Azize Saroglu, Alexander Julianov. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. 2023; doi: 10.5772/intechopen.109524
|
| 781 |
Ksenia Kandurova, Viktor Dremin, Evgeny Zherebtsov, Elena Potapova, Alexander Alyanov, Andrian Mamoshin, Yury Ivanov, Alexey Borsukov, Andrey Dunaev. Fiber-Optic System for Intraoperative Study of Abdominal Organs during Minimally Invasive Surgical Interventions. Applied Sciences 2019; 9(2): 217 doi: 10.3390/app9020217
|
| 782 |
Philipp Schröter, Laura Hartmann, Wolfram Osen, Daniel Baumann, Rienk Offringa, David Eisel, Jürgen Debus, Stefan B. Eichmüller, Stefan Rieken. Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57456-2
|
| 783 |
Amit Dang, Surendar Chidirala, Prashanth Veeranki, B.N. Vallish. A Critical Overview of Systematic Reviews of Chemotherapy for Advanced and Locally Advanced Pancreatic Cancer using both AMSTAR2 and ROBIS as Quality Assessment Tools. Reviews on Recent Clinical Trials 2021; 16(2): 180 doi: 10.2174/1574887115666200902111510
|
| 784 |
Supriya Srinivasan, Austin R. Dosch, Nagaraj S. Nagathihalli. New mechanistic insights into modifiable risk factors that promote pancreatic cancer. Oncotarget 2019; 10(25): 2417 doi: 10.18632/oncotarget.26813
|
| 785 |
Mohammad Roshani, Ghazaleh Baniebrahimi, Mahboubeh Mousavi, Noushid Zare, Reza Sadeghi, Reza Salarinia, Amirhossein Sheida, Danial Molavizadeh, Sara Sadeghi, Farzaneh Moammer, Mohammad Reza Zolfaghari, Hamed Mirzaei. Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers’ progression and diagnosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1014949
|
| 786 |
Varun Suryadevara, Ayan Roy, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Dukhabandhu Naik, Pazhanivel Mohan, Raja Kalayarasan. Incretin based therapy and pancreatic cancer: Realising the reality. World Journal of Gastroenterology 2022; 28(25): 2881-2889 doi: 10.3748/wjg.v28.i25.2881
|
| 787 |
Tugba Basoglu, NalanA Babacan, FatihE Ozturk, Rukiye Arikan, NazimC Demircan, TugbaAkin Telli, Ozlem Ercelep, Faysal Dane, PerranF Yumuk. Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma. Indian Journal of Cancer 2022; 0(0): 0 doi: 10.4103/ijc.IJC_1049_20
|
| 788 |
Carolyn Newberry, Octavia Pickett-Blakely. Geriatric Gastroenterology. 2020; : 1 doi: 10.1007/978-3-319-90761-1_28-1
|
| 789 |
Lu Hong, Liu Xu, Lufei Jin, Kaiwei Xu, Weiwei Tang, Yuchao Zhu, Xuedan Qiu, Jianhua Wang. Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer. Journal of Clinical Laboratory Analysis 2022; 36(6) doi: 10.1002/jcla.24447
|
| 790 |
Margrete Haram, Sofie Snipstad, Sigrid Berg, Patricia Mjønes, Elin Rønne, Jessica Lage, Melina Mühlenpfordt, Catharina De Lange Davies. Ultrasound and Microbubbles Increase the Uptake of Platinum in Murine Orthotopic Pancreatic Tumors. Ultrasound in Medicine & Biology 2023; 49(5): 1275 doi: 10.1016/j.ultrasmedbio.2023.01.014
|
| 791 |
Min-Seok Seo, Jina Yeo, In Cheol Hwang, Jae-Yong Shim. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis. Clinical Rheumatology 2019; 38(11): 3109 doi: 10.1007/s10067-019-04660-9
|
| 792 |
Madiha Niyaz, Mosin S. Khan, Mahboob Ul Hussain, Rauf A. Wani, Omar J. Shah, Syed Mudassar. Expression Undercurrents of Sonic Hedgehog in Colorectal and Pancreatic Cancers. Gene Reports 2018; 12: 310 doi: 10.1016/j.genrep.2018.07.017
|
| 793 |
Dushyant Singh Dahiya, Sumant Inamdar, Abhilash Perisetti, Asim Kichloo, Amandeep Singh, Shantanu Solanki, Dhanshree Solanki, Mohammad Al-Haddad. Decreasing length of stay and inpatient mortality associated with pancreatic cancer hospitalizations: A United States national survey from 2008 to 2017. Pancreatology 2022; 22(5): 590 doi: 10.1016/j.pan.2022.04.008
|
| 794 |
Greta Carioli, Paola Bertuccio, Matteo Malvezzi, Teresa Rodriguez, Fabio Levi, Paolo Boffetta, Carlo La Vecchia, Eva Negri. Cancer mortality predictions for 2019 in Latin America. International Journal of Cancer 2020; 147(3): 619 doi: 10.1002/ijc.32749
|
| 795 |
Sejun Park, Kabsoo Shin, In-Ho Kim, Taeho Hong, Younghoon Kim, Jahee Suh, Myungah Lee. Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression. Journal of Clinical Medicine 2023; 12(16): 5394 doi: 10.3390/jcm12165394
|
| 796 |
Samer Alkassis, Omid Yazdanpanah, Philip Agop Philip. BRCA mutations in pancreatic cancer and progress in their targeting. Expert Opinion on Therapeutic Targets 2021; 25(7): 547 doi: 10.1080/14728222.2021.1957462
|
| 797 |
Ling Li, Tao Deng, Qiuying Zhang, Yanlong Yang, Yang Liu, Leyong Yuan, Mingshui Xie. AK4P1 is a cancer‑promoting pseudogene in pancreatic adenocarcinoma cells whose transcripts can be transmitted by exosomes. Oncology Letters 2022; 23(5) doi: 10.3892/ol.2022.13283
|
| 798 |
Tiansheng Cao, Hongsheng Wu, Tengfei Ji. Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and its application value. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1086309
|
| 799 |
Mark Stasiewicz, Marek Kwaśniewski, Tomasz M. Karpiński. Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers. Cancers 2021; 13(15): 3784 doi: 10.3390/cancers13153784
|
| 800 |
Daniel C. Osei-Bordom, Gagandeep Sachdeva, Niki Christou. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.788869
|
| 801 |
Ashika D. Maharaj, Stella Samoborec, Sue M. Evans, John Zalcberg, Rachel E. Neale, David Goldstein, Neil Merrett, Kate White, Daniel Croagh, Charles H.C. Pilgrim, Peter Evans, Brett Knowles, Trevor Leong, Jennifer Philip, Marty Smith, Liane Ioannou. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. HPB 2020; 22(2): 187 doi: 10.1016/j.hpb.2019.09.002
|
| 802 |
Yu Gao, Yunfei Ma, Mingwei Yu, Guangda Li, Yuhan Chen, Xiaoxiao Li, Xinjie Chen, Ying Xie, Xiaomin Wang. Poultry and Fish Intake and Pancreatic Cancer Risk: A Systematic Review and Meta-Analysis. Nutrition and Cancer 2022; 74(1): 55 doi: 10.1080/01635581.2020.1869276
|
| 803 |
Kirsty Logan, Fiona Pearson, Ryan PW. Kenny, Sanjay Pandanaboyana, Linda Sharp. Are older patients less likely to be treated for pancreatic cancer? A systematic review and meta-analysis. Cancer Epidemiology 2022; 80: 102215 doi: 10.1016/j.canep.2022.102215
|
| 804 |
Faustino Mollinedo, Consuelo Gajate. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer. Cancers 2021; 13(16): 4173 doi: 10.3390/cancers13164173
|
| 805 |
Hanzhang Zhu, Yuqiang Shan, Ke Ge, Jun Lu, Wencheng Kong, Changku Jia. EIF3B promotes cancer progression in pancreatic cancer. Scandinavian Journal of Gastroenterology 2021; 56(3): 281 doi: 10.1080/00365521.2020.1868566
|
| 806 |
Kaitlin M. Dailey, James M. Small, Jessica E. Pullan, Seth Winfree, Krysten E. Vance, Megan Orr, Sanku Mallik, Kenneth W. Bayles, Michael A. Hollingsworth, Amanda E. Brooks, Kadiam C. Venkata Subbaiah. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. PLOS ONE 2023; 18(11): e0289183 doi: 10.1371/journal.pone.0289183
|
| 807 |
Richard Drexler, Kim C. Wagner, Mirco Küchler, Bernd Feyerabend, Moritz Kleine, Karl J. Oldhafer. Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2020; 146(5): 1125 doi: 10.1007/s00432-020-03175-0
|
| 808 |
Sebastian Lundgren, Patrick Micke, Jacob Elebro, Margareta Heby, Ina Hrynchyk, Björn Nodin, Karin Leandersson, Artur Mezheyeuski, Karin Jirström. Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.558169
|
| 809 |
Abdullah K. Malik, Angela Lamarca, Ajith Kumar Siriwardena, Derek O'Reilly, Rahul Deshpande, Thomas Satyadas, Saurabh Jamdar, Aali Sheen, Mairead McNamara, Richard Hubner, Juan Valle, Nicola De Liguori Carino. The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal Adenocarcinoma. Pancreas 2020; 49(2): 201 doi: 10.1097/MPA.0000000000001486
|
| 810 |
Cancan Zhou, Jie Li, Weikun Qian, Yangyang Yue, Ying Xiao, Tao Qin, Qingyong Ma, Xuqi Li. Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway. Biomedicine & Pharmacotherapy 2020; 127: 110126 doi: 10.1016/j.biopha.2020.110126
|
| 811 |
Siouxsie Otterwell, Mark J Baker. Assessment and management of a person experiencing pain from pancreatic cancer ascites: a case study. British Journal of Nursing 2022; 31(5): S16 doi: 10.12968/bjon.2022.31.5.S16
|
| 812 |
Jiandong Liu, Shanshan Jiang, Xinghua Yang, Xiaoqiang Li, Ning Wang. The Significant Value of Preoperative Prognostic Nutritional Index for Survival in Pancreatic Cancers. Pancreas 2018; 47(7): 793 doi: 10.1097/MPA.0000000000001089
|
| 813 |
Nasrina Abdin, Bhanu Pratap Sahu, Sheikh Sofiur Rahman. A Review on Formulation and Evaluation of Nanoniosomal Topical gel of Paclitaxel for skin cancer. Research Journal of Pharmacy and Technology 2022; : 2849 doi: 10.52711/0974-360X.2022.00476
|
| 814 |
Sangeetha Shyam, Darren C. Greenwood, Chun-Wai Mai, Seok Shin Tan, Barakatun-Nisak Mohd Yusof, Foong Ming Moy, Janet E. Cade. Major dietary patterns in the United Kingdom Women's Cohort Study showed no evidence of prospective association with pancreatic cancer risk. Nutrition Research 2023; 118: 41 doi: 10.1016/j.nutres.2023.07.007
|
| 815 |
Rong Tang, Xiaomeng Liu, Wei Wang, Jie Hua, Jin Xu, Chen Liang, Qingcai Meng, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi. Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01900-4
|
| 816 |
Wei-Tao Zhang, Ji-Jun Zhang, Quan Shao, Ying-Kai Wang, Jie-Peng Jia, Bo Qian, Xiao-Wen Tian, Wen-Ji Yan. FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577. Oncology Reports 2021; 47(1) doi: 10.3892/or.2021.8232
|
| 817 |
Sumit Sahni, Christopher Nahm, Christoph Krisp, Mark P. Molloy, Shreya Mehta, Sarah Maloney, Malinda Itchins, Nick Pavlakis, Stephen Clarke, David Chan, Anthony J. Gill, Viive M. Howell, Jaswinder Samra, Anubhav Mittal. Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00237
|
| 818 |
Marinos Pericleous, Shahid A. Khan. Epidemiology of HPB malignancy in the elderly. European Journal of Surgical Oncology 2021; 47(3): 503 doi: 10.1016/j.ejso.2020.03.222
|
| 819 |
Julio Iglesias-Garcia, Daniel de la Iglesia-Garcia, José M. Olmos-Martinez, José Lariño-Noia, J. Enrique Dominguez-Muñoz. Differential diagnosis of solid pancreatic masses. Minerva Gastroenterologica e Dietologica 2020; 66(1) doi: 10.23736/S1121-421X.20.02646-X
|
| 820 |
Thomas Seufferlein, Pascal Hammel, Jean Robert Delpero, Teresa Macarulla, Per Pfeiffer, Gerald W. Prager, Michele Reni, Massimo Falconi, Philip A. Philip, Eric Van Cutsem. Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence. Cancer Treatment Reviews 2019; 77: 1 doi: 10.1016/j.ctrv.2019.05.007
|
| 821 |
Kartick Pramanik, Monish Makena, Kuntal Bhowmick, Manoj Pandey. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer. International Journal of Molecular Sciences 2018; 19(12): 3890 doi: 10.3390/ijms19123890
|
| 822 |
Chengxia Kan, Na Liu, Kexin Zhang, Di Wu, Yunzi Liang, Weiqin Cai, Qi Jing, Fang Han, Shunjie Xing, Xiaodong Sun. Global, Regional, and National Burden of Pancreatic Cancer, 1990–2019: Results from the Global Burden of Disease Study 2019. Annals of Global Health 2023; 89(1): 33 doi: 10.5334/aogh.4019
|
| 823 |
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal Cancers. Translational Oncology 2019; 12(3): 475 doi: 10.1016/j.tranon.2018.11.010
|
| 824 |
Cheng Yang, Junqiang Li, Yongdong Guo, Dongxue Gan, Chao Zhang, Ronglin Wang, Lei Hua, Liaoliao Zhu, Peixiang Ma, Jingjie Shi, Shanshan Li, Haichuan Su. Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.756895
|
| 825 |
Jefferson Zhi Jie Tang, Laurence Weinberg. A Literature Review of Intrathecal Morphine Analgesia in Patients Undergoing Major Open Hepato-Pancreatic-Biliary (HPB) Surgery. Anesthesiology and Pain Medicine 2019; (In Press) doi: 10.5812/aapm.94441
|
| 826 |
Kei Hagiwara, Norifumi Harimoto, Kenichiro Araki, Akira Watanabe, Norio Kubo, Seshiru Nakazawa, Toshiki Yajima, Nobuyuki Uchida, Ken Shirabe. Long-term survival of two patients with pancreatic cancer after resection of liver and lung oligometastases: a case report. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-01029-y
|
| 827 |
Arjun Chatterjee, Neha Sharma, Amandeep Singh, Matthew Franklin, Rajat Garg, Prabhleen Chahal. Synchronous Pancreatic Masses. ACG Case Reports Journal 2023; 10(4): e01037 doi: 10.14309/crj.0000000000001037
|
| 828 |
Steve Dagenais Bellefeuille, Caroline M. Molle, Fernand-Pierre Gendron. Reviewing the role of P2Y receptors in specific gastrointestinal cancers. Purinergic Signalling 2019; 15(4): 451 doi: 10.1007/s11302-019-09678-x
|
| 829 |
Alexandre Sauriol, Euridice Carmona, Molly L. Udaskin, Nikolina Radulovich, Kim Leclerc-Desaulniers, Robert Rottapel, Amit M. Oza, Stephanie Lheureux, Diane M. Provencher, Anne-Marie Mes-Masson. Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30081-5
|
| 830 |
Maedeh Amini, Mehdi Azizmohammad Looha, Sajjad Rahimi Pordanjani, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Marianna De Camargo Cancela. Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease study 2019 data. PLOS ONE 2023; 18(7): e0288755 doi: 10.1371/journal.pone.0288755
|
| 831 |
Liqiong Yang, Yun Bai, Qing Li, Jie Chen, Fangfang Liu, Xiechuan Weng, Fan Xu. Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.695645
|
| 832 |
Marianne Birke Englid, Maria Jirwe, Helen Conte. Perioperative Comfort and Discomfort: Transitioning From Epidural to Oral Pain Treatment After Pancreas Surgery: A Qualitative Study. Journal of PeriAnesthesia Nursing 2023; 38(3): 414 doi: 10.1016/j.jopan.2022.06.007
|
| 833 |
A. Gueiderikh, A. Tarabay, M. Abdelouahab, C. Smolenschi, M. L. Tanguy, M. Valery, D. Malka, T. Pudlarz, A. Fuerea, V. Boige, A. Hollebecque, M. Ducreux, A. Boilève. Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12016-z
|
| 834 |
Bangqiang Xu, Qianwen Zhang, Xiaohui Chang, Dan Zhang, Genqiang Chen, Shi He, Yanfeng Wang, Yangmeng Feng, Hong-Xing Wang. Detection of carbohydrate antigen 19-9 by a diamond solution-gate field-effect transistor sensor. Materials Letters 2022; 318: 132116 doi: 10.1016/j.matlet.2022.132116
|
| 835 |
Weiyang Cai, Wenming Bao, Shengwei Chen, Yan Yang, Yanyan Li. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02378-w
|
| 836 |
Nadezda Lipunova, Anke Wesselius, Kar K Cheng, Frederik J van Schooten, Jean-Baptiste Cazier, Richard T Bryan, Maurice P Zeegers. Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer. Biomarkers in Cancer 2019; 11: 1179299X1989725 doi: 10.1177/1179299X19897255
|
| 837 |
Youfu Zhang, Jinran Yang, Xuyang Wang, Xinchang Li. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99544-x
|
| 838 |
João Godinho, Mafalda Casa-Nova, João Moreira-Pinto, Pedro Simões, Francisco Paralta Branco, Luísa Leal-Costa, Ana Faria, Fábio Lopes, José Alberto Teixeira, José Luís Passos-Coelho. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer—A Retrospective Analysis. The Oncologist 2020; 25(2): e284 doi: 10.1634/theoncologist.2019-0510
|
| 839 |
Jianhui Yang, Jin Xu, Bo Zhang, Zhen Tan, Qingcai Meng, Jie Hua, Jiang Liu, Wei Wang, Si Shi, Xianjun Yu, Chen Liang. Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(20): 10944 doi: 10.3390/ijms222010944
|
| 840 |
Milton Rahman, Letora Washington. The seemingly innocuous presentation of metastatic pancreatic tail cancer: a case report. Journal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2125-5
|
| 841 |
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon-Koon Yoong, Azlina Abdul-Aziz, Sarni Mat-Junit, Perumal Subramanian. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review. International Journal of Molecular Sciences 2022; 23(4): 2093 doi: 10.3390/ijms23042093
|
| 842 |
Catalina Gómez‐Peñaloza, Mónica L. Serrano‐Arévalo, Lidia F. Villegas‐González, Lorena Flores‐Hernández, Leonardo S. Lino‐Silva, Erika B. Ruiz‐García, José Diaz‐Chávez. Addition of analysis of KRAS mutation or immunohistochemistry with MUC1 and carcinoembryonic antigen improves the diagnostic performance of fine needle aspiration cytology for the diagnosis of pancreatic carcinoma. Cytopathology 2019; 30(5): 485 doi: 10.1111/cyt.12697
|
| 843 |
Lucas B. Tavares, Antônio F. Silva-Filho, Mario R. Martins, Kamila M. Vilar, Maira G. R. Pitta, Moacyr J. B. M. Rêgo. Patients With Pancreatic Ductal Adenocarcinoma Have High Serum Galectin-9 Levels. Pancreas 2018; 47(9): e59 doi: 10.1097/MPA.0000000000001126
|
| 844 |
S. Afsar, Rahamat Unissa Syed, Mohammed Khaled Bin Break, Ruba Hamoud Alsukaybi, Reem A. Alanzi, Abeer Mohammed alshobrmi, Noura Mohammad Alshagdali, Ammar D. Alshammari, Fayez Mohammed Alharbi, Abdulaziz Mutlaq Alshammari, Wadaah F. Algharbi, Khadijah Mansour Albrykan, Fayhaa Nafea Alshammari. The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling. Pathology - Research and Practice 2024; 253: 155018 doi: 10.1016/j.prp.2023.155018
|
| 845 |
Changjie Shao, Juntao Zhang, Jing Guo, Liang Zhang, Yuhan Zhang, Leiyuan Ma, Chuanxin Gong, Yaqi Tian, Jingjing Chen, Ning Yu. A radiomics nomogram model for predicting prognosis of pancreatic ductal adenocarcinoma after high-intensity focused ultrasound surgery. International Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2023.2184397
|
| 846 |
Annah Morgan, Michelle Griffin, Lionel Kameni, Derrick C. Wan, Michael T. Longaker, Jeffrey A. Norton. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. Biology 2023; 12(8): 1044 doi: 10.3390/biology12081044
|
| 847 |
Yangyang Xu, Wei Liu, Zheng Long, Lijun Wang, Maigeng Zhou, Peng Yin. Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11258-7
|
| 848 |
Levan Tsamalaidze, Horacio J. Asbun, Roland Montenegro Costa, Luciano D. Olival, John A. Stauffer. Pancreaticoduodenectomy in Patients with Previous Roux-en-Y Gastric Bypass: a Matched Case-Control Study. Obesity Surgery 2020; 30(1): 369 doi: 10.1007/s11695-019-04068-z
|
| 849 |
Md Bayazid Hossen, Md Ariful Islam, Md Selim Reza, Md Kaderi Kibria, Md Abu Horaira, Khanis Farhana Tuly, Md Omar Faruqe, Firoz Kabir, Md Nurul Haque Mollah. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer. Computers in Biology and Medicine 2023; 152: 106411 doi: 10.1016/j.compbiomed.2022.106411
|
| 850 |
Jesse Fest, Lisanne S Vijfhuizen, Jelle J Goeman, Olga Veth, Anni Joensuu, Markus Perola, Satu Männistö, Eivind Ness-Jensen, Kristian Hveem, Toomas Haller, Neeme Tonisson, Kairit Mikkel, Andres Metspalu, Cornelia M van Duijn, Arfan Ikram, Bruno H Stricker, Rikje Ruiter, Casper H J van Eijck, Gert-Jan B van Ommen, Peter A C ʼt Hoen. Search for Early Pancreatic Cancer Blood Biomarkers in Five European Prospective Population Biobanks Using Metabolomics. Endocrinology 2019; 160(7): 1731 doi: 10.1210/en.2019-00165
|
| 851 |
Ying‑Bo Zhang, Hong‑Xin Fei, Jia Guo, Xiao‑Jie Zhang, Shu‑Liang Wu, Li‑Li Zhong. Dauricine suppresses the growth of pancreatic cancer in�vivo by modulating the Hedgehog signaling pathway. Oncology Letters 2019; doi: 10.3892/ol.2019.10790
|
| 852 |
Elizabeth C. Little, Jennifer D. Kubic, Ravi Salgia, Paul J. Grippo, Deborah Lang. Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer. Oncology Letters 2017; 13(6): 4027 doi: 10.3892/ol.2017.5956
|
| 853 |
Eric Y. Lian, Brandy D. Hyndman, Serisha Moodley, Sarah M. Maritan, Lois M. Mulligan. RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma. Oncogene 2020; 39(41): 6493 doi: 10.1038/s41388-020-01448-z
|
| 854 |
Erin N. McAndrew, Hanbo Zhang, Pascal Lambert, Rebekah Rittberg, David E. Dawe, Christina A. Kim. Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy. American Journal of Clinical Oncology 2022; 45(2): 55 doi: 10.1097/COC.0000000000000882
|
| 855 |
Yongjun Nai, Chao Pan, Xueteng Hu, Yong Ma. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR‐539. Cancer Medicine 2020; 9(2): 757 doi: 10.1002/cam4.2724
|
| 856 |
Lukas M. Braun, Simon Lagies, Rhena F. U. Klar, Saskia Hussung, Ralph M. Fritsch, Bernd Kammerer, Uwe A. Wittel. Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures. Cancers 2020; 12(6): 1440 doi: 10.3390/cancers12061440
|
| 857 |
Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe. Potential of Mac‐2‐binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer Science 2024; 115(4): 1241 doi: 10.1111/cas.16087
|
| 858 |
Przemysław Dyrla, Arkadiusz Lubas, Jerzy Gil, Marek Saracyn, Maciej Gonciarz. Dynamic Doppler Ultrasound Assessment of Tissue Perfusion Is a Better Tool than a Single Vessel Doppler Examination in Differentiating Malignant and Inflammatory Pancreatic Lesions. Diagnostics 2021; 11(12): 2289 doi: 10.3390/diagnostics11122289
|
| 859 |
Lin Shan, Chen Hao, Zheng Jun, Cai Qinghe. Histone methyltransferase Dot1L inhibits pancreatic cancer cell apoptosis by promoting NUPR1 expression. Journal of International Medical Research 2022; 50(3): 030006052210884 doi: 10.1177/03000605221088431
|
| 860 |
Manuel Gentiluomo, Verena A. Katzke, Rudolf Kaaks, Anne Tjønneland, Gianluca Severi, Vittorio Perduca, Marie-Christine Boutron-Ruault, Elisabete Weiderpass, Pietro Ferrari, Theron Johnson, Matthias B. Schulze, Manuela Bergmann, Antonia Trichopoulou, Anna Karakatsani, Carlo La Vecchia, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote, Bas Bueno-de-Mesquita, Roel Vermeulen, Torkjel M. Sandanger, J. Ramón Quirós, Miguel Rodriguez-Barranco, Pilar Amiano, Sandra Colorado-Yohar, Eva Ardanaz, Malin Sund, Kay-Tee Khaw, Nicholas J. Wareham, Julie A. Schmidt, Paula Jakszyn, Luca Morelli, Federico Canzian, Daniele Campa. Mitochondrial DNA Copy-Number Variation and Pancreatic Cancer Risk in the Prospective EPIC Cohort. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(3): 681 doi: 10.1158/1055-9965.EPI-19-0868
|
| 861 |
Manuel Gentiluomo, Paula Puchalt García, Alice Alessandra Galeotti, Renata Talar-Wojnarowska, Christine Tjaden, Francesca Tavano, Oliver Strobel, Juozas Kupcinskas, John Neoptolemos, Péter Hegyi, Eithne Costello, Raffaele Pezzilli, Cosimo Sperti, Rita T Lawlor, Gabriele Capurso, Andrea Szentesi, Pavel Soucek, Pavel Vodicka, Martin Lovecek, Thilo Hackert, Giulia Martina Cavestro, Anna Caterina Milanetto, Federico Canzian, Daniele Campa. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients. Carcinogenesis 2019; 40(4): 544 doi: 10.1093/carcin/bgz006
|
| 862 |
Xiaolin Zhu, Tingting Zhang, Ye Zhang, Hao Chen, Jianbo Shen, Xinxin Jin, Jinhuan Wei, Erhao Zhang, Mingbing Xiao, Yihui Fan, Renfang Mao, Guoxiong Zhou. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2. Cellular Signalling 2020; 66: 109470 doi: 10.1016/j.cellsig.2019.109470
|
| 863 |
Dapeng Xu, Rong Qin, Ming Li, Jun Shen, Yongmin Mao, Kai Tang, Aiguo Zhang, Dafeng Wang, Yingzuo Shi. Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma. Medicine 2022; 101(46): e29683 doi: 10.1097/MD.0000000000029683
|
| 864 |
Christopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, Kristin Trone, Amanda Stratton, Ali N. Gunesch, Amy Ivy Liu, Alaaeddin Alrohaibani, Maedeh Mohebnasab, Solange Bassale, Alison Grossblatt-Wait, Dove Keith, Fouad Attia, Erin W. Gilbert, Charles D. Lopez, Adel Kardosh, Emerson Y. Chen, Kenneth G. Bensch, Nima Nabavizadeh, Charles R. Thomas, Skye C. Mayo, Brett C. Sheppard, Aaron Grossberg. Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications. Cancers 2022; 14(3): 609 doi: 10.3390/cancers14030609
|
| 865 |
Aida Cristina Rahy-Martín, Francisco Cruz-Benavides, Mar Sánchez-Lauro, Álvaro Rodríguez-Méndez, Íñigo San Miguel, Pedro Lara, Joaquín Marchena-Gómez. Intraoperative Radiotherapy With the Intrabeam® Device for the Treatment of Resectable Pancreatic Adenocarcinoma. Cirugía Española (English Edition) 2018; 96(8): 482 doi: 10.1016/j.cireng.2018.09.009
|
| 866 |
Joseph M. Herman, Helen Kitchen, Arnold Degboe, Natalie V. J. Aldhouse, Andrew Trigg, Mary Hodgin, Amol Narang, Colin D. Johnson. Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment. Quality of Life Research 2019; 28(11): 2929 doi: 10.1007/s11136-019-02233-6
|